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7Preventing drug use is a universal challenge, and identifying which approaches work
– and why they work – is a specific challenge for evaluators. In evaluating preven-
tion programmes, not only must the measures of success be established, but a way
must also be found to attribute the outcomes either to the programme itself or to
some other factor. In addition, it must be possible to compare the effectiveness of 
different types of intervention in very different settings. This means identifying 
measures of effectiveness that span the entire prevention field.
None of this is easy, but the potential rewards are enormous. The very process of
evaluation can increase communication and ensure that experiences and results are
pooled. This sharing of information, in itself, can help in developing future high-
quality prevention interventions.
Why a monograph on evaluating drug prevention?
A mere glance at the map of Europe indicates the plethora of philosophies, projects,
activities and organisations that exist in the region, all claiming to reduce the
demand for drugs. But a closer look at these thousands of interventions reveals that
surprisingly few have either been studied or been shown to be demonstrably 
effective. There are many depressingly familiar reasons for this lack of transparency
and scrutiny, in other words for this lack of evaluation.
• Lack of interest – prevention activities are often carried out in an ad hoc manner,
as an immediate response to what is deemed an alarming problem. The aim is
usually for something to be ‘seen to be done’, and there is seldom any further
assessment, either of the problem itself or of the intervention’s effectiveness.
• Fear – many practitioners and programme-planners fear that they will lose 
funding if evaluation shows that their approach is ineffective. Thus they often opt
for a ‘soft’ evaluation and simple number crunching, rather than undertaking any
deeper, more critical analysis.
• Lack of expertise – much of the current knowledge about scientific evaluation has
been monopolised by a few ‘centres of excellence’. These institutions specialise
in scientific assessment on a contract-by-contract basis, and receive a large 
proportion of the funds available for such work. Programme-planners, on the
other hand, often do not know how to evaluate an intervention or even how to
monitor the work of external evaluators.
• Cost – evaluation can be expensive, especially when it is undertaken externally.
Whatever the reasons for it, the lack of rigorous evaluation of drug-prevention 
activities clearly hinders any improvement in, development or quality control of
European programmes. The paucity of evaluation demonstrates that Europe takes a
back seat in assessing prevention. In the long term, the lack of commitment to 
Introduction
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adequate prevention evaluation confirms the scientific community’s view that drug
prevention is extortionate, uncoordinated and unproved, its survival guaranteed
merely because it is ‘sexy’.
This was the situation when the European Monitoring Centre for Drugs and Drug
Addiction became operational at the end of 1995. One of the major goals of this
European Union agency is to improve the image of prevention evaluation in the EU
Member States. This was made explicit in the EMCDDA’s first demand-reduction
Work Programme, which committed the Centre to:
Improving the quality of prevention activities by assessing the state of the art and 
examples of good practice of evaluation in the Member States and by promoting the devel-
opment and improvement of evaluation methodology. 
Within this broad framework, the EMCDDA aims to engender a cultural shift in the
ideology of prevention. If it is to have any meaningful future, prevention must be 
scientifically sound, flexible and open to discussion and review. The use of resources
– both time and money – must also be scrutinised. The Monitoring Centre’s goal is a
simple one: to dispel the fear of evaluation by facilitating clear and simple access to
its methodology. In addition, the EMCDDA seeks to encourage the view of ‘preven-
tion as intervention’, where measuring effects and results is routine and where – from
the outset – activities are implemented flexibly in accordance with clearly defined
objectives. 
This monograph marks one of the first milestones of these efforts. It is not the end result,
but the beginning of the EMCDDA’s project on, and philosophy of, demand reduction.
The EMCDDA programme to evaluate drug prevention
The EMCDDA has initiated a comprehensive programme for evaluating drug pre-
vention. This project involves a number of interdependent elements:
• the organisation of the ‘First European Conference on the Evaluation of Drug
Prevention’, resulting in the publication of this monograph;
• the finalisation of the EMCDDA’s Guidelines for the Evaluation of Drug
Prevention and their worldwide implementation and promotion; and
• the founding of an Evaluation Instrument Bank at the EMCDDA’s Lisbon head-
quarters.
This monograph contains the papers, workshop summaries and a synopsis of the clos-
ing roundtable discussion from the ‘First European Conference on the Evaluation of
Drug Prevention’ held on 12–14 March 1997 at the EMCDDA in Lisbon. Some 80
prevention experts and professionals from all over the world participated in the
Conference, the first in Europe dedicated exclusively to assessing drug prevention. It
was organised to encourage the practice (as well as the theory) of evaluation in
Europe, and to promote higher standards, good practice and quality control. It demon-
strated that ‘prevention works’ and that the resources allocated to such activity and its
evaluation are well invested. 
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At the Conference, the first draft of the EMCDDA’s Guidelines for the Evaluation of
Drug Prevention were presented. These Guidelines – the final version of which form
the companion volume to this monograph – were developed in collaboration with
Munich’s Institut für Therapieforschung (the German National Focal Point in the
REITOX network) and a panel of international experts. 
The Guidelines offer practical advice on how to ensure optimal quality and good
practice in evaluating drug-prevention activities, providing a checklist of all the ques-
tions that need to be addressed when evaluating an intervention, together with
examples of good practice and a glossary of terms. The Guidelines are not only
aimed at professionals working in the drug field, but also at scientists, policy-makers
and others less directly involved. The publication should enable all to ensure that
drug prevention is properly evaluated, and that funding decisions are taken on the
basis of the best possible information.
Another important tool of the EMCDDA’s evaluation project is the Evaluation
Instrument Bank, which follows the structure and philosophy of the Guidelines. The
Bank is a collection of high-quality, widely used instruments, with a general intro-
duction to implementing and adapting these instruments to specific settings. Each
instrument is supported by a commentary, and the Bank is equipped with a search
structure for the easy retrieval of instruments for different purposes and contexts. The
Bank is to be available on the Internet. A report describing the Bank is currently
available at the EMCDDA.
Co-operating partners
The EMCDDA’s evaluation project is carried out in partnership with other European
institutions and groups active in the drug field. One of its major partners is the
Council of Europe’s Pompidou Group, which is currently developing a Handbook for
Prevention. This Handbook is intended as a ‘pick-and-mix’ manual for planning and
implementing drug-prevention interventions. This publication and the EMCDDA’s
Guidelines are complementary and cross-reference each other. 
The European Commission’s COST-A6 programme has also supported several work-
ing groups of European researchers in the drug field. In 1997, one of these groups
published a Delphi study on evaluating prevention, which serves as an in-depth 
consensual report on definitions, boundaries, categories and theoretical models of
prevention evaluation.1 It is largely aimed at researchers and scientists and is intend-
ed to shed light on the conceptual and terminological ‘fog’ of evaluation. The 
terminology used in the Guidelines and in the present monograph accords with that
agreed in the COST-A6 Delphi study.
1 A Delphi study is a technique for identifying a consensus (or differences) in expert opinion about a given
topic and involves at least three waves of questionnaires submitted to an expert panel. A summary 
feedback from the first wave forms the starting point for the questions in the second wave of the study.
10
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Structure of the monograph
This monograph follows the broad structure of the ‘First European Conference on the
Evaluation of Drug Prevention’. 
Part I on the history of, and background to, evaluating prevention presents a broad
overview of the current status of prevention research in Europe and the US, as well
as an introduction to the theoretical foundations of evaluation. 
Part II deals with the technical and practical aspects of evaluation, highlighting some
important examples of research in the field, and providing information on the most
commonly encountered methods, instruments, problems and obstacles.
Part III consists of abridged reports of the Conference workshops. These workshops
illustrated the role the Guidelines could play in the most important and common
areas for drug prevention: the mass media; synthetic drug use; community-based 
initiatives; youth subcultures; schools; and peer groups. The specific features of pre-
vention in these various settings were explained and clarified during the workshops
using the participants’ own unique experiences. 
Part IV summarises the roundtable discussion held at the end of the Conference. A
panel of high-ranking experts and policy-makers debated how best to promote eval-
uation in Europe. In a complex and fascinating exchange, political, societal and 
scientific points of view were shared. It is this debate – one which is still raging –
that will help to clarify the future direction that evaluation in Europe should take.
11
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Introduction
he first three chapters of this monograph describe the history and current 
practice of prevention activities and their evaluation. 
In Chapter 1, Gerhard Bühringer and Jutta Künzel cover the historical development
of prevention and evaluation in Europe, summarising its major results and discussing
possible future developments. While clarifying the boundaries of their study, the
authors’ definitions of relevant terms and related concepts are central to the whole
monograph and will be of particular use to readers in later chapters.
Chapter 2 examines the present state of knowledge in the United States, arguably the
birthplace of prevention research. Zili Sloboda outlines the main efforts of preven-
tion researchers to create the discipline of prevention science, beginning with a 
historical summary that describes the evolving theoretical foundation for the field. The
author then examines the scientific basis for prevention and assesses the influence of
research into the origins of drug misuse. Although it has taken some time to incor-
porate these theoretical findings into practical prevention, the principles on which
effective interventions are based can now be discerned. Sloboda concludes by iden-
tifying the gaps that remain in current knowledge about drug prevention and the
areas on which future prevention research should concentrate.
Chapter 3 acts as a bridge to Part II by introducing the concept of evaluation and
the difficulties this poses for programme-planners. Teresa Salvador-Llivina examines
the questions that should be addressed when evaluating prevention interventions.
While the need to monitor the effectiveness of prevention is now recognised, the
automatic inclusion of evaluation in all prevention programmes is still a long way
off. The author discusses the most common difficulties, barriers and problems,
touching on issues of planning, funding, implementation analysis and reporting.
Salvador-Llivina also details the decision-making process and analyses the benefits
and risks of evaluation, while addressing the use to which unexpected outcomes
can be put and the need to differentiate between such outcomes and the project’s
findings.
t
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Evaluating Preventive 
Intervention in Europe
Gerhard Bühringer and Jutta Künzel
Ever since Europe’s contemporary drug problem first emerged at the beginning of the
1970s, preventive measures have been taken to reduce the number of drug users.
During the 1970s, the political agenda was dominated by treatment efforts, and
tended to focus on and allocate most resources to delivering, analysing and improv-
ing various forms of care. The limited interest in prevention stemmed from an 
equally limited understanding of the factors that can influence or encourage drug
misuse in individuals, communities and societies. 
In the 1980s, prevention became a major area of interest. This was not because the
pool of knowledge had expanded, but rather because a growing body of evidence
from studies of treatment outcomes had called its effectiveness into doubt. At the
same time, epidemiological data demonstrated that the scale of the drug problem
had not diminished significantly.
More sophisticated scientific concepts, however, were still required to explain the
factors that influence the onset of drug use, and those that can lead to a harmful 
pattern of drug use or to the cessation of such behaviour. The scientific methodology
was only partly available and, in practice, preventive activities rarely included 
evaluation as an integral tool for monitoring and improving the quality of the work.
Since then, major steps have been taken, both in developing scientifically based
theories of prevention, and in implementing them across Europe. Much of this
scientific know-ledge derives from the United States (see Chapter 2), but there is also
a strong tradition of prevention in Europe, especially in the United Kingdom and
Scandinavia (Cázares and Beatty, 1994; Leukefeld and Bukoski, 1991; Künzel-
Böhmer et al., 1993, 1994).
Drugs, prevention and evaluation: some definitions
Drugs
The term ‘drugs’ is used in prevention evaluation to describe illicit drugs as identi-
fied by international treaties. For practical purposes, no distinction is made here
between these drugs (for instance, between ‘soft’ and ‘hard’ drugs), even though
approaches that classify drugs according to their assumed individual or social risks
can be found in nearly all European states.
Chapter 1
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Psychoactive substances 
The term ‘psychoactive substances’ (or simply ‘substances’) is used to include other
drugs – such as alcohol and tobacco – that affect the central nervous system. It is
essential to include such substances in any discussion of prevention – despite social
and legal differences – for the following reasons: 
• The use of any psychoactive substance enhances the risk of using others (for
example, early alcohol and tobacco consumption increases the risk of illicit drug
use – Herbst and Kraus, 1995).
• Many factors known to be responsible for the onset of drug use (such as family
or peer-group influences) are largely independent of the specific substance used.
• Different substances appear to have biological similarities (for example,
cannabis, opiates and alcohol).
• It is more efficient for prevention activities to address all substances, rather than
to develop different programmes for different drugs.
• If a prevention intervention is to be credible to the young, it must include licit
substances which young people see adults abusing on a daily basis.
For these reasons, most primary drug-prevention programmes do not differentiate
between substances. Information on specific drugs is clearly necessary, but providing
such information does not play a major role in many preventive activities.
Prevention
The term ‘prevention’ indicates any activity that seeks to reduce or delay the onset
of drug use over a given period. While this definition may seem like common sense,
researchers, politicians and practitioners all understand the word differently. Figure 1
illustrates some of the more common interpretations of the term ‘prevention’. 
Health professionals usually define prevention as any demand-reduction activity
intended to modify behaviour and so reduce the desire for drugs. In many cases, this
approach is further limited to primary prevention – reducing the wish to begin taking
drugs. Using the current jargon, this means strengthening ‘protective factors’ and
weakening ‘risk factors’. Both groups of factors could relate to an individual’s genetic
make-up and personality, or to their familial, social and physical environment.
Criminal-justice experts, politicians and probably most of the general public under-
stand prevention to mean supply reduction. The less available a psychoactive 
substance, the less likely the onset of drug abuse. Examples of prevention to reduce 
supply include price controls and taxation, limiting access to the substance, public
safety and, of course, the threat of punishment. This last approach can range from
fines for driving while drunk to total prohibition.
Others stress that prevention is best carried out by raising awareness and promoting
‘healthy living’ among the population at large. These activities can include public-
information campaigns, explicit commitments from politicians to keep the issue at
17
Chapter 1
Figure 1: Different concepts and intervention strategies in the field of prevention
Demand reduction
Primary                  Secondary                  Treatment                      Tertiary
prevention                 prevention                interventions                 prevention
Supply reduction
Promoting awareness of the problem within the general population
1. Mass-media campaigns
2. Public commitment of politicians
3. Preventive intervention training for relevant others
4. Financial support
1. Price, taxation
2. Limiting access:
• partial or total prohibition
• monopolies
• rationing
• controlling number of outlets
• controlling availability
• regulating drinks according to strength
• regulating hours and days of sale
• protecting children and young people
3. Public safety:
• workplace
• traffic
4. Threat of punishment
1. Protective and risk factors affecting the onset of substance abuse:
• heredity
• family environment (education, modelling)
• peer-group pressures
• social conditions
2. Protective and risk factors affecting heavy substance abuse (early intervention)
3. Protective and risk factors affecting relapse after treatment (relapse prevention):
• external and internal factors
• individual and interactional factors
the top of their agendas, and adequate financial support for prevention and teacher
training.
These different views of what prevention really means illustrate that the term is a
‘movable feast’, depending on who is using it. The variety of concepts is further com-
plicated by secondary and tertiary prevention. In these cases, the aim is not to 
18
Background to Evaluation
prevent the onset of drug use, but to tackle problem drug use or to prevent an individ-
ual who has successfully undergone treatment for drug abuse from reverting to old
habits (‘relapsing’). Both these concepts overlap with contemporary approaches to
treatment (such as early intervention and preventing relapse), which can sometimes
blur the boundaries between preventive and treatment strategies.
The concept of prevention has been complicated even further in recent years by the
introduction of the term ‘harm reduction’, a possible variant on secondary preven-
tion. Harm reduction does not target drug abuse per se, but rather the onset of a
harmful pattern of drug use. In this context, the wish to take drugs is no longer the
focus; instead, the aim is to reduce the negative consequences of continuing drug
use. Whether such an approach really can be classified as prevention or not is
debatable. It can be argued that harm reduction is in fact a pragmatic treatment strat-
egy for those clients unable or unwilling to stop their drug use. At least, the argu-
ment goes, they are being encouraged to change their drug-abuse behaviour in a
way that reduces the harmful consequences as much as possible.
A final confusion for those wishing to understand prevention is the emergence of the
‘civil-rights’ argument into the field. There is growing opposition, in Europe at least,
to the social need to define certain drugs as ‘illicit’. The ‘right to take drugs’ has
become the catchphrase of this approach and, in this light, prevention becomes no
longer preventing drug abuse as such, but promoting certain forms of drug use that
have few or no harmful consequences. If these harmful consequences are seen pre-
dominantly as related to social pressure (punishment, public approbation, and so on)
then preventing drug abuse becomes synonymous with abolishing such penalties
and – in the extreme – with public support for drug use. 
This brief synopsis of the issues involved in defining prevention is not intended to
confuse, but to demonstrate the wide degree of understanding of the issue. The 
variety of approaches to prevention complicates international co-operation and
clearly influences how prevention strategies and activities are evaluated.
A detailed history of the various concepts of prevention would far exceed the scope of
this chapter. Instead, it will focus on preventive activities as a form of primary preven-
tion within the field of demand reduction. This does not mean that other approaches
are ineffective. On the contrary, a recent publication on the social consequences of
alcohol abuse clearly demonstrates the effectiveness of supply-reduction activities (see
Edwards et al., 1994, 1997).
Evaluation
Evaluation has been defined as ‘the systematic application of social research pro-
cedures in assessing the conceptualization and design, implementation, and utili-
ty of social intervention programmes’ (Rossi and Freeman, 1985). Other aspects of
evaluation are discussed later in this monograph, but this chapter addresses two
major misunderstandings of the concept which mirror those in the field of 
prevention. 
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Evaluation is not simply ‘something researchers do’ each time a new prevention 
programme needs to be assessed. Instead, it is an integral part of everyday practical
work. This does not, of course, mean that every single activity has to be accompanied
by a major research project. The level of evaluation in any prevention activity must
be adapted to the given situation. The reason why integrating evaluation procedures
into everyday practice is so vital is that it guarantees constant feedback on the 
actual quality of an intervention. This allows any procedure to be adapted in line with
changes in the field of prevention and new research findings.
The second misunderstanding comes from the belief that prevention activities can
only be evaluated according to their outcome. While this is a major purpose of eval-
uation, it is not the only one. Evaluation must also include a needs analysis to assess
systematically the need for intervention in a particular situation, as well as the design
and development of an effective intervention. In addition, evaluation involves a
process that analyses the quality of the implementation.
A European history of prevention and evaluation
The relationship between prevention and evaluation is a fundamental one. For
example, the effects of different policies on the levels of alcohol-related problems in
various countries could only be analysed once adequate statistical methods had
been developed and epidemiological data collected (Edwards et al., 1994). The rela-
tionship is also a long-standing one (for a more detailed historical analysis, see
Völger and Welck, 1982).
While the Bible is among the first written records to tackle drunkenness (with the
story of Noah’s ‘relief’ after the flood), the first long descriptions of alcohol use can
be found in early Greek literature, which discusses alcohol’s positive and negative
effects and suggests ways to regulate drinking. Homer, for instance, wrote about
Odysseus’ behaviour when drunk; Hippocrates gave detailed medical descriptions
of the factual and assumed consequences of drunkenness; and Plato was one of the
first to draw up drinking regulations according to age (see Preiser, 1982). He
declared that up to the age of 18 boys should not drink at all, and up to the age of
30 they could drink, but only in moderation. After 30, however, getting drunk was
acceptable! Plato also proposed regulations for prohibition, such as during wars, for
all slaves, for drivers, politicians and judges during working hours, for everyone dur-
ing the day and for men and women when trying to conceive. 
In the Middle Ages, the concept that alcohol could be harmful simply did not exist –
excessive drinking was fun (Legnaro, 1982). In fact, rituals that included excessive
drinking were very important, and daily drinking – including getting drunk at least
twice a month – was an essential part of all good medical advice. The literature of the
time is full of the positive consequences of drinking, and no notion of preventive
activities existed. 
With the beginning of the modern age in Europe in the 16th century, the traditionally
positive connotations of excessive drinking began to change. The increasing
20
Background to Evaluation
emphasis on self-control and self-determination was applied to drinking behav-
iour, and drunkenness began to be seen as a sign of weak character. Alcohol lost
its dominant position as a major therapeutic agent in the medical literature, and
regulation re-emerged after 2,000 years. The first temperance organisations sprang
up in Germany in the 1520s and several German parliaments banned ‘raising a
glass’.
At the same time, the previously uncritical use of opium as a cure-all was also 
challenged (Schmitz, 1982). The therapeutic use of opium was described for the first
time as the ultima ratio (‘the last resort’), while medical literature was full of detailed
descriptions of the drug’s negative consequences.
In the 19th century, the Industrial Revolution brought modern techniques to alcohol
production. Prices fell and consumption soared, causing another shift in attitudes
towards excessive drinking. Mirroring the medical profession’s better understanding,
alcoholism began to be seen as a disease rather than as a weakness of character.
The modern Temperance Movement took off in the middle of the 19th century in
Germany, Scandinavia, the UK, a number of other European countries and the United
States. This Movement was encouraged, on the one hand, by doctors wishing to 
tackle alcohol’s effects on health and, on the other, by industrialists wishing to tackle
its effects on their businesses (Levine, 1982). The Temperance Movement changed the
concept of alcohol-related problems by seeing the substance, not the drinker, as the
cause. This left abstinence as the only possible option. Temperance regulated the
drinking behaviour of millions, peaking in the 1920s and 1930s with partial or total
prohibition in Scandinavia and the US. In addition to this clear ‘supply-reduction’
approach, large-scale demand-reduction activities emerged for the first time in the 
latter half of the 19th century. These included mass-media campaigns, pamphlets,
paintings, plays and many other social activities and meetings run by local and 
national ‘temperance societies’. In effect, the Temperance Movement was the first
large-scale prevention initiative in Europe.
However, this initiative was privately run, and it was only at the turn of the 20th cen-
tury that the Movement’s activities spawned the first comprehensive public approach
to alcohol control in Europe. The Scandinavian countries implemented the first 
alcohol-control policy, with partial and total prohibitions, monopolies, high prices,
taxation, rationing and limits on the number of retail outlets and their opening hours.
For the first time, a whole society began to understand the relationship between the
quantity of alcohol consumed and the level of alcohol-related problems in their
country. This was the precondition for what could be defined as the first systematic
evaluation of preventive measures. The Scandinavian supply-reduction policy was
‘evaluated’ in terms of the effect it had on the amount of alcohol consumed, and the
number and severity of alcohol-related problems. 
At about the same time, preventive techniques began to be applied – at least in 
theory – to other psychoactive substances. From 1900–20, the volume of medical
literature produced on the effects of cocaine and opiates led to the first proposals for
concerted supply reduction beyond the general warning given by doctors to their
21
Chapter 1
patients. This emphasis on measures to reduce supply dominated the first half of the
20th century.
In the 1950s, the early seeds of preventive activity in the field of demand reduction
were sown. The need for various demand-reduction activities was formally discussed
at conferences in 1953 and 1959, and although there was almost no scientific
knowledge base, personal experience and intuition produced some very modern
thinking, for example that: 
• attitudes should be changed and accurate information disseminated;
• prevention should not just be drug-specific, but should be related to the whole
person;
• observing parents has a major influence on children’s use of alcohol, whether
positive or negative; and
• a positive family environment is important for avoiding alcohol-related problems
(Deutsche Hauptstelle gegen die Suchtgefahren, 1954, 1961).
In the early 1970s, Bejerot attempted to evaluate Sweden’s supply-reduction 
measures for illicit drugs (Bejerot, 1975). He concluded that liberal laws increase –
and repressive laws decrease – drug use and drug-related problems. This debate is
still as powerful today as it was then, but as the methodology of time-series analysis
was relatively unsophisticated then, it can now be argued that Bejerot’s methodological
analysis does not support his conclusions. 
Despite Bejerot’s findings, there was a move away from supply reduction to demand
reduction in the 1970s, a shift that gained more and more authority as preventive
concepts and programmes became accepted in modern research. Three phases can
be distinguished in the decades since then (Künzel-Böhmer et al., 1993):
• Information dissemination, based on moral principles, factual knowledge and
fear arousal.
• Value clarification, based on concepts of self-worth and developing positive
alternatives to drug use.
• Risk factors and protective factors, based on increasingly strong empirical research.
With hindsight, and given the modern emphasis on scientific analysis, it is hardly
surprising that the concept of evaluation began to increase in importance. In 1979,
the United Nations published a report on measures to reduce the demand for illicit
drugs (United Nations, 1979). This report summarised the major research findings of
the time, and the clear message was that evaluating prevention activities would be
pivotal in future. The report highlighted not only the need for evaluation, but also the
need for a balance of supply- and demand-reduction activities in prevention initia-
tives; the need to educate the public about alternatives to drug use; programmes to
cope with adolescent problems; and the need to incorporate drug-abuse prevention
into health education.
The next step was the UN Expert Group on Drug Abuse Reduction, which met in
Vienna in 1983 (Expert Group on Drug Abuse Reduction, 1983). This Group also
22
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called for a balance of supply- and demand-reduction measures, and for the pro-
motion of ‘positive alternatives to drug use’. For the first time, it urged that licit 
substances be included in prevention programmes, but the Group also demanded
a critical evaluation of fear-based information activities and a positive evaluation of
long-term school, parental and community programmes. For this to be achievable,
the Expert Group recommended training educational staff in schools and 
workplaces and called for simple, ‘off-the-shelf’ evaluation techniques based on an
adaptive learning system that would allow preventive activities to be continually
analysed and improved.
Alongside these conceptual and regulatory developments, the basic information
needed to improve not only prevention, but also its evaluation, was collected and
analysed much more systematically and on a larger scale. By the early 1980s, the
quantity and quality of epidemiological surveys in Europe, and of prevention
research and evaluation technology in the United States, was such that a number of
new techniques and programmes could be developed. Chief among these were:
• the concept of ‘social inoculation’ to resist drug offers (Evans, 1976);
• the Life-Skills Training programme (Botvin and Wills, 1985);
• the evaluation of national mass-media campaigns in Germany, Sweden and the
UK (for example, Bühringer et al., 1994); and
• the evaluation of modern school-based programmes in Greece, the Netherlands
and Scandinavia (for example, Mostriou et al., 1995).
By the mid-1980s, all the necessary components for modern preventive concepts
and interventions were in place. First, epidemiological information about the size
and structure of the problem was widely available. Second, the theoretical concepts
of risk and the factors that could protect against the onset and development of sub-
stance abuse had been developed. Finally, the prevention programmes themselves
that used both this information and theory were well under way, and the first body
of research to evaluate the effectiveness of these approaches was in the public
domain.
Over the last 50 years, the dominant prevention approach has shifted from supply
reduction to demand reduction, and, in the last few years, slightly back again. This
final move seems to be based on an understanding that modern prevention has to use
all the tools available, and that more research is needed to determine the proper 
balance of these approaches.
The current state of evaluation
It is somewhat artificial to define when modern, large-scale prevention activities in
Europe first began, but 1986 is as good a starting point as any. In 1986, the World
Health Organisation (WHO) Regional Office for Europe launched the ‘Healthy City
Network’. Twenty European cities joined together in a common effort to reduce sub-
stance abuse and, for the first time in a large-scale programme, evaluation played an
integral role (WHO, 1994).
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In 1990, the European Community – building on the WHO’s work – increased its
prevention efforts with another large-scale programme. The European Drug
Prevention Weeks of 1992 and 1994 were part of this effort, and three European
Action Plans against drugs, alcohol and tobacco were launched, all of which explicitly
included evaluation.
The high levels of acceptance that evaluation now inspired were graphically demon-
strated in a 1992 survey of over 1,100 European prevention projects. The survey
found that 54% of these projects included some type of evaluation, even though the
quality varied among them (Centro de Estudios sobre Promoción de la Salud, 1992).
Two years later, the Council of Europe’s Pompidou Group launched a three-year
work programme which specifically covered prevention evaluation.
At the same time, the COST-A6 prevention working group concentrated on the ‘eval-
uation of primary prevention’. The group held workshops (on topics as varied as
evaluating drug education in schools and the sociocultural aspects of primary 
prevention) and produced a Delphi study on the format and content of primary 
prevention evaluation.
In 1996, on behalf of the EMCDDA, the Institut für Therapieforschung, Munich,
conducted a survey of European prevention programmes that had already been
evaluated. This survey informed the development of the Monitoring Centre’s
Guidelines for the Evaluation of Drug Prevention, a companion to this volume. The
same year, the EMCDDA published its 1995 Annual Report on the State of the
Drugs Problem in the European Union (EMCDDA, 1996), of which the major con-
clusions relating to prevention were: 
• Prevention today is generally understood to be primary prevention within the general 
strategy of demand reduction, rather than in the field of supply reduction.
• Prevention interventions exist all over Europe, but are predominantly school-based.
• Prevention interventions are based more and more regularly on modern research-based
knowledge.
• Prevention interventions are more regularly evaluated.
The above brief outline has demonstrated that in the last ten years, prevention has
shifted from being a limited research tool to being implemented under the aegis of
European public bodies. This implementation has helped to integrate prevention and
evaluation, so that the result – prevention evaluation – is now a normal and 
necessary part of any co-ordinated action against drug abuse.
Examples of evaluated projects
The following examples of prevention programmes illustrate the types of intervention
currently being evaluated in Europe (Bundeszentrale für gesundheitliche Aufklärung,
1995). The list is not exhaustive, but demonstrates the wide variety of approaches to
evaluating prevention interventions.
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Development of secondary-school drug-educational material (Austria)
In 1991, this programme developed educational materials for teachers to use in 
secondary schools within the general curriculum. The materials contained both
drug-specific and non-specific components. The main theoretical framework was
that poor life skills can precipitate drug problems. The non-specific components,
therefore, aimed to promote such skills and self-awareness in schoolchildren. The
project was evaluated using questionnaires completed by both pupils and teachers
six months after the programme began. In general, both groups assessed the materials
positively. At the end of the project, one-third of the 665 pupils had a more critical
view of their own consumption behaviour.
Evaluating the ‘Mia’s diary’ school programme (Denmark, Finland, Norway, Sweden) 
‘Mia’s diary’ is a school-based prevention programme for pupils aged 13–15
(Nersnaes, 1995), and is used in all the Nordic countries except Iceland. The pro-
gramme, presented in the form of a diary written by Mia, a 15-year-old, takes as its
theoretical basis Botvin’s Life-Skills Training (see Chapter 2). The project’s main aim
is to strengthen social skills, thus enabling children actively to resist pressure to take
drugs. The programme was evaluated in 1994, with data collected from about 1,500
schoolchildren in Denmark, Finland, Norway and Sweden (Nersnaes, 1995). The 
evaluation was carried out using questionnaires completed by a selected group of
classes before and after they had finished the programme. The evaluation found that
the project had increased the level of knowledge about substance abuse, but had not
had any significant impact on attitudes. The lack of attitudinal change was partly
explained by insufficient evaluation methods.
The ‘ALF’ school prevention programme (Germany)
ALF is a life-skills training programme for schoolchildren aged 10–14. It was con-
ducted by trained teachers in Bavarian schools, and – for evaluative purposes – 
compared two versions of the curriculum (with and without specific information
about psychotropic substances). After the first 12 sessions, the evaluation results for
the group that had received specific information about tobacco and alcohol were
very positive. The number of smokers had not increased, whereas the number of
smokers in the control group had nearly doubled.
School-based health-education programme (Greece)
In the late 1980s, a health-education programme to prevent drug abuse was piloted in
two secondary schools (see, for example, Mostriou et al., 1995). Both drug-specific
and non-specific elements were included in the programme, with the latter aimed at
developing life skills. The materials used had been translated from Swedish and English
and then adapted to the Greek environment, and the programme was carried out by
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specially trained teachers. Students were encouraged to participate in community
activities, while community leaders were encouraged to take part in activities aimed at
informing and mobilising the general public on health issues. Evaluation data were
collected from students, community leaders and officials using questionnaires and per-
sonal interviews. The results were positive, especially those related to student attitudes
towards drug use, which shifted in the desired direction.
Drug prevention in schools (Ireland)
From 1992–94, the Substance Abuse Prevention Project was carried out as a pilot
scheme in eight secondary schools in Ireland (Morrow, 1995). During the project,
classroom materials were developed and piloted, teachers implementing the pro-
gramme trained and supported, and interventions started at an organisational level
to maximise school support for the programme’s goals. The programme contained
drug-specific and non-specific elements, and was mainly aimed at developing and
encouraging children’s identity, self-esteem, communication and decision-making
skills. During the trial phase, the project was evaluated. The methods and results
included: 
• teacher feedback on the materials, which was incorporated before the final
printing;
• evaluation of teacher training, which reported a high level of satisfaction; 
• the reactions of teachers and students, which were very positive on the content
of the programme itself, the teaching and the class atmosphere; 
• interviews with head teachers and staff members, which again were very 
positive; and 
• a comparative study (pilot schools versus control schools), which found that chil-
dren at the pilot schools had a more negative attitude towards drugs, greater
knowledge about the consequences of drug use and better developed life skills
than those at the control schools.
Prevention of alcohol and tobacco use in elementary schools (the Netherlands) 
Based on the assumption that 12 is the best age for preventive education, a pro-
gramme for primary schools was established in 1985 (Spruyt, 1995). Its main objec-
tives were to enable children to resist peer pressure and advertising messages, and
to develop a reasonable attitude towards the use of alcohol and tobacco. The 
programme was evaluated between 1985 and 1988. An experimental and a control
group completed questionnaires on four separate occasions (before the programme
began, and six, 12 and 36 months after it ended). Results from the six- and 12-month
follow-ups were encouraging. Knowledge about the risks of smoking and drinking
were good, and delayed the onset of these behaviours. Unfortunately, the effects
appeared to decrease after three years, indicating that continuing the programme is
a very important element.
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Primary drug-prevention programme (Portugal)
In 1989, a community drug-prevention project was set up for young people aged 12–19
in two communities in Portugal. The basis for the project was an epidemiological
study of the psychosocial aspects of drug use, the general interests and drug con-
sumption of the target group (Correia da Silva, 1995). Based on the results of this sur-
vey, an intervention model was developed that included activities in young people’s
groups as well as community interventions. The model aims to promote a healthy
lifestyle, the active participation of young people in the community, knowledge about
jobs and the world of work, and to reduce risky behaviour. The activities were 
evaluated by questionnaires and individual interviews with the participants and their
parents, although this evaluation was geared more towards the project’s ‘effects’ than
its ‘efficiency’.
Conclusions
Taking into account modern drug-prevention theories, current knowledge of the 
initiation and development of substance use and the actual state of evaluation, the 
following conclusions can be drawn.
A comprehensive prevention approach requires both supply- and demand-
reduction measures. Research – especially into alcohol issues, where policy 
differences between countries make comparative evaluation easier – has shown
that demand-reduction measures must be supplemented by supply-reduction
measures (Edwards et al., 1994). While more research is undoubtedly needed to
‘weight’ demand and supply measures correctly, the fact itself can no longer be
questioned.
Modern demand-reduction activities in primary prevention are based on a proba-
bilistic theory of how harmful use develops, and explain it through ‘protective’ and
‘risk’ factors. It is obvious that no single factor is responsible for the development
of drug abuse. Genetic, psychological and environmental conditions all play a role
in this process, both as potential risk and protective factors. This ‘biopsychosocial’
concept means that a broad range of risk factors must be taken into account, and
also that a variety of protective factors must be supported. As with demand and
supply reduction, the relative weight of risk and protective factors is largely
unknown, and so for practical purposes both types of factor should be taken into
account.
Major risk factors include family education and parenting styles (such as lack of
support in identifying problems and a failure to build self-confidence), while sub-
stance use in the family (‘copycat’ behaviour), peer pressure and the general avail-
ability of drugs must also be monitored. This points towards the need for more
activities in the family, especially in early childhood, and indicates that prevention
measures should start early – among six-to-ten-year-olds – before peer-group
influence usurps family influence.
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Major protective factors include promoting certain life skills and drug-specific 
resistance training. As with treatment approaches, prevention evaluation is still in its
infancy and few long-term results of such interventions are available. But those pro-
grammes that have been evaluated clearly support the promotion of certain life
skills, such as self-confidence, problem-solving, communication skills, stress man-
agement and drug-specific resistance training (for example, learning how to refuse
drugs).
Most current prevention is either carried out in schools or via public-information
campaigns, but comprehensive community-based approaches (making use of the
family, youth centres, local businesses, the police, and so on) have also been shown
to improve the outcome. In fact, focusing on families (particularly those with young
children) would perhaps be more beneficial, as well as targeting the workplace and
the health system. On the other hand, ‘one-off’ time-limited prevention activities are
of little value. 
The appropriateness of a particular prevention activity is also crucial. Public-
information campaigns, for example, cannot change harmful use (they may even
increase it) and should not be used for this purpose. Drug users, therefore, should not
be the target group for a public-information campaign. Such campaigns can, however,
promote public awareness and support for financing prevention activities. They can, in
turn, provide support for specific groups, such as parents and youth-club leaders. 
In other words, preventive measures should start early, take a long-term approach
and avoid flashy spectacle. But just as important is the basis for any intervention.
Prevention is only effective with actual experimental research and continual evalu-
ation. Without research, prevention has no foundation; but without evaluation, it has
no future. Continuing evaluation is essential for assessing the initial situation (‘needs
analysis’), for planning and carrying out prevention activities adequately and to a
high standard (‘process evaluation’), and for adapting the approach depending on
the results (‘outcome evaluation’).
Future perspectives
In general, it appears that in the field of drug prevention and its evaluation much
more is known in theory than is implemented in practice. The first and overriding
future need must therefore be to make proper use of research findings. This means
that scientific advances must be communicated to practitioners in a way that they
understand and can use in their daily work. Other vital demands are:
• Both prevention and evaluation must be integral to the job descriptions of local
and regional authorities and practitioners in the health and social-care field. This
is necessary not only for those who specialise in prevention, but also for those
with a broad range of health and social-care responsibilities.
• As with environmental protection, it is absolutely vital that politicians and the
media publicly support drug-prevention activities and the need for continuing
evaluation.
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• More research is needed into the balance between supply and demand reduction
in prevention. Until recently, this discussion has been predominantly influenced
by beliefs rather than by scientific knowledge. While accepting the place for 
values, the debate is sterile without research into the balance between the two
approaches.
• More research is needed into early family intervention, peer-group intervention
and intervention in the workplace. While there is some knowledge of risk and
protective factors, the major role of family education/parenting styles and 
modelling behaviour, as well as peer-group influence, is neither reflected in the
level of research nor in the level of practical actions.
Ultimately, however, it must be acknowledged that the progress made in the last
decade is astonishing. After many years of imperceptible change and one-off, unsup-
ported prevention activities, public and scientific awareness of large-scale research
projects and prevention intervention in Europe since 1985 has soared. It is now
abundantly clear that the concept of prevention will play an increasingly important
role in European, national and local health and social politics.
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State of the Art
of Prevention Research
in the United States
Zili Sloboda 
In the United States, research into preventing drug abuse has evolved, slowly and
painfully, into a science. This evolution required the development not only of 
measurement instruments, but also of evaluation methodologies – both experimental
and non-experimental – and the creation of a detailed epidemiological knowledge
base. Furthermore, sound behavioural-change theory and a clear understanding of
the pharmacological effects of drugs were vital if prevention researchers were to
develop theories and effective strategies to tackle drug abuse. 
At the outset, it is important to differentiate ‘research’ from ‘evaluation’ from ‘sci-
ence’. Each term addresses different questions and issues. Research is the process
used to discover a set of principles or laws that have been replicated through sys-
tematic approaches. Evaluation is a research approach that specifically determines
the level of effectiveness of an intervention strategy. In the United States, the attempt
to integrate both research and evaluation in order to specify principles of prevention
established prevention science. This process relied on a set of empirically based 
theories, accepted terminology, standardised measurements, and agreed research
designs and data-analysis methodologies.
In 1989, in a bid to develop the field into a science, the National Institute on Drug
Abuse (NIDA), based in Rockville, Maryland, held a succession of meetings to 
solicit some level of agreement on theory, design, measurement and analytical
approaches. The outcomes of these meetings are documented in a series of 
monographs and papers, and laid the foundations of prevention science. A guide for
prevention planners and practitioners setting out the principles of successful 
prevention intervention was also produced, and the Society for Prevention Research
was established in 1991.
This chapter outlines the often overlooked battle fought by the many unsung 
prevention researchers over three decades. It documents their struggles and their 
victories, and the history of their work highlights the importance not only of good
research approaches, but also of integrating and translating theory into effective
interventions.
Chapter 2
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The history of prevention research in the United States
In a recent paper (Botvin, forthcoming) the author points out:
The goal of identifying effective prevention approaches has been illusive. While many
approaches have increased knowledge of the adverse consequences of using drugs and
some have increased anti-drug attitudes, very few programs have demonstrated an impact
on drug use behavior.
The last 50 years of US research into drug-prevention illustrate Botvin’s point very
clearly. The post-war development of health-related behaviour theory was heavily
influenced by scare tactics used by the United States Army during the Second World
War to discourage negative – and reinforce positive – health behaviour among the
troops. It was this theoretical base, in conjunction with empirical data and informed
observations, that shaped the drug-abuse prevention approaches of the 1950s and
1960s. Since then, US prevention research has progressed rapidly from strategies
emphasising information dissemination and affective education, to social influence
and skills building.
Information-dissemination programmes were based on the presumption that indi-
viduals are capable of rational decision-making. The belief was that once children
knew the negative consequences of drug use, they would choose not to use drugs.
Fear-arousal techniques were sometimes used to emphasise the dangers more force-
fully.
However, evaluations of such programmes have failed to demonstrate any positive
effects on behaviour, although they have shown that knowledge of the harmful
aspects of drugs increased, as, in some cases, did a negative attitude towards drug
use (Swisher and Hoffman, 1975; Dorn and Thompson, 1976; Schaps et al., 1981).
Early research also suggested that the onset of drug use was associated with a degree
of confusion about it. ‘Affective-education’ programmes were therefore developed,
focusing on issues such as ‘values clarification’, ‘self-understanding’ and effective
communication. Again, evaluations failed to demonstrate the effectiveness of such
programmes against drug use, although, once more, many did have an impact on
associative factors, such as feelings of self-worth (Kearney and Hines, 1980; Kim,
1988).
The theoretical and scientific basis for prevention
In the late 1970s, largely supported by the NIDA, a national research programme
was initiated. This consisted of prospective studies of children and adolescents to
determine the origins of, and routes to, drug abuse. In addition, the NIDA designed
a system to monitor household and high-school surveys to give an informed estimate
of the nature and extent of substance misuse. The results of these and other studies
gave researchers a fresh perspective on the origins of drug abuse, and a new era in
which to advance prevention research began.
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Perhaps one of the most important outcomes of the research at that time was the by-
now almost commonplace ability to pinpoint the ‘age of initiation’ into drug use. For
example, the results of long-term epidemiological studies suggest that most drug
users begin between the ages of 12 and 17.
The onset of tobacco and alcohol use, both of which have been associated with the
use of cannabis and other drugs, generally occurs earlier, largely due to the easy
availability and social acceptance of these substances. The ‘sequence’ of use from
tobacco and alcohol to cannabis and then on to other drugs has been a consistent
finding in almost all longitudinal studies of young people (Kandel et al., 1992;
Newcomb and Bentler, 1986). But ‘sequencing’ does not imply ‘inevitability’ – that
because someone smokes cigarettes or drinks alcohol they will automatically use
cannabis or other drugs. Rather, it shows that among tobacco and alcohol users, the
risk of progressing to cannabis is much higher (an estimated 65 times) than if an indi-
vidual had never smoked or drunk. Likewise, the risk of graduating to cocaine is
higher (an estimated 104 times) for those who have taken cannabis than for those
who have not (NIDA, 1996).
No research has been able to explain the mechanisms underlying these connections.
But what these findings suggest is that interventions should focus on children at an
early age and must attempt to prevent or delay the onset of tobacco and alcohol use.
They also suggest that prevention interventions should be appropriately designed for
the developmental stage of the specific age group.
Patterns of use
As well as identifying precisely the age of initiation, research has also uncovered 
patterns of use. Trend analyses of school-age drug use – such as the national survey
of eighth, tenth and twelfth graders (the ‘Monitoring the Future’ study) – have shown
two clear patterns in the prevalence of drug use over time.1 First, they demonstrate
that the use of illicit substances increases with age, with the highest levels of use
among the twelfth graders. Second, the trend analyses show that cannabis use,
which had been declining during the 1980s, began to rise in 1992 across all three
age groups, with continued increases each year, particularly among the younger 
students (Johnston et al., 1996). The challenge facing the prevention practitioner is
to slow this upward trajectory, and the challenge facing the epidemiologist is to
understand why these new increases are occurring. 
Several hypotheses have been posited, but studies addressing this issue are still too
preliminary to be conclusive. It is known, however, that these trends have been pre-
ceded by changes in the students’ perceptions of the harmful effects of cannabis and
1 The ‘Monitoring the Future’ study, supported by a grant from the NIDA since 1974, is conducted by the
Institute for Survey Research of the University of Michigan. Until 1991, the study was administered
annually in the classroom among approximately 17,000 seniors attending a national probability sample
of both public and high schools, beginning with the class of 1975. In 1991, the survey was expanded to
similar numbers of eighth- and tenth-grade students.
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its social acceptability. Earlier, increased negative perceptions had likewise been
associated with decreases in use (Bachman et al., 1990 and 1988). This suggests that,
in order to influence their attitudes, prevention programmes must seek to provide
young people with accurate information about the health risks and consequences of
drug use.
Risk and protective factors
Furthermore, studies that track young people over time clearly show that the process
of initiating or continuing drug use is highly complex, involving many factors. These
range from genetics, biology, personality and psychology to the family, school experi-
ences, peer pressure and environmental influences (Hawkins et al., 1992; Pandina,
forthcoming). The strongest influences on initial drug use, however, are interpersonal
relationships – the family and peer groups. 
Much information is available on ‘family process’ and the initiation of drug-using
behaviour. These factors include the quality of the parent–child relationship and of
parent–child attachment; the quality of parenting; the consistent enforcement of
rules and boundaries; the establishment of a supportive environment; the 
clarification of norms against drug use; and family identification and bonding
(McCord and McCord, 1959; Jessor and Jessor, 1977; Hirschi, 1969; Brook et al.,
1990; Cohen et al., 1990; Cadoret et al., 1986; Shedler and Block, 1990; Demarsh
and Kumpfer, 1986; Kaplan, 1985; Kandel et al., 1978; Pandina and Johnson, 1989;
Patterson et al., 1992).
Interventions that aim to improve parenting practices have actually reduced the
onset of drug use, even when these interventions target adolescents (Bry and Canby,
1986; Friedman, 1989; Lewis et al., 1990; Schmidt et al., 1996). Interventions aimed
at younger children have not followed the subjects for long enough to observe any
impact on drug use (Webster-Stratton, 1984 and 1990), although significant
improvements in parent–child relationships and school behaviour have already been
observed. In fact, for the more vulnerable populations, it has been found that with-
out including the family in the intervention, family functioning can rapidly 
deteriorate, while ‘risk’ can increase not only for the individual, but also for other
family members (Szapocznik and Kurtines, 1989; Dishion and Andrews, 1995;
Dishion et al., 1996). 
In addition, epidemiological studies have found that peers can make drugs accessi-
ble and encourage and reinforce drug use, while ‘peer pressure’ or ‘modelling
behaviour’ is also closely allied to the initiation and continuation of drug use.
Further links have been found between drug use and other social factors, such as
poor school performance, failure to internalise educational norms and lack of iden-
tification with school rules. A number of factors associated with the individual have
also been identified. These include low self-esteem, poor self-control and inade-
quate social coping skills. Other factors identified by the research are tolerance of
deviant attitudes, sensation seeking, stressful life events, depression and anxiety.
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In addition, it has been found that the more of these an individual experiences, the
greater the likelihood of drug use or abuse. This all suggests that prevention 
interventions should address ‘risk’, while also aiming to enhance ‘protective’ factors.
Developmental stages
People are most vulnerable when in transition from one developmental stage to 
another, and thus prevention should occur throughout the life cycle, particularly 
during stressful periods of change. One example is the change children undergo when
moving from elementary school to middle school or junior high, when they often face
social challenges and pressures, such as learning to get on with a wider group of peers.
It is at this stage, early adolescence, that children are likely to encounter drug use for
the first time. Later on, when they enter high school and face further social, psycho-
logical and educational hurdles, they will again be exposed to ‘risk’ situations. Even
when young adults go to college, get married or enter the workforce, they face risks in
their ‘new’ adult environment. Therefore, as risks are present at every transition from
infancy to young adulthood, prevention-planners need to develop programmes that
provide the necessary support at each developmental stage.
Laboratory research
Basic laboratory research is also critical to the design of prevention interventions, not
only because it stretches the bounds of knowledge, but also because it can act as a
credible educational tool or resource to demonstrate the pharmacological and phys-
iological effects of drugs to youngsters.
For example, the new brain-imaging technologies, such as magnetic resonance
imaging (MRI) and computerised axial tomography (CAT) scans, allow the living
human brain to be viewed. This has implications for drug research, because these
techniques can identify the basic brain mechanisms involved in addiction and the
specific areas in the brain where these effects occur (Volkow et al., 1991; Childress
et al., 1995; Altman, 1996). Craving and other physiological processes that are 
significantly altered in the dependent state have also now been understood. Such 
information can be effective in prevention programmes by demonstrating the nega-
tive impact of drugs.
Applying research findings to effective prevention interventions 
Evans and his colleagues (Evans, 1976; Evans et al., 1978) were among the first to
make use of such findings and theories in developing a novel prevention approach –
social inoculation. This approach was used to counter pro-smoking messages from
peers, family and the media by arming children with the skills to identify the source of
the pressure and to resist it. The programme also sought to demonstrate that smoking
was not a normative behaviour. This was the first time that a theoretical basis had been
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applied to the use of illicit drugs. Over the next two decades, variations on the social-
inoculation model were widely tested, and the combination of training in drug-
resistance skills and decision-making, as well as correcting misperceptions of the 
normative nature of drug abuse, has been demonstrated time and again to be effective
in preventing drug use (Hansen and Graham, 1991; Botvin et al., 1995; Pentz et al.,
1989). 
Life-Skills Training
An excellent recent example of a successful programme to have emerged from this
perspective is Life-Skills Training (LST), developed by Gilbert Botvin, which incor-
porates both social-learning theory (Bandura, 1977) and problem-behaviour theory
(Jessor and Jessor, 1977). In this context, drug abuse is viewed as learned and func-
tional behaviour, encouraged by social influences. Life-Skills Training does what it
says – it combines training in basic interpersonal skills with information about the
risks and prevalence of drug abuse, all held together by training in the skills and
knowledge to resist social pressure.
In a recent study of 56 high schools in New York State, LST sessions were given to
seventh graders (with an average age of 13), with booster sessions in both eighth and
ninth grade. By the end of the twelfth grade, students who had received the full pro-
gramme reported significantly reduced levels of tobacco, alcohol and cannabis use
than those who did not receive the training (Botvin, forthcoming).
Adolescent Transitions Program
Other programmes have focused on indirect factors that have been found to
decrease the potential for drug use. These protective factors include good perfor-
mance at school and strong bonds with social institutions, such as the family, school
and church. Given the family’s key role and function in any society, and its central
position in theories of drug-use initiation, it is hardly surprising that the family is the
target and mechanism for many drug-abuse prevention interventions. 
The school-based Adolescent Transitions Program, developed by Thomas Dishion,
specifically focuses on parenting practices. Targeting the families of young adoles-
cents in middle and junior high school, it sets up a ‘Family Resource Room’
equipped with a video and other materials designed to help parents identify risk 
factors. The programme aims to teach effective family-management skills, including
positive reinforcement, monitoring, limit-setting and relationship-building. It also
offers the ‘Family Check-Up’, a service that allows family members to assess any
problems they may be having. They can then seek professional support, either in a
Parent Focus or Teen Focus curriculum. Studies of this and other similar parent-
focused interventions have indicated their effectiveness for high-risk young people,
with repeated booster sessions throughout the period of risk. 
37
Chapter 2
Seattle’s Social-Development Project
Other researchers have focused on the risk factors found in the school setting.
Academic failure, antisocial behaviour, awkwardness and lack of confidence have
all been targeted by effective interventions. One such pilot programme is designed
to promote social bonding through a comprehensive family, school and peer-
focused prevention programme (Hawkins et al., 1992). Using instructional methods,
students are taught about effective learning, co-operation with their peers and posi-
tive attitudes towards school. They are also taught peer-refusal skills to help them
resist social pressure to use drugs. At the same time, parents are trained to increase
their children’s involvement in the family and teach them to withstand peer pressure.
Preliminary results for this programme (preliminary, because the children in the
study are only now entering adolescence) reveal positive outcomes in five areas: 
• a reduction in antisocial behaviour;
• an improvement in academic skills;
• increased commitment to school;
• reduced levels of alienation and poor bonding; and 
• reduced misbehaviour at school. 
In addition, fewer incidents of drug-taking on school premises have been reported
(O’Donnell et al., 1995).
The model for this type of integrated, comprehensive approach to preventing drug
abuse is the programme of community-based interventions designed to combat heart
disease in the United States (Farquhar et al., 1990). This approach was founded in turn
on observations by Sechrest (1985) and others (Cassel, 1976) that interventions to
change people’s lifestyle and behaviour had to move from the clinic out into the com-
munity. Despite some initially mixed results, recent findings show that for those most at
risk of cardiovascular illness and death, the comprehensive nature of the programme  –
using a wide range of media and settings – supported change (Winkleby et al., 1994).
Project STAR
Within such general-population programmes, components can also be designed for
the target group – in the case of drugs, children in their pre-teen years. The most 
successful of these programmes was designed by Mary Ann Pentz and her colleagues
and is known as the Midwestern Prevention Program (MPP) or Project STAR –
‘Students Taught Awareness and Resistance’. This project tests five interventions
under controlled experimental conditions in Kansas City and Indianapolis. The core
is the STAR school-based peer-resistance programme. This focuses on the psycho-
social consequences of drug abuse. It corrects misinformation; provides training in
social resistance skills to offset the pressure to use drugs; gives lessons in assertive-
ness and problem-solving; and makes a public commitment to avoid using drugs.
The rest of the programme is built around this core, including education to encourage
better communication between parents and their children, establishing community
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task groups to promote anti-drug activities, and implementing health policies aimed
at eliminating drug use both in schools and in the wider community (for example,
creating drug-free zones and no-smoking areas). A mass-media campaign supports
all these components.
Research has demonstrated positive long-term effects. Students who began the pro-
gramme in junior high school, and whose results were measured in their senior high
school year, showed significantly less use of cannabis (30% less), cigarettes (25%
less) and alcohol (20% less) than children in schools that did not receive the pro-
gramme (Pentz et al., 1989).
Further analyses of these data by MacKinnon and his colleagues (1991) show that the
programme reinforced children’s perceptions of the negative effects of drugs. Their
friends were more intolerant of drug use, while they were better able to communicate
about drugs as well as other problems. The most powerful mediator found to reduce
drug use was the increased perception that friends were intolerant of drugs.
Populations at risk
As well as focusing on risk factors and behaviours, many prevention researchers
have developed programmes specifically for groups most at risk, such as children of
substance abusers or children with behavioural problems. Such interventions are
much more direct than those described above.
One example of this type of intervention is the Strengthening Families programme,
designed by Karol Kumpfer. This is a multi-component, family-focused programme
aimed at six-to-ten-year-old children of substance abusers. There are three elements
to the programme:
• parent training (which aims to improve parenting skills and reduce parental sub-
stance use);
• children’s skills-training (which aims to decrease negative behaviours and
increase socially acceptable ones); and 
• family skills-training (which allows parents and children to learn and practice
their new behaviours and skills). 
The programme comprises 14 two-hour weekly sessions. The parents and children
are trained separately in the first hour, coming together in the second hour for 
family training. After multiple assessments, this programme has been found to
reduce family conflict, improve family communication and organisation, and reduce
youth conduct disorders, aggressiveness and substance abuse (Kumpfer et al., 1996). 
A similar programme is the Reconnecting Youth Program, designed by Leona Eggert.
Under this scheme, young people in ninth to twelfth grade who have been identified
as being ‘at risk’ are taught skills to increase their resilience to their specific risk 
factors (whether substance abuse or suicidal tendencies). The programme has been
shown to improve school performance, reduce drug involvement, decrease deviant
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peer bonding, increase self-esteem and social support, and reduce aggression, stress
and depression (Eggert et al., 1994).
Overall effectiveness of prevention programmes
Recognising the complexity of the paths that lead towards drug use and abuse has
resulted in the development of several broad prevention strategies. Nancy Tobler of
the State University of New York has carried out a meta-analysis of 143 evaluated
prevention interventions (Tobler, 1992). As a result, she identified five prevention
modalities:
• knowledge only;
• affective only;
• peer programmes;
• knowledge plus affective; and
• alternatives.
She then compared the performance of each intervention according to the following
desirable outcomes:
• increased knowledge about drugs and their effects;
• changes in attitudes towards drugs and other deviant behaviours;
• decreased or non-use of drugs;
• enhanced refusal, social and life skills; and
• decreased negative behaviours.
Peer programmes had the greatest effect on several outcomes. The enhancement of
social skills and assertiveness caused by these programmes was generally found to
reduce (or prevent initiation into) drug use. Programmes that offer alternatives to
drug use – providing opportunities for recognition and personal achievement
through involvement in community or ‘self-help’ activities – were found to be most
effective for those most vulnerable to drug abuse.
In a further analysis, Tobler explored predictors of success in the most effective 
programmes. Two important factors were found in all of them. First, the nature and
content of the programme focused on group interaction; and, second, the 
programme was conducted by trained mental-health professionals and counsellors. 
In addition, age-related strategies appeared to be important. Most effective for 
children aged 12–14 were strategies that stressed learning interpersonal and refusal
skills. These programmes provide information about the social pressures to use drugs
and allow the necessary time to practise using these skills. For older children, 
successful programmes were found to include more structured, drug-focused sessions. 
From the above extensive and comprehensive research base, principles or laws for
preventing drug abuse can begin to be elucidated. The following preliminary princi-
ples address the content, structure and delivery of prevention services. 
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Prevention principles for children and adolescents
Prevention programmes should:
• be designed to enhance protective factors and attempt to reverse or reduce
known risk factors; 
• target all forms of drug abuse, including tobacco, alcohol, cannabis and solvents;
• include skills to resist drugs when offered, strengthen personal commitments not to
use drugs, and increase social competency (for example, in communication, peer
relationships, self-efficacy and assertiveness);
• when targeted at adolescents, include interactive methods, such as peer discus-
sion groups, rather than didactic teaching techniques alone;
• include a component for parents or care-givers that reinforces what the children
are learning and that provides opportunities for family discussion since family-
focused prevention has a greater impact than strategies that focus solely on 
parents or children;
• be long term, taking place throughout the school career with repeat interventions
to reinforce the original prevention goals – schools offer opportunities to reach
all populations and are also important settings for specific ‘at-risk’ groups;
• strengthen norms against drug use in all drug-abuse prevention settings, 
including the family, school and the community – as with family interventions,
community programmes are more effective when accompanied by school and
family components;
• be adapted to address the specific nature of the drug-abuse problem in the local
community;
• be more intensive and begin earlier the higher the level of risk experienced by
the target population; and
• be age-specific, developmentally appropriate and culturally sensitive.
Future directions 
Despite the tremendous achievements of drug-prevention, there remain significant
gaps in knowledge. For instance, although much attention has been paid to the 
efficacy of education, information and other interventions for school-age children,
there is still much to be learnt about the influence of the school environment on 
prevention outcomes. Even today, little is known about how the classroom and
school composition influence the effectiveness of interventions. Likewise, very little
is known about school policies on drug use, how they vary and how they are 
implemented. For example, in some schools, children found to be involved with
drugs may be expelled, while in others such children may be referred for 
counselling. What impact such decisions have on school-based drug education
remains to be seen. There is also a general belief that drug prevention must begin
early in the school career, but there is a dearth of research findings about the 
effectiveness of earlier exposure to prevention efforts.
Another critical area that requires more work is that of using early ‘markers’ for later
problems. Research suggests that initial indicators of later problem behaviour can be
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identified as early as elementary school. These markers can include inconsistent and
inadequate parenting practices, physical and/or sexual abuse, a low degree of social
bonding to family and school, and high levels of sensation seeking. But much more
work is needed to understand the relationship between these markers and whether
they have any biogenetic base. Special attention should therefore be paid to children
of alcoholics and substance abusers. This is one area in which epidemiologists can
work more closely with the prevention-intervention researchers to develop reliable
risk profiles and protective-factor configurations that predict drug use.
The final gaps to be filled relate to the use of persuasive communication techniques for
prevention interventions and the diffusion of this cumulative knowledge to practitioners.
As communications research has become more sophisticated, it has become 
equally important for prevention practitioners to tailor their message to their specific
audience through appropriate channels of communication. But not enough research
has been conducted to determine the efficiency and effectiveness of these channels.
Also, while the emerging information highway challenges prevention professionals to
recognise the advantages of new, multiple ways of reaching audiences, it must also
be recognised that competitive, negative uses of those same channels can undermine
preventive efforts. 
Finally, while prevention research has made much progress in developing and
testing new models for family-, school- and community-based programmes, few
replication studies validate these programmes, and even fewer test ways of putting
them into practice. This is a serious gap and one that prevention researchers are cur-
rently trying to address in the United States. The greatest challenge today is to estab-
lish the link between research and the community.
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Barriers and Challenges to Evaluation
Teresa Salvador-Llivina
The purpose of this chapter is not to review why the drug-prevention field should
adopt the practice of evaluation. However, the benefits that sound evaluation
can bring to the field must be borne in mind. Despite current efforts, prevention
intervention is still a relatively new discipline, and only a few proven 
interventions and a limited knowledge base exist. In this context, the grounds for
conducting evaluations become both more urgent and more attractive. 
The following arguments for evaluation have been advanced by a number of
authors (Hawkins and Nederhood, 1987; Klitzner and Stewart, 1990; Green and
Kreuter, 1991; Kumpfer et al., 1993; Muraskin, 1993):
• To determine whether an intervention effectively addresses its stated objectives.
• To verify, document and quantify activities and their effects.
• To allow the intervention’s efficacy and efficiency to be improved.
• To provide a rational basis for decision-making.
• To facilitate informed choices between the different approaches available.
• To provide feedback and systematic assessment to staff about their job
performance.
• To provide a positive forum in which to discuss operational issues that might 
otherwise remain hidden and lead to staff burn-out.
• To act as positive reinforcement for those involved in programme-planning and
implementation.
• To increase public awareness.
• To add credibility to or legitimise programmes, both technically and 
politically.
Many other benefits of evaluation could be added to this list, but this chapter deals
instead with exactly the opposite – the problems that must be faced and addressed
in order to root evaluation firmly within the prevention field.
The first problem in discussing evaluation is one of the general themes of this 
monograph – the diversity of meanings. The very word ‘evaluation’ means different
things to different people. For politicians, the main purpose of evaluation might be
to increase social well-being, control budgets and raise their own electoral 
popularity. For programme staff, however, evaluation might represent an ethical
responsibility to ensure that their approach is ‘sound’, while success, of course,
grants them professional recognition and promotes their prospects. Evaluators and
Chapter 3
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researchers, on the other hand, may simply see evaluation in terms of promoting
‘good practice’ and doing their job well.
All these can be the right reasons if, at the same time, evaluation ultimately leads to
improvements in current interventions and serves as a useful tool with which to plan
future interventions.
The following sections analyse in greater detail some of the main non-methodological
factors that can interfere in, or create difficulties for, any evaluation process. 
Down to earth: the context of evaluation
Some determining factors need to be considered before the main obstacles to 
planning and implementing an evaluation can be described.
Decision-making and allocating resources
For nearly two decades, it has been recognised in Europe that the effectiveness of
prevention interventions should be monitored. Yet implementing evaluation fully
remains a complex task. The literature shows that evaluating outcomes in general,
and medium- and long-term follow-ups in particular, is given a low priority in
planning and funding an intervention.
The theoretical recognition of the need for evaluation is counterbalanced by a
practical lack of European interventions that have been evaluated (see, for example,
European Prevention Assessment System, 1994; Hanewinkel, 1994; European
Commission, 1994; Künzel-Böhmer et al., 1994; Salvador-Llivina and Ware, 1995).
One study that compared national policies in the European Union found that
research into the efficacy of prevention interventions is not defined as a priority in
any Member State (Centro de Estudios sobre la Promoción de la Salud, 1995). With
such a lack of political support, it is extremely difficult to ‘normalise’ evaluation as
an essential part of prevention.
Countries should, therefore, urgently consider including evaluation as a condition
sine qua non for implementing prevention interventions, and a percentage of the
drug budget should be set aside for systematic evaluations. Without such a 
commitment, any progress relies on the voluntary efforts of prevention professionals,
and will, therefore, often suffer from instability and burn-out.
Internal versus external evaluation
In principle, the choice of internal or external evaluation should depend on the
questions the evaluation seeks to answer. It must be remembered that evaluation is
a specialised task requiring highly developed skills, such as experience of
experimental designs, statistics, psychometry and data processing. Ideally, the 
evaluator will also have a comprehensive knowledge of drug prevention, its
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methodology and practice. External evaluators who meet these criteria, and who are
properly integrated with the implementation team, can help to ensure objective and
high-quality evaluations and outcomes. 
In practice, the choice of internal or external evaluation normally depends on the
level of financial support available. Expertise is expensive and most current
interventions cannot afford it. Recognising the scarcity of resources devoted to 
evaluation, it may be more realistic to ask ‘who could?’ rather than ‘who should?’
undertake the evaluation. This, then, raises the question: how can good evaluation
be facilitated by evaluators who are not experts?
Taking these constraints into account, providing implementation teams with 
easy-to-use methods and protocols that enable them to monitor, at least to a certain
extent, their own activities must be considered. This raises new issues, such as the
allocation of resources to training budgets and the distinction between being 
evaluated and conducting an evaluation. Only when these are answered by the field
as a whole can a viable model be drawn up to normalise evaluation within the 
prevention sector.
The basic distinction between evaluation and research
The ‘technology-transfer’ approach sees evaluation as an essential element of the 
scientific process. From this perspective, prevention methodologies and interven-
tions grow from research into application, and evaluation is based on controlled 
trials that allow the programme to be further tested and, hopefully, lead to the 
eventual widespread adoption of the intervention in non-research settings (Schinke
and Orlandi, 1991).
Table 1
Technology-transfer stages Drug-abuse prevention stages
1. Basic research Theory development; data synthesis
2. Applied research Case study; clinical work; exploratory studies
3. Technology development Construction of intervention curricula
4. Evaluation Clinical trials; analogue and outcome
5. Demonstration Field studies with evaluation; focus on population
6. Adoption Use in non-research settings
7. Application in practice Widespread acceptance and use of intervention 
among line practitioners
8. Obsolescence Disuse of old intervention technology; 
evolution to a new technology
Source: Schinke and Orlandi, 1991
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However, reality is more complex than the neat technology-transfer approach 
suggests. In practice, the rationale for a prevention intervention comes not just from
empirically based data, but also from social perceptions and public demands. Thus,
it is also necessary to make a basic distinction between research and evaluation.
The nature of descriptive and explanatory research
Research is the only tool that can definitively establish causal relations and identify
outcomes. It does so by maintaining controlled conditions. However, research 
usually only adds to knowledge over a long period of time. There are broadly two
types of research.
Descriptive research is essentially practice-based, relying on observation, allowing
for population-based trends, and estimating national, regional and local prevalence
and incidence of drug use. It also helps to define the characteristics of those who use
drugs, and identifies risk factors and other conditions associated with drug misuse.
This assists in developing causal hypotheses as well as identifying consequences. 
Explanatory research, on the other hand, is based on causal rationales and calls for
explanations  – hypotheses, tests, methodology and controlled trials (Howard, 1990).
The ultimate purpose of such research is to define the components of effective 
interventions – by measuring intermediate and ultimate outcomes – as well as 
to validate any causal relationships. Furthermore, explanatory research is above all
theory-based, allowing generalisations to be made from one intervention to another,
even though their setting may vary. This incrementally builds up the knowledge base.
Formative and summative evaluation
Evaluation is a very particular form of research that is intended to assess the results
of a non-experimental intervention. As such, and unlike laboratory research, evalu-
ations must cope with the uncertainty of real life (Rossi and Freeman, 1989). As a
recent report stresses (Centre for Substance Abuse Prevention, 1993), evaluations
can therefore suffer from many uncontrollable conditions:
• mid-stream changes in the intervention, leading to new measures of process and
outcome and, usually, a revised evaluation design;
• changes in ‘site’ participation (entire schools dropping out, for instance), 
distorting the initial research design;
• poor retention and high attrition rates at the individual level, that may jeopardise
statistical analysis and the evaluation results in general; and
• strained relationships between the evaluation and implementation teams, 
frequently reflecting different professional incentives, systems and goals.
Despite these challenges, evaluation as a tool for developing knowledge makes two
major contributions. First, its findings can be used directly by the implementation team
to help them improve their interventions (the by-now familiar concept of ‘formative
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evaluation’ – Scriven, 1967). Second, ‘summative evaluation’ allows policy-makers to
make wide-ranging and long-term assessments of interventions in general. 
In this context, then, evaluation’s primary goal is to further knowledge and increase
feedback about the implementation process. Unlike research, it can also pilot new
ideas in the field. This distinction between research and evaluation is vital. If evalu-
ation is to be normalised, it must be flexible – practitioners, teachers, parents and
youth workers everywhere will simply not (and quite rightly) conduct a controlled
trial every time they want to prevent drug misuse. The fear that research strikes into
people sometimes means that nothing is done. Research can also scare people into
believing that evaluation is an impossible task. The challenge is to promote evalua-
tion as necessary and ultimately useful.
Common problems in evaluating prevention
It is difficult to discuss in the abstract the problems faced during an evaluation. The
evaluation process will encounter different obstacles depending on its 
origin – whether it emerged from within the programme, or was foisted on it from
outside. The process may also vary depending on who conducts the evaluation.
Without attempting a comprehensive analysis of all potential situations, this section
outlines some of the most frequent problems faced during evaluations.
Prior problems
Despite its value, evaluation is not always welcomed. Often, a planned evaluation
must overcome several barriers before it becomes part of a programme. Many obsta-
cles arise simply out of fear, the most common being that the data provided by the
evaluation will reveal a fatal flaw in the programme. This derives from a basic
misunderstanding of the potential of evaluation to guide programme activities and
goals. Klitzner and Stewart (1990) suggest that the most common fears are:
• that evaluation poses a threat to those with an investment in the intervention’s
success;
• that an evaluation may interfere in other activities; and
• that resources otherwise allocated to programme activities will be diverted.
A further fear is that the evaluation outcomes will be manipulated by parties who
wish the intervention to fail and will be used to justify long-standing decisions, such
as budget cuts, sackings or postponing certain projects.
Process problems
Once the above obstacles are overcome, the actual implementation of the 
evaluation itself frequently creates further problems that need to be anticipated and
tackled appropriately.
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Many of these problems are methodological (for example, the difficulties 
encountered when seeking a valid sample or ensuring that intermediate variables are
monitored). These aspects have already been discussed in previous chapters. Other
problems with implications for the success or failure of an evaluation go beyond
methodological issues and relate to the practical aspects of implementation.
Institutional problems
This refers to difficulties raised within the organisation that is implementing the 
evaluation. The most likely institutional problem is that the evaluation will create an
understandable resistance to change. Classic institutional inertia could halt a need
for change because implementing the new practices requires investment (in time,
resources or manpower) which is not possible at the time. Furthermore, the required
changes could be seen as unacceptable because they conflict with current 
institutional expectations or with institutional values, and the potential changes
could ultimately be incompatible with the institution’s ideology, thus threatening 
its very raison d’être.
Interpersonal problems
Another group of problems can derive from interpersonal conflicts. Evaluators may be
greeted with a certain degree of distrust or non-cooperation, especially when the
evaluation is external. While the project-implementers are likely to be concerned
with clients and the ‘here and now’, professional evaluators can have a ‘colder’
approach to the situation, one that may not endear them to the project workers.
Another philosophical point of departure is that practitioners often have a messianic
belief in what they are doing, while evaluators systematically question every aspect
of their work. The roots of this may, on the one hand, be the practitioner’s fear of the
evaluator, and, on the other, arrogance on the part of the evaluator.
Technical problems
Many technical difficulties can interfere with the implementation of an evaluation.
The most frequent ones are:
• Inadequacies in the terms of reference. Before implementing an evaluation plan,
terms of reference should be drawn up so that all involved know exactly what is
to be achieved and how success is to be measured. These terms of reference
should be clearly defined during the planning phase, as any weakness can lead
to serious shortcomings in the quality of the whole process. Should the method-
ology be inappropriate, the assessment will be based on false assumptions and
the conclusions will be unsatisfactory.
The most serious mistakes tend to be made when goals are being defined. The
objectives of any evaluation are the key to how successful the process will be. All
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too frequently, however, the aims are unclear or open to different interpretations.
Without well-defined objectives, any measurement will be very difficult. If an
objective cannot be measured, evaluation is impossible.
• Incompatible evaluative needs and models. A poor choice of evaluative model
can cause serious problems for the procedure. It is all too easy to fall into the trap
of using over-sophisticated tools when simpler ones would suffice, and vice
versa. Similarly, if an evaluator is collecting information using inaccurate instru-
ments and the wrong methodology, the results will be founded on misleading
information and therefore lead to the wrong conclusions.
• Lack of technical expertise in the evaluation team. It is vital that the evaluation
team use a statistical consultant to review the model and plans, thus ensuring that
they are appropriately matched. Without such consultation, the analysis may,
once again, reach unsustainable conclusions. 
Operational problems
The practical implementation of the evaluation can also create conflict and 
difficulty. The most common problems are:
• Inappropriate dissemination of evaluation results. Using any unofficial channel to
distribute initial evaluation results (leaking results to people who had no respon-
sibility for the intervention) should be avoided as it creates irregular and often
unmanageable situations.
• Inappropriate timing in reporting the results. An evaluation’s results are often com-
municated to funders and executive bodies after decisions have been made about
the intervention’s future. There may be many valid excuses for such a lack of co-
ordination, but results clearly cannot be used if they have been presented late.
Problems can also arise when only one aspect is emphasised in the initial release of
the evaluation results. This will negatively affect, and certainly bias, any further
decision-making processes.
Challenges for the future
All the difficulties discussed above, although daunting, are not insurmountable.
Obstacles can instead be turned into challenges and barriers into opportunities.
Overcoming fear
Some of the fears discussed above relate to negative results and having no control
over their use. Evaluators must be aware of these fears, and accordingly ensure that
their evaluation reports become useful management tools (Springer, 1990). In other
words, evaluators are responsible for finding ways to make evaluation serve inter-
ventions and not jeopardise them. Evaluation has to become a constructive 
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management tool, if not a trusted companion for interventions (Centre for Substance
Abuse Prevention, 1993).
Experience suggests that the fear of evaluation can be reduced by including project
managers and staff in the planning process. Their contributions should be sought from
the beginning, and they should be given an active role in interpreting the results.
Facing institutional barriers
Before evaluation planning begins – that is, before engaging in a process that might
suggest changes to the programme itself – the project’s capacity to implement struc-
tural or functional alterations should be analysed. This analysis should consider other
‘shaping’ factors, such as political aspects, the financial situation and even group
psychology. By undertaking this simple analysis of what is possible, an organisation
can be spared engaging in a costly process which might lead to inapplicable results.
By simply talking to programme-managers, evaluators can also discover a great deal
about the characteristics of a particular institutional environment, as well as the 
institution’s ability to absorb change.
In the final analysis, evaluators should be realistic, keeping proposals for change
within the realms of the possible. If there is any doubt about the capacity for 
institutional change, the evaluators should suggest several alternative measures to
deal with the problem. In this way, decision-makers will be able to opt for the most
suitable measures.
Dealing with interpersonal misunderstanding
Given the characteristics of the relationship between evaluator and evaluated, it is
very difficult to eliminate totally all sources of conflict. However, some measures can
help to reduce these conflicts as much as possible (Espinoza Vergara, 1986). For
example, evaluators can share and clarify the evaluation’s objectives with the 
participants. Such pooling of ideas can enrich the final evaluation. Furthermore, co-
operation between practitioners and evaluators can be enhanced by involving all
parties in discussions about the evaluation’s objectives. Finally, evaluators should
avoid overloading participants with too many commitments. Programme-managers
and staff are weighed down with work at the best of times, and evaluation should
not add to their burden.
Dealing with unexpected results
High-quality outcome evaluations should be designed to verify, document and
quantify programme activities and their effects. This information can both determine
any unintended effects (whether negative or positive) and identify factors separate
from the intervention that could have affected the outcomes. This is why programme
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teams should learn not to fear unexpected results – they can be beneficial and can
even provide alternative explanations for an apparently failing intervention.
Gottfredson et al. (1990), for instance, reported that a group-counselling intervention
was actually found to increase rather than decrease involvement with drugs.
Fortunately, however, the authors had collected additional information that 
demonstrated that the unintended outcome was in fact due to an increase in negative
peer pressure within the group because only ‘at-risk’ young people were included in
the intervention (Kumpfer et al., 1993). This clearly illustrates the relevance 
of differentiating ‘results’ from evaluation ‘findings’. In other words, identifying 
negative results and their causes is crucial if practitioners and evaluators are to learn
about unforeseen influences and be able to suggest changes that will improve the pro-
gramme’s effectiveness.
Identifying a programme’s weaknesses is just as important as identifying its
strengths. If impacts are not measured in a valid manner, or are hidden because
negative consequences are too unpalatable, then evaluation results will not help
improve a programme – which should, after all, be the ultimate purpose of any
evaluation.
Improving reporting procedures
The presentation of the evaluation results and the link between their availability and
future decision-making processes are the final keys to an evaluation’s success.
The assessment report should be given to all those who request it, and – as discussed
above – the evaluators should also avoid presenting partial material that could be
misunderstood. The completed report must be available in good time so that
informed decisions can be made. This means that the evaluation must finish on
schedule. In the real world, of course, delays do happen, but when they do, 
decision-makers should be informed and any major decisions postponed until 
accurate evaluation information is available.
The other crucial issue that the final report raises is ‘where do we go from here?’ Too
often, evaluative reports end up on an office shelf. Clearly, the recommendations
must be acted upon immediately (although this does not mean that they have to be
implemented immediately). Speed is of the essence, and although decision-making
processes are generally slow, it must be impressed upon all involved that 
social processes – such as the pressure to take drugs – move quickly.
European co-operation to facilitate evaluation
There are no magic solutions to the complex problems of prevention evaluation. The
challenge today is to convince politicians of the need for evaluation. Prevention
evaluation is unlikely to be greatly advanced without the systematic allocation of
resources.
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The recession of the early 1990s has meant that social services in many European
countries have experienced dramatic cutbacks. More than ever, this calls for evalu-
ation to eliminate naïve and ineffective activities. At the same time, the real costs of
evaluation need to be lowered.
The European Union can play a key role in normalising evaluation. European 
institutions can act as a forum for agreeing a set of evaluation standards that can save
time and money – and lives. One of the goals of the Union’s five-year Programme of
Community Action on the Prevention of Drug Dependence is the development of 
‘a strategy for research on the use of appropriate techniques for preventive purposes’.
This present monograph, and the accompanying Guidelines for the Evaluation of
Drug Prevention, are successful examples of the European effort to promote 
this strategy.
On the other hand, the Member States are not starting from scratch. Most European
countries already have isolated but effective experiences of evaluation, and 
well-trained professionals can help to create national policies on evaluation.
Finally, new and imaginative strategies must be explored and tested so that existing
evaluative resources can be used efficiently. Co-operation with research institutes
and universities could provide the key to cheaper evaluation (Ferrer-Pérez, 1985),
while co-ordinating disparate programmes can help to reduce investment in 
manpower, materials, dissemination of good practice and the development of 
measurement instruments.
References
Center for Substance Abuse Prevention (CSAP) (1993) Progress Report. Learning About the
Effects of Alcohol and Other Drug Abuse Prevention, Rockville, MD: CSAP.
Centro de Estudios sobre la Promoción de la Salud (CEPS) (1995), ‘Comparative study on drug
abuse prevention policies of the Member States of the European Union. Background infor-
mation’, in Conference on Drugs Policy in Europe, Brussels: European Commission.
Espinoza Vergara, M. (1986) Evaluación de Proyectos Sociales, Buenos Aires: Humanitas.
European Commission (1994) ‘Integrated approach and general directions of the European
Union’s action to combat drugs (1995–1999)’, unpublished report.
European Prevention Assessment System (EPAS) (1994) COPE, Madrid: EPAS.
Ferrer-Pérez, X. (1985) ‘La evaluación de la prevención del abuso de drogas’, Paper 
presented at the ‘XII Jornadas Nacionales de Socidrogalcohol’, Palma de Mallorca.
Gottfredson, D., et al. (1990) Compendium of Instruments to Measure Drug Use and Risk
Factors for Drug Use, Baltimore, MD: Johns Hopkins University Press.
Green, L., and Kreuter, M. (1991) Health Promotion Planning. An Educational and
Environmental Approach, Mountain View, CA: Mayfield Publishing.
Hanewinkel, R. (1994) ‘Methods of evaluating primary prevention measures’, Paper 
55
Chapter 3
presented at the Seminar ‘Evaluation of Primary Prevention’, International Congress on the
Occasion of European Prevention Week, Aachen.
Hawkins, D., and Nederhood, B. (1987) Handbook for Evaluating Drug and Alcohol
Prevention Programs, Rockville, MD: CSAP.
Howard, J. (1990) ‘Prevention research at NIAAA: confronting the challenge of uncertainty’,
in Rey, K., et al. (Eds) Prevention Research Findings, Rockville, MD: CSAP.
Klitzner, M., and Stewart, K. (1990) Evaluating Faculty Development and Clinical Training
Programs in Substance Abuse: A Guide Book, Bethesda, MD: Pacific Institute for Research and
Evaluation.
Kumpfer, K., et al. (1993) Measurements in Prevention. A Manual on Selecting and Using
Instruments to Evaluate Prevention Programs, Rockville, MD: CSAP.
Künzel-Böhmer, J., et al. (1994) Expert Report on Primary Prevention of Substance Abuse,
Munich: Institut für Therapieforschung.
Muraskin, L. (1993) Understanding Evaluation: The Way to Better Prevention Programs,
Washington DC: Westat, Inc., and US Department of Education.
Rossi, P., and Freeman, H. (1989) Evaluation: A Systematic Approach, 4th edition, Newbury
Park, CA: Sage.
Salvador-Llivina, T., and Ware, S. (1995) ‘Drug abuse prevention policies and research in
Europe: notes for a future agenda’, Drugs: Education, Prevention and Policy, 2(1), 7–15.
Schinke, S., and Orlandi, M. (1991) ‘Technology Transfer’, in National Institute on Drug Abuse
(NIDA) (Ed.) Drug Abuse Prevention Intervention Research: Methodological Issues, Rockville,
MD: NIDA.
Scriven, M. (1967) ‘The methodology of evaluation’, in American Educational Research
Association (AERA) (Ed.) Perspectives on Curriculum Evaluation, Chicago, IL: Rand McNally.
Springer, J. (1990) ‘Learning from prevention policy: A management-focused approach’, in
Rey, K., et al. (Eds) Prevention Research Findings, Rockville, MD: CSAP.
57
Chapter 4
Pa
rt
 I
IEvaluation
in Practice

59
Introduction
art II examines the issue of evaluation in detail. In Chapter 4, Christoph
Kröger presents the conceptual basis of evaluation. He briefly sketches the
different types and aspects of evaluation before examining the diversity and
complexity of a number of prevention-evaluation models in more detail.
Thomas Jertfelt then tackles the practicalities of evaluation and the very real prob-
lems of ensuring that an evaluation report is taken seriously. Any evaluation must be
accepted as a tool for future work, and so it is crucial for all the parties involved to
reach a common understanding of an evaluation’s processes and findings. In other
words, the author concludes, effective evaluation requires public relations and 
communication skills just as much as it requires scientific knowledge.
In Chapter 6, Han Kuipers examines one of evaluation’s more complex methodological
issues – that of ‘mediating variables’. According to the author, these factors, which can
influence drug use, are key to the success or failure of a drug-prevention intervention.
If a programme targets mediating variables that are causally related to drug use, then
that drug-use behaviour can be changed. The difficulty, of course, is to isolate the ‘right’
mediating variable, and by analysing a number of theoretical models that have been
tested in the field, Kuipers gives some examples of how to do so.
Mark Morgan’s chapter discusses the development and implementation of evaluation
instruments. Many of these are similar to those used in epidemiological research, such
as inconsistent application. In many cases, developing evaluation instruments is
assumed to be a simple task, an assumption that has led to the use of inappropriate
instruments, making comparisons between studies difficult. The author argues that
structured questionnaires are among the best ways to measure evaluation outcomes. 
In Chapter 8, Christine Godfrey and Steve Parrott examine the issue of cost-effectiveness
in drug-prevention programmes. Economic evaluation is a well-established field, and
the authors propose adapting existing guidelines for drug prevention. Godfrey and
Parrott outline the questions that economic evaluation techniques could address, as
well as the different types of economic evaluations and the situations in which they
can be applied most appropriately. The authors also compare the different types of cost
and benefit that can be used in an economic evaluation of a drug-prevention 
initiative, and outline the steps necessary to undertake such an evaluation.
Finally, Richard Hartnoll discusses how the science of epidemiology can be of 
practical value to drug prevention and prevention-evaluation research. Using 
concrete examples and models, he demonstrates how epidemiological analysis can
help in assessing problems and needs related to established and problematic drug
use, and in identifying new trends. However, the tools that epidemiology offers have
not always been fully exploited in prevention and prevention research, and Hartnoll
concludes by proposing closer links between epidemiology and prevention, 
research and practice.
P
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Evaluation: Definitions and Concepts 
Christoph Kröger
It is clear from the literature on prevention that the term ‘evaluation’ has no single
meaning. Indeed, there sometimes appear to be as many definitions and classifications
as there are handbooks and evaluators. The phrase ‘evaluating prevention 
interventions’ is therefore misleading, as it suggests that there is only one type of
evaluation. Yet, over the last few years, many individuals and organisations have
been working towards a single concept of ‘evaluation’.
In 1993, the European Commission’s COST-A6 working group on evaluating 
prevention held a series of expert meetings and published a Delphi study in an
attempt to define primary prevention and its evaluation. The result of all this work
has been a comprehensive overview of how to classify prevention evaluation. This
classification is, perhaps, the best place to begin (Uhl, 1997a and 1997b).
Evaluating process and outcome
The most commonly accepted definition of ‘evaluation’ distinguishes between
‘process’, ‘outcome’ and ‘impact’.
Process evaluation refers to the systematic recording of data during an intervention.
It examines all the work carried out by the project staff and the reactions of the 
target population, asking why and how an intervention achieves its results. It does
not, however, evaluate those results.
Outcome evaluation begins where ‘process’ ends – after an intervention has taken
place. It tests whether, and to what extent, the expected results materialised, and
attempts to answer the fundamental question of whether the intervention was 
‘successful’. Outcome evaluation is what most people understand evaluation to be.
Impact evaluation records how the intervention affected people and places beyond the
defined targets and target groups. It looks for unexpected effects, the generalisation of
effects, and the negative as well as the positive impacts of an intervention. 
Generally, little distinction is made between outcome and impact evaluation as both
look at the effects of a given intervention. The term ‘outcome evaluation’ is, 
therefore, commonly used to describe all the effects of an intervention. However, it
is vital to separate process and outcome evaluation, as this creates the framework for
many other evaluation terms and definitions.
Chapter 4
62
Evaluation in Practice
Other concepts extend the process–outcome model to include creating and 
planning the intervention.
Formative and summative evaluation
Another frequently used classification distinguishes between ‘formative’ and ‘sum-
mative’ evaluation (Liedekerken et al., 1990; Uhl, 1997b).
Formative evaluation takes place during the development and piloting of a new
intervention. It may give some insights into effectiveness and efficiency, as it follows
an intervention from the very beginning to its final implementation.
Summative evaluation begins once the intervention has been developed. It attempts
to assess the overall effects of the intervention and asks whether certain effects can
actually be achieved. This type of evaluation is often used to decide whether an
intervention should be continued or stopped.
Formative and summative evaluation also differ methodologically and epistemologically.
Classification by methodology
Evaluation implies the systematic application of social-science research methods to
provide a criterion by which to classify evaluation (Rossi, Freeman and Hofmann,
1988). ‘Experimental’, ‘quasi-experimental’ and ‘non-experimental’ designs can be
distinguished.
Experimental designs employ a ‘control group’ as well as the ‘experimental group’.
Each condition being examined must use both groups, with the experimental group
receiving the intervention, and the control groups either not receiving it, or 
receiving an irrelevant intervention. All groups are pre-tested and post-tested, and
are randomly assigned to the experimental or control condition. 
Quasi-experimental designs are identical to ‘true’ experimental designs except that the
groups are not randomly, but deliberately assigned to the different conditions.
Non-experimental designs investigate only one experimental group. Data can be
collected either before and after the intervention, or only afterwards.
Data quality
The quality of the data collected is yet another way to categorise evaluation.
‘Quantitative’ and ‘qualitative’ studies differ in terms of the instruments used to 
collect evaluation data.
Qualitative studies rely on interviews and field observation for their data. They deal
flexibly with data analysis in order to generate new ideas, hypotheses and theories.
These studies present their results descriptively.
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Quantitative studies use standardised data-collection instruments that deliver so-
called ‘hard’ (empirically based) data. These studies tend to have experimental
designs and apply complex statistical analysis. Experimentally designed quantitative
models are used to test hypotheses and verify theories.
Epistemological aims
Deciding which method to choose is closely related to the epistemological aim of a
particular evaluation – is it simply to document an intervention, or to broaden the
field’s knowledge base? Three paradigms of the epistemological approach have been
identified (Uhl, 1997a).
Descriptive evaluation deals with monitoring, documenting and summarising an 
intervention. It does not attempt to discover new phenomena or to formulate new
hypotheses.
Exploratory evaluation, on the other hand, attempts to develop new ideas and 
theories. It does not test hypotheses, and the results are therefore preliminary.
Confirmatory evaluation sets out to test hypotheses, using commonly accepted
methods (control-group designs, empirical data analysis, and so on).
Phase models
Many classifications of evaluation focus on the development or genesis of an inter-
vention. The distinction between formative and summative evaluation is the basis for
these classifications, two of which are described below.
The Herman model
Herman, Morris and Fitz-Gibbon (1989) distinguish four hypothetical phases 
in an intervention’s life: initiation; planning; implementation; and accountability.
The development of any programme begins with its initiation. This stage identifies
the goals to be accomplished and the needs to be addressed. Evaluation at this stage
helps programme-developers focus their efforts.
In the planning phase, controlled piloting and market testing can be undertaken to assess
the effectiveness and feasibility either of a new programme or of a pre-existing one.
Implementation describes the execution of the programme. Evaluation during this
phase (corresponding to formative evaluation) covers implementation and assesses
the operation of the programme. These efforts allow the intervention to be improved.
Finally, accountability begins once the programme is established. The main aim is to
prove the effectiveness and impact of the intervention, and the evaluation here cor-
responds to summative evaluation.
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The Uhl model
According to Uhl (1997a and 1997b), the process of creating and evaluating a 
programme can be divided into five stages: basic research; prevention research; 
programme development; controlled implementation; and final implementation
with routine application.
Developing a programme begins with basic research. This covers all research areas
relevant to the development of any intervention, although it does not cover preven-
tion itself. These basic research areas include addiction research, developmental and
social psychology, epidemiology, social marketing and developing assessment tools.
At the prevention-research stage, models and theories are developed to describe the
initiation, maintenance, reduction and cessation of substance misuse.
The results of both basic and prevention research form the basis for the development
and evaluation of a prevention programme.
During programme development (corresponding to the formative phase), the interven-
tion is planned and evaluation begins. Ideally, as a first step, preliminary programmes are
developed and evaluated in pre-tests and pilot studies, then are modified and finalised
into an intervention that is ready to be used in the field without major problems.
After a programme has been finalised, its usefulness is confirmed by controlled
implementation. At this stage, feasibility and efficiency should systematically be 
tested under controlled conditions.
The final implementation and routine application begin once the effectiveness of the pro-
gramme has been demonstrated. At this stage, further proof of effectiveness is not central,
and it is more important to ensure that the programme is carried out to a high standard.
The intervention’s implementation is monitored, as are unexpected positive or negative
effects and any changes in the situation which may affect implementation.
Implementation-focused models
Many classifications of evaluation are based on the process–outcome model, focusing
on implementing a prevention intervention. Two such models are described below.
The Rossi–Freeman model
Rossi and Freeman (Rossi et al., 1979 and 1982) have produced a model based on
process–outcome that includes programme planning and differentiates between the 
evaluations of each phase. They identify four types of evaluation research for: programme
planning; monitoring implementation; assessing impact; and measuring efficiency.
The first type of evaluation, programme-planning research, is essential for any new
intervention or for major modifications in pre-existing ones. It attempts to answer the
following questions:
65
Chapter 4
• What is the extent and scale of the problem and who is the target population?
• Has the programme been designed in line with its intended goals, and have the
chances of successful implementation been maximised?
Monitoring programme implementation checks whether the actual implementation
corresponds to the programme design. The following questions are relevant:
• Is the programme reaching the target group?
• Is the programme providing the intended resources, services and other benefits?
Impact assessment monitors the programme’s effectiveness. Questions to ask could be:
• Is the programme achieving its intended results?
• Can these results be explained by any other process unrelated to the programme? 
The key concepts of measuring efficiency are cost–benefit analysis and 
cost-effectiveness analysis (see Chapter 8). Relevant questions are:
• What are the costs of delivering the service and the benefits to the programme
participants?
• Does the programme make the best use of available resources compared to 
alternative uses?
A modified model published in 1982 distilled the four phases into three themes: 
programme concept and design; monitoring and accountability of implementation;
and assessment of programme utility.
The Kok model
Kok and Jonkers (1986) stress the importance of the planning stage. Their model con-
tains five steps in both the planning and evaluation phases. They link the 
relationship between planning and evaluation by using the same keywords for both
phases. 
The five steps in the planning phase are:
• to identify the specific problem to be tackled;
• to identify the relationship between the problem and the problem behaviour;
• to identify the determinants and causes of the behaviour;
• based on this determinant analysis, to identify an appropriate intervention; and
• to decide how to implement the intervention.
In the evaluation phase, the following five steps can be followed:
• to describe the course of the implementation;
• to describe how the intervention was carried out,
• to describe the effects of the intervention on the determinants of behaviour;
• to describe the effects of the intervention on the behaviour itself; and
• to assess how far the intervention has contributed to solving the problem.
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Conclusion
As should by now be apparent, two basic concepts form the core of the scientific 
evaluation models described: process–outcome evaluation; and formative–summative
evaluation. Both concepts differ in the way they look at a programme to be evaluated. The
process–outcome model focuses on the process of implementation, while the formative–
summative model focuses on the process of creating and developing an intervention.
It should also be clear that the literature describes numerous different models, which
rarely employ any common terminology – and when they do, the same terms are
often used differently. For example, the term ‘outcome evaluation’ can be used in a
very specific sense (dealing only with the defined objectives and expected results) or
in a very broad sense, covering all the outcomes. Likewise, the same process will
have a different name in different models  such as ‘accountability’, ‘effectiveness’ or
‘impact’ – when in fact all that is different is the researcher’s own perspective.
These phantom distinctions are carried through into different kinds of evaluation –
quantitative and qualitative approaches, it is argued, exclude each other, while
exploratory and confirmatory studies cannot both be carried out. But in reality, as all
evaluations share the same goal of extending knowledge about a particular inter-
vention, there are more similarities between them than the different models suggest.
The encouraging sign is that, whatever model or terminology an evaluator chooses,
there is, overall, an overwhelming consensus on what evaluation is for.
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Evaluation Planning
Thomas Jertfelt 
There are two approaches to designing any evaluation: the scientific; and the outcome.
The scientific approach concerns those parts of the evaluation that deal, for instance,
with methods, samples and interpreting statistics. Some of these aspects are described
elsewhere in this monograph. This chapter focuses on the outcome of an evaluation or,
to be more specific, its ‘acceptance’. It must, however, be stressed that the scientific
standard is the basis for accepting any evaluation. Put more simply, an evaluation 
succeeds or fails depending on its methodology.
If the evaluation is viewed as a piece of work in its own right and as a springboard to
a new understanding of how to improve a particular intervention, and not (as so often)
simply as a summary and justification of already-completed work, then it soon
becomes clear that an evaluation must be acceptable as a tool for future use. There are
many crucial points in the evaluation process, but, ultimately, if the conclusions and
recommendations are accepted by the principal actors involved, then the evaluation
can play a positive role.
Planning the evaluation is one such crucial point. At this stage – and with the 
participation of the main actors – the ground is prepared for the evaluation and its 
conclusions to be ultimately accepted. In other words, the success or otherwise of the
evaluation not only depends on its scientific integrity, but also on how it is received. It
could, indeed, be said that the evaluation should not be seen simply as a ‘narrative’,
explaining the situation, but as an instrument for developing future prevention activities.
There is nothing worse than an ignored evaluation. Therefore, from the very beginning
of the planning process, the evaluation’s outcome must be prepared pragmatically to
make it acceptable to those who will continue the preventive efforts.
Fundamental planning issues
This section examines, first, the evaluation’s more technical aspects and, second, its
more process-oriented ones. The two, however, cannot function without each 
other – some technical elements drive the process-oriented ones.
Each and every evaluation share a number of objectives. These can include:
• outcomes, relating to the initial objectives and the final target group;
• what actually happened;
Chapter 5
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• why it happened;
• the results of different activities;
• the possible future outcomes of the activities;
• who did what;
• how the resources were used;
• the logistics;
• the time-frame; and
• the relationship between those undertaking the work.
All these minor objectives should lead towards conclusions and recommendations
on how to improve the preventive work – the whole point of the evaluation.
The following brief scheme – which can be seen as a model for structuring any 
planning process – can facilitate evaluation planning. Each section is self-contained
and should be included in the evaluation, while the subsections give brief com-
mentaries on how to tackle the subject.
Background study
A background study clarifies the initial situation and positions of the main actors.
In any evaluation, it is first important to know where the proposal for the inter-
vention originated and what was identified as the problem. Drug use, after all, is
rarely caused by a single factor. The interaction of various elements is the key to
understanding drug use. Thus the evaluator should attempt to find out which
factors were identified and where the priority lay – not forgetting where the 
priority did not lie.
The problem looks different from the perspective of a teenager, a social worker or a
politician. It is essential, therefore, for the evaluator to identify the individual or
organisation that took the lead in defining the phenomenon. It is also important to
assess whether all the parties to an intervention agree that it is necessary. A common
mistake is for organisations to agree to an intervention that they are not happy with
simply as a means of accessing funds. Semantic problems may also arise, with
different parties understanding certain key terms, theories and processes in different
ways.
Finally, it is important to know whether which methodology to use was discussed.
This may seem supplementary, but it is of interest if the intervention is to be 
evaluated seriously. Knowing why one method was chosen instead of another can be
of great value when preparing to analyse the data collected. It also allows external
factors which may have favoured one methodology over another to be examined.
Objective study
Studying the intervention’s objectives can help in understanding its expected effects.
It is essential to consider how the intervention’s aims will affect the identified 
problem. Often, rather than a problem being recognised, solutions are proposed that
do not correspond to the problem. If the methodology has been adequately assessed,
this pitfall can be avoided. 
Just as vital as agreement between all parties about the need for the intervention is
agreement as to its objectives and their interpretation.
Methodological study
This element of evaluation investigates whether the methods used for the intervention
were appropriate, and asks whether the phenomenon actually ‘selected’ them, or
whether other motives influenced the choice of methodology. The relevance of the
methodology should also be discussed with reference to the background study, to see
whether the issue was fully explored at this earlier stage.
Process study
Evaluating the process clarifies the interaction between the parties involved which
will be useful at later stages. Whether and how the target group was included in
planning, executing and evaluating is crucial for the intervention’s integrity, and
the same questions can be asked of all the parties. Whether the participants were 
qualified to fulfil their roles with any enthusiasm should also be addressed here.
As for allocating responsibility, the initiating organisation is often responsible for the
programme, even if others carry out the work. This normally gives the executive
organisation the right to include or exclude others. Thus, analysing the roles of the
actors involved can be crucial if the intervention is to be understood. Closely allied
to the issue of responsibility is ‘communication’. This is not just a technical issue, but
rather a description of who made the decisions during the intervention and how
these were discussed with the other actors.
Resource study
Resources are always of interest when input is measured alongside outcome.
Moreover, the use of resources can say much about why an intervention was 
successful or not. Conventional issues of income and expenditure obviously need to
be addressed. But this is also the point at which to discuss how any financial or
resource decisions affected the intervention. For any evaluation, the use to which
resources – both human and financial – are put is essential.
Involving the main parties
All the areas mentioned above can be addressed by any evaluation. Some are more
difficult than others, but they can all be evaluated. Once this is done, the data can
be easily analysed, conclusions reached and recommendations made.
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The above list is not only a tool for planning, but also a tool for co-operation and
involvement. At each stage, different interpretations will naturally arise which may
lead different parties to different conclusions. Conflict can, however, be avoided by
involving the main participants in the intervention’s planning and implementation.
At least three actors should always be involved here: the final target group; the 
executive organisation; and the funding body.
Ideally, of course, all the relevant actors would be involved in planning the evalua-
tion. But if, for instance, the intervention is a public-information campaign, it may
be difficult to engage the target group and this may ultimately be of little importance
for the outcome. If, however, the intervention relies on community participation,
leaving out the target group is hardly a sensible strategy.
The executive organisation must be involved, and the funding body can choose to
be if it so wishes. But even if the funders decide not to participate directly, they
should be regularly updated about the evaluation’s planning and execution.
An evaluation should satisfy all the main actors, although they will certainly have
different opinions about the intervention’s outcome. The final target group may
ask, ‘was the effort any good for me?’; the executive organisation, ‘did we do what
we promised?’; and the funders, ‘did we get what we paid for?’ The evaluator’s
task is to bring these perspectives together and to make them acceptable to all
parties.
Terms of reference
The first stage is to draw up agreed ‘Terms of Reference’ for the work. Such a 
protocol should ideally contain:
• a background summary of the intervention’s history and the aims of the evalua-
tion;
• information on the evaluation’s objectives, which must include the main goal as
well as supplementary ones, and should be easy to understand;
• a description of the methods to be used in the evaluation;
• an explanation of the different responsibilities of those involved in the evaluation;
• a timetable; and
• an outline of how the information will be reported back (for example, interim
reports, the structure of the final report, and so on).
Once all these issues have been settled, the final evaluation is more likely to be
accepted and its conclusions and recommendations are more likely to be of real
value in the future.
An even stronger way to reinforce the relationship between the evaluator and those
who are being evaluated is to set up an evaluation team. The advantage of such a
team is that it performs both an internal and external evaluation at the same time.
Such a combination of broad knowledge and objectivity (the external evaluator
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should still maintain control over the final report) makes it much easier for the 
evaluation to be accepted both within and outside the programme. The negative
aspect of evaluation teams is their cost.
What is needed for evaluation
Information on the work undertaken
Reports on the intervention itself can be addressed to various target groups, such as
funders, intermediate and final target groups. It is worth comparing these reports to
ensure their compatibility.
Data are also vital not only to the original budget and the financial outcome, but also
to how the funding situation changed during the course of the intervention. It is very
important to analyse whether the financial situation had any impact on the work and
its outcome.
Other information relating to the intervention’s implementation may include con-
tracts with outside experts, records from decision-making meetings, and other
examinations carried out during the intervention (for instance, by a student writing
a thesis on the project, or the report of an individual on work placement).
The people involved
Staff members should be interviewed about the intervention and the final target
group analysed. Any other groups involved during the planning and implementation
stages (such as reference groups, expert witnesses, and so on) should also be asked
about their roles in, and impressions of, the programme.
Media interest
It is also useful to evaluate any media coverage the intervention may have received,
either locally or nationally. If anything has been written about the programme –
either in a book, scientific journal or newspaper – or anything reported by the media,
then it should be examined. Such inputs may actually shed new light on the 
intervention by highlighting any controversial aspects.
Conclusions
This chapter has demonstrated that planning any evaluation involves designing
appropriate methods, and preparing for the final report to be accepted.
If evaluation is seen as a tool to improve and develop future preventive work, then it
is essential to ensure that people accept it and take notice of its recommendations. If
not, the evaluation report – however methodologically sound – will never be used.
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Such a situation must be avoided or, at least, the risk of such an outcome minimised
by involving the main actors in planning, and even executing, the evaluation. In
other words, evaluation requires public relations and communication skills just as
much as it requires scientific knowledge.
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Measuring Outcomes: Methodology, 
Theory and Mediating Variables
Han Kuipers
The social-science discipline of ‘evaluation’ first emerged in the 1960s. During the
following two decades – especially in the United States – it almost became an 
industry. But throughout that first boom, evaluation was essentially a 
non-theoretical, method-driven ‘science’. Even highly respected evaluation
researchers like Scriven (1967) and Suchman (1967) defined their field in 
non-theoretical terms. Within this framework, however, competition was fierce
between those who had opted for the experimental approach (Cook and Campbell,
1979) and those who defended the naturalistic approach (Guba and Lincoln, 1981).
Developing methodology
In classical experimental designs, the ‘experiment’ (or intervention) was manipulated
in a controlled setting in which subjects were randomly assigned to both 
experimental and control groups, measurements were objective, and analysis was
undertaken using proven statistical techniques. By contrast, the qualitative and 
ethnographic methods of the naturalistic approach used trained observers to study 
behaviour in natural settings. Data were analysed using a specific protocol that
enabled researchers to interpret the results and formulate concrete conclusions and
recommendations.
These differing perspectives on evaluation made valuable contributions to the 
development of the field. The intensive debate between researchers helped to form a
large body of knowledge, so that today an established set of instruments, techniques
and procedures is always applied to an evaluation study, while issues such as 
internal validity and bias are no longer real debating points. The naturalistic approach,
with its qualitative methods, has likewise increased awareness of the importance of
social context and has provided valid instruments to measure its influence.
The problem, of course, is that experimental designs are inadequate for evaluating a
broad-based or fluid programme. In such a case, Weiss and Rein (1969) have stated
that the results may be misleading or even artificial. Cronbach (1982) believes that
evaluations that follow an experimental design are not very useful for policy 
decisions because too much attention is paid to trivial issues. That is clearly a seri-
ous problem, since most evaluation exists to provide policy-makers with relevant
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feedback. This has been noted by Chelismky (1977), who reported that programme-
stakeholders believe that most evaluations fail to provide them with relevant and
useful information. This failure is a result not just of using the experimental design,
but also of the evaluator’s inadequate understanding of the problem.
Similar difficulties occur with naturalistic methods. Such methods have failed to
demonstrate clearly that they generate valid and important information that can be
generalised from the specific to the universal (Chen et al., 1988).
As awareness of the deficiencies of traditional approaches has grown, there has been
a shift towards combining qualitative and quantitative methods. Although it is clear
that doing so will be expensive and requires a combination of skills, the benefits
arguably outweigh the costs (Smith, 1986). Smith also proposes that a combined
approach is preferable when:
• a complete description is necessary;
• circumstances indicate that the results of a qualitative study can be generalised;
• a combination of methods might enhance validity; and
• qualitative feedback can influence a stakeholder’s opinions.
Shotland and Mark (1987), however, point out that an evaluation may be more 
difficult to interpret when the different methods used generate conflicting results.
Theory development
One result of this focus on research methods has been to neglect theory 
development for many years. This omission, however, was rectified somewhat in the
1980s with a move towards theory-oriented evaluation. This shift has accelerated in
the last few years, for a number of reasons. First, too many interventions were classi-
fied as ineffective because the focus on methodology meant that a programme’s
effectiveness was often left unaddressed. Second, it was believed that evaluation as
a discipline needed its own theory. Third, closer attention began to be paid to the
format and content of an intervention. Finally, researchers began to believe that
methods should be considered as the means to develop knowledge and not as its end.
The traditional method-oriented approach can be seen as a ‘black-box’ form of 
evaluation. It is a rather simple input–output model which seems not to acknowl-
edge any of the complexity of the social process that takes place when any system
is exposed to an intervention. Lipsey (1987) urges the development of a theoretical
framework to differentiate the causal processes that serve as a basis for planning and
organising evaluation activities. It has also been proposed (Cordray, 1986) that 
evaluation should broaden the evidential basis by actively considering plausible
alternative explanations, by examining implementation procedures and by 
investigating mediating and contextual factors.
This shift towards theory-driven evaluation does not, by any means, herald the rejec-
tion of appropriate research methods. What it does mean, however, is that the
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theory-driven perspective, although developed as a reaction against the traditional 
‘black-box’ approach, has to be seen as an expansion of traditional perspectives
(Chen, 1990).
Theory-driven evaluation and drug prevention
A number of intervention examples have been developed within the field of 
primary prevention in line with this perspective. The most common is the use of a
theoretical framework known as ‘social influences’.
The ‘social-influences’ approach is premised on the fact that actors in the social
environment (parents, peers and the media) can exert great influence – either 
positively or negatively – on young people’s risk-taking behaviour. Youngsters
should therefore be taught and trained to strengthen non-risk-taking behaviour and
to transform their risk-taking into non-risk-taking behaviour. They must be equipped
to identify social pressure both from their peers and from their families, and they
must be taught the skills to resist these pressures. This ‘social-influences’ approach
is broadly based on three theoretical models: Social Learning Theory (Bandura,
1977); Problem Behaviour Theory (Jessor, 1987); and the Theory of Reasoned Action
(Ajzen and Fishbein, 1980).
Mediating variables
These theories provide a framework in which to understand individual and group
health behaviour and to prevent health problems (Flay and Petraitis, 1991; Lorion
et al., 1989). Social Learning Theory’s concept of ‘modelling’ is a case in 
point – non-smoking parents can be a positive model for their children in terms of
smoking behaviour. Such a concept can act as a ‘mediating variable’ within a 
prevention intervention, a variable which has been defined thus:
A variable functions as a mediator if the variable accounts for the relation between 
exposure to the prevention program and the outcome measure.
(Baron and Kenny, 1986)
In other words, a theoretical basis can be constructed for choosing the mediating
variable. The intervention is set up and tested in a way that ensures it will influ-
ence this mediating variable and consequently affect the outcome.
Mediator analysis
In the context of theory-driven evaluation, a prevention programme can be said to
be designed to change mediating variables that are assumed to be causally related
to outcome. If this causal relationship is proven, and if it is also proven that the 
intervention affects the mediating variables, then, all being equal, the prevention 
programme will change the outcome (MacKinnon, 1994).
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Mediating variables can be biological, psychological or behavioural. As discussed
above, drug-prevention programmes based on the social-influences approach have
to be designed to increase resistance skills or to establish conservative norms
towards drug use (Flay, 1985).
Mediator analysis (MacKinnon, 1994) is based on the effect an independent variable
such as exposure to drugs can have on mediating variables, and the link between
programme effects on mediating variables and programme effects on outcome.
Figure 1
Prevention programme       ➟ Mediating variables        ➟ Outcome results
(intervention)                         (parents’ social norms)                (onset of drug use)
Figure 2
Mediator
Independent variable             ➟ Dependent variable
Source: MacKinnon, 1994
➟ ➟
By measuring mediating variables, researchers gain not only vital information about the
prevention intervention, but also increase their knowledge of the theoretical model that
acts as the intervention’s framework. Such an analysis is variously known as ‘process
analysis’ (Baron and Kenny, 1986) or ‘effect decomposition’ (Hayduk, 1987). Neither
term is really suitable, however, as the former also refers to evaluating the implementa-
tion process and the latter is commonly used in non-experimental studies to distinguish
between the direct and indirect effects of an independent variable on outcome. That is
why this author prefers the term ‘mediator analysis’ as introduced by MacKinnon.
Mediator analysis is necessary for several reasons. MacKinnon (1994) lists the most
important ones:
• It provides a check on whether the intervention had the desired effects on the medi-
ating variables.
• It identifies successful and unsuccessful components of an intervention and enables
those who developed it to improve on it.
• It provides information about how the intervention achieved its effects and 
generates more data on underlying mechanisms and processes.
• It tests the theoretical assumptions of the model on which the prevention interven-
tion is based.
Looking more closely at the statistical analysis of mediating variables, it is clear that,
in practice, interventions target a great many mediators and that achieving a 
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completely random selection of subjects is not easy. But even when such a 
selection is possible, it is still difficult to interpret the relationship between 
mediator and outcome. If, for instance, it is felt that an intervention has no effect,
rather than jettisoning the entire programme, as has so often happened in the past,
mediator analysis could provide a more useful interpretation of the reasons for 
failure. It could be argued that individual mediators have some effect (whether 
positive or negative), but that, taken as a whole, they cancel each other out.
The effect of a mediator on an outcome must, of course, be statistically significant.
If not, the only evidence is that an assumed relationship between mediating variable
and health behaviour is unproven. Even then, such an apparently inconclusive result
can still contribute to the development of theory because it questions a theoretical
assumption which may, on closer inspection, have no basis in fact.
Methodological problems
No research methodology is perfect. Often, there is not enough time to be totally
thorough (in undertaking the literature study, planning, piloting, making adjustments
and implementation), affecting the degree to which internal and external validity can be
guaranteed. Evaluators and stakeholders must be aware of these possible shortcomings.
Another aspect is the paradoxical effect that an innovative and radical intervention
may have on its own outcome. Sometimes an intervention is just too ‘interesting’ and
attracts a much larger target group than it can cope with. Such effects can, 
however, end up as mediating variables (media attention, for instance, can reinforce
a desired outcome). But whatever the case, these effects force the evaluator to state
very clearly how the results are to be interpreted.
Examples of evaluation studies
Hansen et al. (1988) conducted an evaluation study in which the effects of three 
alcohol-prevention curricula on a number of hypothesised mediating variables were
tested and compared. The three curricula were based on different mediating 
concepts all derived from the ‘social-influences’ approach: teaching social 
resistance skills; strengthening conservative norms towards drinking; and increasing
understanding of the consequences of alcohol consumption. The results confirm that
the curricula did affect the mediators and the outcome. In other words, the study
adds to the evidence that there is a relationship between the mediating variables and
the targeted behaviour. Furthermore, it demonstrates that the constructed 
interventions have proved effective.
Gorman (1992) reviews a number of evaluation studies to understand more about
the use of theory in developing interventions. The prevention projects 
reviewed – Project SMART (Self-Management and Resistance Training), Project
ALERT, the Life Skills Training (LST) Programme and the Midwestern Prevention
Programme (MPP) – were also developed from the social-influences model, but their
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results illustrate that no single prevention strategy is universally effective. Gorman
argues that this suggests that a comprehensive prevention strategy is not viable and
that interventions should be more specifically targeted at, for example, non-users, 
experimental users or regular users. In addition, the more that is known about 
mediating concepts the better able researchers will be to tailor prevention to 
specific groups and specific health behaviours.
Ellickson et al. (1993) examined the impact of Project ALERT on a number of 
mediating variables believed to affect actual drug use. These variables included 
adolescents’ beliefs in their ability to resist drugs, what they perceive as the 
consequences of drug use, their perceptions of peer use, and their tolerance to drugs
and expectations of further use. A survey of 4,000 US seventh and eighth graders
revealed that the programme affected perceptions about the use of tobacco, alcohol
and cannabis. It showed that the curriculum successfully reduced cognitive risk 
factors, indicating that the social-influence model can have an impact on a broad
range of drug-related beliefs.
The final example is again provided by Hansen (1996). A new prevention 
intervention was tested in a recently published pilot study. The mediating variables
were: a personal commitment to avoid participating in high-risk behaviour; ideals
that conflicted with high-risk behaviour; bonding with ‘pro-social’ institutions; and 
conventional beliefs about social norms. The study’s primary purpose was to 
evaluate the programme’s potential to change variables that had been identified by
empirical research as strong mediators for initial substance use. The conclusion was
that the programme successfully changed the targeted variables which in turn are
heavily correlated to the targeted behaviours.
Conclusion
This chapter has demonstrated that prevention programmes should be based on 
theoretical models. This is because theories can help to target mediating variables,
which should be chosen in accordance with empirical findings. In turn, mediator
analysis can help to interpret the outcome and improve the intervention.
MacKinnon (1994) states that mediator analysis is rarely conducted. Perhaps this will
change in the near future as more researchers become accustomed to analysing the
results of theory-driven evaluation. Hansen argues that recent developments make it
possible (and also vital) to conduct studies that treat mediating variables as an inte-
gral part of programme development and evaluation. His own study (Hansen, 1996)
must be considered as the first example – although hopefully not the last – of the
possibilities that mediator analysis offers for the future.
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Instruments and Measurement 
in Evaluation Studies
Mark Morgan 
Evaluating programmes designed to prevent the onset of drug use has produced
mixed results (Tobler, 1986; Moskowitz, 1989; Morgan, forthcoming). Therefore, the
care and attention that developing and applying evaluative measures require cannot
be overstressed. Appropriate evaluative instruments not only indicate whether or not
an intervention was successful (summative evaluation), but they can also inform the
success of a programme’s implementation (formative evaluation) as well as the ways
in which outcomes are approached.
Reliability and validity
The extent to which measuring instruments, and questionnaires in particular, are a
reliable and valid indicator of substance misuse is central to all evaluation. In 
general, recent evidence supports the conclusions of earlier work that indicate that
questionnaires fare well when compared to other tools, such as physiological 
measures or collateral reports on ‘significant others’ (Akers et al., 1983). Nor is there
much evidence to suggest that additional techniques enhance the validity of a ques-
tionnaire above and beyond that which is obtained under conditions of anonymity
and confidentiality (Evans et al., 1977). 
However, while accepting that self-report items are in principle the most effective
way to gather evaluation information, not all questionnaire designs are equally trust-
worthy. Two of the more salient features that can affect validity and reliability were
isolated in a study by Embree and Whitehead (1993). These features are a question’s
capacity to aid recall, and the extent to which a question prompts a socially desir-
able response. Questions that produce valid and reliable responses, the researchers
concluded, do so for identifiable reasons, and measurement instruments can be 
radically improved by assimilating these particular features. 
Studies of internal reliability demonstrate that questions are notoriously sensitive to
wording. A UK study (Measham et al., 1994) found that 27% of 14–15-year-olds
replied to questions inconsistently, stating that they had tried cannabis in the last
year and then contradicting this in a later answer. It should be noted, however, that
there was a subtle difference between the questions: the first one referred to trying
cannabis; the later one to smoking the drug. But whatever the reason for this 
inconsistency, phrasing is clearly crucial.
Chapter 7
Measurement issues in evaluation
Table 1 below illustrates the measurement questions used in some recent
evaluation studies.
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Table 1: Evaluation studies 
Study/Country Focus Measures
Ellickson et al. (1993) Project ALERT Range of risk factors
US high school versus control groups including beliefs,
attitudes and skills
Donaldson et al. (1994) Evaluation of Project Resistance skills,
US fifth grade Alcohol and Drug Use perception of norms
(ADU)
Botvin et al. (1995a) Comparison of prevention Self-reports for legal
US high school with control group and illegal substances
Botvin et al. (1995b) At-risk minority students Self-reports
US high school targeted with culturally and intentions of legal
appropriate programme and illegal drug use
Gislason et al. (1995) Skills for Adolescence (SFA) Self-reports
Iceland programme versus of prevalence
control groups
Dukes et al. (1996) DARE programme Self-reports of legal 
US high school versus control groups and illegal drug use:
resistance to peer
pressure, self-esteem
Emshoff et al. (1996) Evaluation of programme Outcomes confined
US parents and children designed to enhance to measuring
self- and cultural esteem ‘mediating’ influences 
Gottfredson et al. (1996) Evaluation of programme Outcomes include
US high school targeting school curriculum unobtrusive school
and norms measures (attendance
and suspensions)
Morgan et al. (1996) Comparison of ‘On My Self-reports of legal
Ireland, 14–16-year-olds Own Two Feet’ programme and illegal substances: 
with control group beliefs, attitudes
and intentions
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A number of features emerge. First, it can be seen that self-report questionnaires are
the dominant measurement instrument. While there are clearly other approaches, as
in the unobtrusive measures reported by Gottfredson et al. (1996), these tend to be
used as supplementary data to back up the questionnaires.
Second, most of the studies did not focus exclusively on illegal substances, but 
tended also to be concerned with legal substances, especially alcohol. In some
instances, this resulted in an index of substance misuse that combined alcohol with
other drugs. It is also worth noting that, in most cases, ‘classical’ prevalence terms
were employed, such as lifetime use of a substance, use in the previous 12 months
and use in the previous 30 days. This usually involved some measure of frequency
for those respondents who answered positively.
Third, in most cases the measurement tools were specifically created for the study in
question. This has a number of negative consequences. It makes comparisons
between studies difficult, and questions the validity of the specific instruments that
have typically been designed for that particular evaluation.
A fourth point is that ‘mediating variables’ were used in some studies to assess 
factors other than purely drug-related outcomes (see Chapter 6 for more on 
mediator analysis). In some cases, these mediating variables were cognitive or 
attitudinal (for example, attitudes towards drug use or developing resistance skills),
while in others – for example, self-esteem – they were less directly related to 
behaviour. What these variables have in common, however, is that although they are
not solely related to drug use, they are assumed on the basis of theoretical models
of behavioural change to exert some influence on drug use.
Finally, relatively few of the studies in Table 1 appeared to be concerned with 
programme implementation. Thus, when results were not as predicted, it is unclear
whether this was due to non-adherence to the programme. This issue is extremely
important, as failure needs to be explained, if only to avoid the same mistakes in
future. The relationship between programme adherence and outcome has been
demonstrated by Pentz et al. (1990), who evaluated this relationship in the US
Midwestern Prevention Project (MPP). Implementation was measured through
teacher self-reports and by research-staff reports. Drug use was measured by student
self-reports and a breathalyser was used to verify the accuracy of self-reported drug
use. It was found that levels of implementation were strongly related to outcome.
Table 2 overleaf gives a brief but instructive comparison of the evaluation studies
covered in Table 1. It examines a small sample of recent studies that were not 
concerned with evaluation, but with causal and mediating factors. What is perhaps
most striking is that the measures used in these latter studies bear a remarkable
resemblance to those employed by the evaluation studies. As in Table 1, the basic
measure is that of prevalence, while the studies in Table 2 typically targeted other
mediating factors believed to influence behaviour.
84
Evaluation in Practice
Table 2: Studies of causal and mediating factors
Study/Country Focus Measures
Morgan and Grube (1991) Peer influences Prevalence and
Ireland 13–17-year-olds on drug use frequency measures;
peer approval and
peer behaviour
Measham et al. (1994) ‘Normalisation’ of drug use Prevalence measures
England 14–15-year-olds as well as 
‘offer’ questions
Jessor et al. (1995) Risk and Drug use
US seventh to ninth grade protective factors as a problem behaviour,
in problem behaviour measures
of protective factors
McCusker et al. (1995) Conceptual On basis of prevalence
Welsh adolescents basis for different and intention,
forms of usage four categories of user
defined
Kandel and Davies (1996) Profile of six stages of Prevalence measures 
US high school drug use, legal and illegal of legal and illegal drugs
Wills and Cleary (1996) Mediating factors Measures
US seventh to ninth grade in legal and illegal of peer influence 
drug use
Current developments
Models of drug use
Most measurement procedures are not based on a particular ‘model’ of substance
misuse. Instead, they tend to use simple prevalence measures and, in some cases, a
concept of what is meant by ‘misuse’ is introduced to the study after the event. In
other words, rather than deciding on an a priori basis that particular levels of 
substance use constitute a ‘problem’, categories of use are formed on the basis of
information extracted from questionnaires. Normally, these categories are based on
‘frequency of use’, but sometimes other measures are introduced, such as the 
number of substances used, the use of legal substances and the context of their use.
For instance, in the McCusker et al. study (1995), respondents were divided into one
of four groups based on their responses to specific questions about past use and
future intentions. These groups could then be differentiated from one another in
terms of social and personal factors. The resistant group was made up of those who
had never taken any of the illegal drugs and who said that they would definitely
refuse them if offered. The vulnerable group were those who, although they had
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never tried a drug, would either take one if offered or were not sure if they would do
so. The experimental group was defined as those who had used an illegal drug but
only ‘once or twice’, whereas the repeated user group were those who continued to
use illegal substances either ‘sometimes’ or ‘regularly’.
Such efforts to conceptualise drug use are valuable, but only when their construct
validity can be sustained (that is, when the distinctions between types of use and
users can be supported in terms of influences and consequences). Because of this,
evidence that consistently supports any particular conceptualisation is scarce. A
standard example of an evaluation that ensured construct validity is the Shedler and
Block (1990) study that contrasted discrete groups of non-users, experimenters and
abusers. The main measure of personality characteristics was the California Q-sort
made up of 100 personality descriptive statements from which a profile can be
extracted. These measures were obtained at the same time as, but independently of,
the measures of substance use. In addition, psychological descriptions were 
available for all the subjects from early childhood onwards. 
The results indicated that adolescents who had experimented with drugs (primarily
with cannabis) were the ‘best’ adjusted of the sample. In contrast, those who used
drugs frequently were maladjusted, with a distinct personality syndrome marked by
alienation, poor impulse control and manifest emotional distress. Finally, those who
had never experimented with any drug by the age of 18 were relatively anxious,
emotionally constricted and lacking in social skills.
Broadening the basis of prevention efforts
Another feature of recent studies is that the interventions tend to have a broader
community base, frequently involving parents, churches, community groups, the
local media as well as schools (see, for example, Pentz et al., 1990; Johnson et al.,
1996; LoSciuto et al., 1996). In some cases, targeting a particular community has led
to a programme being modified to ensure that it is culturally appropriate. This was
the case in the study carried out by Botvin et al. (1995b) which compared the effec-
tiveness of a prevention programme based on generic skills with a ‘culturally 
modified’ one. The results suggested that the latter programme was more effective in
terms of substance use and future intentions.
While the move to broader community-based projects is laudable given the limited
success of projects with a narrower focus, it does mean that efforts to gauge the
impact of the intervention can be hampered. If, for instance, posters, magazines and
leaflets are distributed widely throughout a community, measuring the effects of
these media is more difficult than if only one leaflet had been distributed in one
school. Furthermore, it is almost impossible to isolate the precise factors responsible
for observed outcomes. 
This broadening of prevention efforts also targets other behavioural variables. In line
with the stance taken by Jessor et al. (1995) that drug use is just one aspect of a 
larger syndrome of ‘problem behaviour’, some studies have sought to change 
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antisocial behaviour itself. Thus, the task of measuring outcomes has spiralled to include
issues such as delinquency, precocious sexual activity, rebelliousness and truancy.
Targeting risk factors
Targeting students identified as being ‘at risk’ is yet another recent development (see, for
example, Gottfredson et al., 1996; Richards-Colocino et al., 1996). One of the prob-
lems with this approach, as with broadening the effort, is that it involves myriad
potential factors, most of which are not easily susceptible to simple targeting.
Researchers can also be ‘duped’ by deceptively obvious factors, such as social back-
ground, which have not been shown in the international literature to have a strong
relationship with drug use.
The risk-focused approach has been advocated largely because of the success of
campaigns aimed at reducing risk factors for coronary heart disease. Proponents of
this approach have pointed to the failure of campaigns that ignored risk factors, and
while ‘risk’ is a valid variable, Hawkins et al. (1992) have demonstrated that a num-
ber of steps must be taken if the approach is to demonstrate its worth: high-risk 
factors need to be identified for substance use; effective strategies for reducing such
risks must also be identified; and these methods must then be applied, both to high-
risk and to general populations. It is fair to say that very few studies have actually
managed to carry through all three steps. From the point of view of measurement, a
crucial ingredient that is all-too-often missing from the risk-focused approach is
measuring changes in the risk factor being targeted. 
Lessons from negative outcomes
In examining the many studies of prevention programmes that have been carried
out, the relatively small impact evaluation has had on practice is striking. There is 
little evidence that programmes that have produced negative results have been 
discarded in favour of more promising programmes, or even that the lessons from
negative results have been learnt. For example, as stated earlier, it is now becoming
increasingly clear that a major factor in negative results is the failure to implement
the programme properly. A recent evaluation found this to be extremely significant.
Students were divided into those who had experienced the full programme, and
those who had only partially experienced it, and dramatic differences were found
(Botvin et al., 1995a).
It also appears that the efficacy of a programme is only one, and perhaps not even
the most important, factor in determining whether a particular prevention approach
is adopted. It seems that the ‘face validity’ of a programme may be especially influ-
ential in convincing policy-makers and educators of its effectiveness. If an approach
appears to ‘tell it as it is’ about drugs, then, regardless of the results of formal evalu-
ations, an objective view might suggest that the approach will work. But whatever
the reason, evaluations are only one factor in deciding the fate of a programme.
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Conclusion
This chapter has demonstrated that using structured questionnaires is one of the best
ways to measure evaluation outcomes. Currently, most measurement approaches are
very similar to those in the fields of epidemiology and causal analysis. But less 
attention has been paid to the distinctive aspects of evaluation itself, such as effec-
tive implementation and the extent to which participants experience all the aspects
of a programme. The challenges which these and other issues pose for evaluation
cannot be avoided.
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Chapter 8
The Cost-Effectiveness of Drug Prevention
Christine Godfrey and Steve Parrott
The resources available globally for drug-prevention initiatives are severely limited
and there is often considerable competition for funds. While interest in judging the
cost-effectiveness of different prevention initiatives has grown, very few published
studies are available – although a number of general guides to economic evaluations
do exist (for example, Tolley, 1992; Gold et al., 1996; Drummond et al., 1997). Such
economic evaluations are closely linked to outcome-evaluation techniques –-
identifying, measuring and then valuing both the outcomes (benefits) and the inputs
(costs) of a number of alternative interventions or scenarios. As such, these evaluations
mirror many of the disciplines already outlined in previous chapters, and can be just
as valuable when gauging the relative success of different prevention approaches.
What questions can economic evaluation address?
At the strategic level, policy-makers use economic evaluation when considering in
which areas additional resources would yield more benefits – treatment, prevention
or enforcement. Rydell and Everingham (1994) undertook such an analysis of
cocaine policies in the United States, and concluded that demand-oriented pro-
grammes were much more cost-effective than enforcement activities designed to
reduce the supply of drugs. Economic evaluation can help answer other broad ques-
tions about budget allocation between settings, population groups, drug types and
forms of drug use.
These issues can then be broken down further. In any specific setting, such as a
school or workplace, questions may also relate to the balance of resources between
primary and secondary prevention. Other economic evaluations may compare 
different prevention programmes with similar goals – such as public-information
campaigns versus venue-specific interventions – while still more specific evaluations
would, for example, address the cost-effectiveness of different methods of delivering
school-based prevention.
Questions are, however, rarely framed as stark choices between one type of 
prevention programme and another. More realistically, policy-makers have to choose
how to combine different approaches. Often choices are made at a marginal level,
determining how to use a small increase in overall resources or planning how
resources should be cut. At a more systematic level, questions can be framed to eval-
uate adding or removing one element of a more complex programme. Would, for
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instance, the addition of a mass-media campaign increase the overall effectiveness
of a national health programme?
There is, therefore, a very long list of questions that economic-evaluation techniques
may help address, and many different reasons for asking them. Policy-makers and
funders are likely to be interested in some of the broader issues, while those engaged
in providing drug-prevention programmes on the ground may be more interested in
the relative value of specific aspects of the programme they are delivering. 
Those asking the questions may also determine the study’s perspective and, conse-
quently, the types of costs and benefits included and the alternatives to be evaluated.
Workplace interventions provide an interesting example of how different 
perspectives can shape an economic evaluation. Employers are principally interested in
the effects of programmes within their workplace. They are concerned with factors such
as productivity, sick leave, job turnover and safety. If the study is conducted solely from
this perspective, only the costs and benefits that occur in the workplace would be iden-
tified, measured and valued. The most cost-effective or cost-beneficial programme from
the employers’ perspective may not, however, be the most cost-effective from a 
different perspective. For example, one particular programme may involve referring 
individuals to community-based rather than in-house workplace services – in other
words, shifting the costs. From a society perspective, in-house services may be more
cost-effective than the community-based alternative, and there may be more benefit to
the community if its services are used for groups other than those employed in a 
particular workplace. Most economists would therefore suggest that a full societal 
perspective tracing all costs and benefits – not just current cash flow – is necessary.
Different types of economic evaluation
Economists start from the basic principle that all resources – land, labour, raw 
materials, capital and human skills – are scarce. Using a particular resource means that
the potential benefits associated with putting it to some other purpose are lost. Judging
whether a community’s scarce resources have been used to maximise the benefits to the
citizen is one of the primary criteria for economists. In other words, economists are not
only seeking to answer the question ‘does a drug-prevention programme work?’, but
also ‘can the resources needed to make the programme work be better used 
elsewhere?’ While this type of efficiency is the economist’s main criterion, other goals
may also have to be considered. For example, policy-makers may well be concerned
about specific groups in society, such as the young and disadvantaged. Thus it may also
be important to identify which groups ‘gain’ from the particular intervention and which
groups ‘pay’ for it.
There are four main types of full economic evaluation:
• cost minimisation;
• cost-effectiveness;
• cost utility; and
• cost–benefit analysis.
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Full economic evaluations require examining both costs and benefits, and 
comparing two of more alternatives. Other types of economic studies attempt to 
estimate the social costs of drug use, but these are not classed as evaluations as such
and are not discussed in this chapter. A full description and guidelines for 
undertaking such studies are given in Single et al. (1996).
Partial economic evaluations can also be undertaken. Some studies examine the
resource inputs or costs in more detail, such as the factors that influence the costs of
delivering prevention interventions to different groups, or the costs of different 
components of the intervention. Some health-promotion studies have examined the
relationship between outcomes and the resource inputs for one particular type of
programme (see Shipley et al., 1995, for an example of this using ‘Quit and Win’
stopping-smoking competitions).
In all types of economic evaluation, the costs are measured and valued in monetary
units. In general, many of the wider benefits of programmes, such as health-care 
savings or criminal-justice costs, are also measured and valued in money terms. The
distinction between the four types of economic evaluation is how to measure and
value the narrower benefits for the individuals targeted by the intervention.
Cost minimisation
This form of evaluation tends to assume that the various interventions under consid-
eration are equally effective and that the benefits for the individual are also broadly
equivalent. Obviously, if this assumption is made, the analysis only needs to 
consider the costs of the various interventions. This simplifies the task, but the
assumption made is a major one and is unlikely to apply in the real world.
Cost-effectiveness
Cost-effectiveness analysis is the most common economic-evaluation technique.
Indeed, the very term ‘cost-effectiveness’ is often assumed to be generic to all types
of economic evaluation. Technically, however, it only refers to those evaluations in
which the effects on individuals targeted by the intervention are measured in some
‘natural’ unit. This unit could be drug prevalence, incidence, problematic drug use,
morbidity or mortality. Examples include the proportion of the target group that is
drug-free at some given time; the change in overall levels of drug use attributable to
the interventions; and changes in different problem indicators, such as needle-
sharing, or even quality of life. There are, of course, many other choices for outcome
indicators, and this choice depends largely on the purpose of the study. Evaluative
studies may adopt a package of outcome measures, but problems can arise if
researchers do not follow a pre-arranged analysis plan. There is always a risk that
some bias may occur if the indicator is chosen after the evaluation is complete. 
Alternative interventions are compared in cost-effectiveness studies either on the
basis of the lowest net cost required to achieve some set level of the outcome 
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indicator, or by identifying the intervention with the highest outcome levels for a
given budget. The choice of an adequate outcome measure is clearly an important
part of this analysis. Net costs are defined as the total costs of the intervention less
any non-individual benefits measured in monetary terms. By calculating net costs per
unit of outcome across the different alternatives, it can also be determined whether
one intervention dominates others in terms of costs and outcomes, whatever the level
of target outcome or resources. In addition, any trade-offs in costs and outcomes
between the different interventions can be identified. In practice, alternative 
outcome measures may be presented, especially in an area such as drug prevention
where no agreed generic measures are available.
Cost-effectiveness is best suited to situations in which the programmes being com-
pared have very similar goals. It becomes much more difficult to use cost-effectiveness
as a tool to compare interventions with different settings or targets. It would, for
example, be difficult to isolate one measure that would adequately compare a
school-based programme aimed at reducing drug initiation, and a programme for
reducing injecting drug use among current drug users. 
Cost utility
The other types of economic evaluation use broader outcome measures to ease com-
parison for interventions that may be competing for scarce resources. Cost-utility
analysis uses multiple individual outcome measures to combine an individual’s
expected lifespan with many of the dimensions that would influence their health-
related quality of life. These measures, such as Quality Adjusted Life Years (QALY),
have been used in studies of smoking-prevention programmes (Fiscella and Franks,
1996) and HIV-directed measures (Holtgrave and Kelly, 1996). However, as these
measures focus only on health-related quality of life, they may be inadequate for
capturing all the benefits to an individual of a drug-prevention programme. 
Cost–benefit analysis
An alternative measure is to attempt to place a value on the programme for the indi-
vidual by measuring outcomes in monetary terms. If all costs and consequences –
including those to individuals – are measured in money, the economic evaluation is
defined as a cost–benefit analysis. There are a number of methods available for mea-
suring outcomes in monetary form, including examining what people actually pay to
avoid risks, or, conversely, the premium they will accept to take risks.
Another method is to ask individuals or groups to take part in experiments to value
different outcomes in a ‘willingness-to-pay’ study. Clearly, such studies must be care-
fully designed to ensure the reliability and validity of the outcome measures. Putting
a monetary value on life is problematic at the best of times, and could reflect socio-
economic inequities if based on an individual’s willingness or ability to pay. This can
partly be avoided by using a representative sample of the population in the study.
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Identifying, measuring and valuing the costs 
and benefits of drug prevention
The actual costs and benefits included in an economic evaluation will depend on
the questions asked and the perspective taken. 
Costs of drug prevention
The costs of prevention activities fall into four main groups:
• direct costs to the agency delivering the intervention;
• direct costs to other agencies involved in the intervention;
• direct costs to the individuals participating in the intervention; and
• indirect productivity costs.
The direct costs of the intervention include all staff costs and resources (such as
leaflets, telephone bills, and so on). Many of these costs may be directly observable,
although calculating staff time when staff are engaged in more than one intervention
may present some difficulty. It is important, however, to include all resources used –
including capital and management expenses – in the intervention. The proportion of
fixed costs, such as buildings or equipment, and semi-fixed costs, such as staff, help
to determine the ratio between total direct costs and the proportion of the interven-
tion delivered. Some programmes, for instance, may incur considerable initial capi-
tal costs. If only a few participants are attracted, the average cost per participant
would be extremely high. The marginal cost, or cost for every extra person, would
then fall as the number recruited increased.
Drug-prevention programmes may involve many agencies, especially in community-
based initiatives. Support may be given ‘in kind’, such as volunteer time and donated
resources, rather than in the form of directly accounted resources. Such help is
often difficult to quantify, but if these resources have a possible alternative use, then
they have some form of economic value which should be included in the economic
evaluation.
There may also be costs incurred by the individuals involved or their families.
Programmes may require travel or other monetary expenses, such as visits to a doc-
tor, while families may need to buy certain items themselves as part of the 
intervention.
Indirect costs in terms of ‘lost productivity’ are the subject of some controversy.
Clearly, if people undergo treatment or take part in a prevention programme, they
are spending time that could be spent on other activities. This lost productivity is
usually valued in terms of the individual’s earning capacity, and has dominated the
results of some health-care evaluations. A way of dealing with this is to present
results with and without these indirect costs and benefits (Drummond and
Jefferson, 1996).
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Benefits of drug prevention
The list of potential benefits of drug-prevention programmes can also be divided into
a number of different groups (Rosen and Lindholm, 1992):
• health benefits to the individuals targeted by the intervention;
• consumption benefits of the intervention;
• other non-health benefits;
• social diffusion effects; and
• effects on future resource use.
Which individual health outcome is chosen to be measured will be determined by
the economic evaluation design. In a cost-effectiveness study, for instance, only one
indicator would be used. In cost-utility studies, health-related quality-of-life mea-
sures only cover a limited number of dimensions. Problems associated with drug
use, however, include a far wider range of issues, among them physical health, men-
tal health, employment, criminal activity and personal relationships. Prevention 
programmes could have an effect both on an individual’s quality and quantity of life
across one or more of these different dimensions.
It could, therefore, be argued that some of the many existing measures are inadequate
to capture the full range of effects. Perhaps some super-QALY is needed that would
include more than health dimensions, for example, some of the life skills, self-esteem
and other consumption benefits that form part of many primary-prevention drug
programmes. Alternatively, some means of capturing these different effects in terms
of willingness to pay or other monetary measure could be viable. However, the
danger of choosing one effectiveness measure over another is that other outcomes
may not be perfectly correlated with the chosen measure and could lead to an 
incorrect comparison between the programmes.
Drug-prevention programmes can also provide a range of potential social benefits.
Rosen and Lindholm (1992) suggest that the outcomes of many interventions are
underestimated because effects are measured only on the participating individuals.
They argue that additional benefits arising from the social diffusion of the inter-
vention throughout the community must be recognised. Such effects can be seen, for
instance, in the large reduction in smoking in many European countries.
Society may also benefit from a low rate of drug-related problems as a result of a 
successful prevention programme. These may be in the form of direct effects, such
as a lower rate of HIV infection, or in the form of reduced resources needed for
health, social-care and criminal-justice activities directed at drug misusers. In the
case of drug treatment, these social benefits from reduced drug use have been 
substantial (see, for example, Gerstein et al., 1994).
Most of these wider benefits are measured in monetary terms. However, not all 
societies value these benefits equally. For example, in some countries more weight
may be given to preventing any drug use than to preventing problems among 
existing drug users (Godfrey and Sutton, 1996). These values are often reflected, if
95
Chapter 8
not made explicit, in current policy decisions. Therefore, when undertaking an 
economic evaluation, the value system used to measure individual and social 
benefits has to be made explicit.
Steps required in planning an economic evaluation
Planning an economic evaluation involves a number of major steps. Several texts
give more detailed step-by-step guidance for undertaking such studies (Tolley, 1992;
Drummond et al., 1997; Gold et al., 1996), but this chapter will consider the fol-
lowing issues: 
• defining the study’s economic issues and perspective;
• choosing the alternatives to be evaluated;
• designing the study to collect both benefit and cost data; and
• planning the data analysis, including discounting, sensitivity analysis and incre-
mental measurement.
The perspective and purpose of the study, as discussed above, will help decide
which preventive interventions to compare. The choice of which alternative inter-
ventions to evaluate is obviously a crucial part of any study. Comparing two 
prevention initiatives and finding one to be more cost-effective than the other is not
much help to providers or policy-makers if a third promising option was not 
included in the study. The narrower the question being addressed the easier it
becomes to trace all possible options, including the status quo approach. Including
a status quo option is important in this early stage of knowledge about the 
cost-effectiveness of drug prevention. Any new initiative should, therefore, be com-
pared to any current one.
It is clear that no programme can be judged ‘cost-effective’ if it is not also ‘effective’.
The design of the study to determine both costs and benefits needs to be robust.
Reviews of the evaluation of workplace testing programmes have highlighted some
of these specific issues. Many studies have suggested that pre-employment drug
screening benefits employers. Dinardo (1994) suggests, however, that because most
designs have been observational rather than experimental in approach, it is difficult
to attribute causality. Drug users differ from non-users in many ways, and hence the
observed work differences between those testing positively for drugs and those who
do not may just reflect these differences in characteristics and possible confounding
effects. These and other broader study-design issues are covered in other chapters.
Ideally, economic evaluations would take place alongside other forms of evaluation.
One alternative is to use effectiveness evidence from reviews and to compile the
resource and cost data either retrospectively or prospectively. In prevention 
programmes, many of the benefits may occur in the future and it would be difficult
and costly to observe these effects. Epidemiological models may therefore be used
with the review or observed-effect data. Holtgrave and Kelly (1996) provide an
example in which the effects of HIV prevention programmes from a trial were 
modelled to identify gains in QALYs, while the cost data were calculated 
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using data from the same trial. Likewise, Kahn (1996) examined HIV prevention
using epidemiological models and reviews of effectiveness data to simulate the 
number of HIV infections avoided by increasing the budget by $1 million.
These are clear examples of the fact that the costs and benefits attached to different
prevention programmes often manifest in different time periods. In general, benefits
are sought immediately while the costs are delayed for as long as possible.
Obviously, prevention programmes follow the reverse pattern, with costs incurred at
the outset while some (if not all) of the benefits become apparent only well into the
future. In order to make some comparison, therefore, it is necessary to put the costs
on some common, usually current, value system. In most commercial activities,
costs and benefits that occur in the future are given a lower weight. 
Consider a prevention programme aimed at reducing deaths from overdose. For sim-
plicity’s sake, this is assumed to result in ten people each living five years longer from
the year the programme was conducted. Undiscounted, this is a total of 50 life years.
Discounting at 5% yields 10.0 years in the first year, 9.5 years the second year, 9.0
years the third year, 8.6 years in the fourth year and 8.2 years in the fifth year – an
estimated total of 45.3 life years gained from the prevention programme.
Discounting health benefits will lower the comparative cost-effectiveness of preven-
tion programmes. Parsonage and Neuburger (1992) have set out the arguments for
and against such discounting, and conclude that studies should report a range of 
discount rates on benefits, including the undiscounted figures. As well as life years
gained, discounting will also affect projected future savings on health, criminal-
justice and other welfare services, although there is more consensus that non-health
benefits should be discounted. Discounting may also alter the results of a cost-
effectiveness analysis within population groups, possibly favouring older groups or
those with existing drug habits who may benefit in the short rather than the long term.
Economic-evaluation techniques provide a framework, but all studies require a 
number of assumptions to be made at every step of the process. Some costs and 
benefits may be omitted, and assumptions may be made about the size or variability
of effects or resource use. Clearly, the sensitivity of any results to changes in these
assumptions must be tested in some way.
Conclusions and the use of study results
Economic evaluations can have powerful results, proving that one type of inter-
vention is not as cost-effective as another. However, the general lack of cost-
effectiveness information can cause the results to be over-generalised from one 
specific evaluation to a more general situation. This over-generalisation can, of
course, create all sorts of problems.
Such problems can partly be avoided by adopting good practice as outlined in general
economic texts. The major problem, however, is the lack of evidence. The paucity 
of existing research means that many studies must have larger research components 
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if some of the complex issues raised in this chapter are to be tackled effectively. The
lack of economic evaluation also means that individual studies cannot cross-check
their findings against others. This creates the danger of stretching a study beyond its
design to answer the wide-ranging questions to which policy-makers want the
answers. The obvious solution is to undertake more economic evaluations, but this
involves resources and prioritisation. Even with a paucity of data, there is still a 
considerable advantage in undertaking preliminary work, so that the most important
economic questions can at least be established.
Economic evaluation has been seen as a necessary, but sometimes unwelcome,
addition to other types of evaluation. The challenge now is to make economic eval-
uation more accessible, and to demonstrate its use as a tool for making more 
explicit policy choices and illuminating the value system by which such decisions
are made. It is clear that this form of evaluation must be based on robust study
designs as discussed elsewhere in this monograph, but there is also a need to 
develop adequate economic measures relevant to drug-prevention programmes.
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Epidemiology, Prevention and Evaluation
Richard Hartnoll
The first priority of the EMCDDA, as specified in its founding Regulation, concerns
the demand for drugs and reducing that demand. In operational terms, this is 
reflected in the Centre’s organisation and in the creation of the two departments that
deal primarily with the scientific content of its work programmes: Epidemiology; and
Demand-Reduction. The relationship and relevance of epidemiological information
and research to the implementation and evaluation of demand-reduction activities is
thus a central issue.
This chapter examines selected examples of areas in which epidemiology can be of
practical value to drug prevention and prevention-evaluation research. It begins by
briefly examining what epidemiology is and how it relates to drug prevention and
evaluation research. The chapter concludes with suggestions for areas in which co-
operation would increase the synergy between epidemiology and prevention
research, and for mechanisms that might encourage greater cross-fertilisation, to the
mutual benefit of all involved.
Epidemiology, prevention and prevention research
Epidemiology is sometimes perceived as an esoteric science for collecting and
analysing statistics, and one that is distinct from prevention interventions and evalu-
ation research. In fact, this is misleading and misrepresents the purposes and 
functions of epidemiology, even if the misperception is an understandable one.
Epidemiology is concerned with questions that are fundamental if policies and 
interventions are to be based on evidence rather than on preconception and to
develop in a relevant and effective manner. Wherever an epidemiological approach
is applied – be it in the field of infectious diseases with which it is traditionally 
associated, or in areas such as smoking and lung cancer, environmental pollution
and asthma, or drug use and drug-related problems – it addresses common key
issues. These issues include:
• identifying and describing the nature and extent of a problem or phenomenon (its
prevalence, distribution in the population, characteristics and consequences); 
• investigating the ‘how’ and ‘why’ (aetiology, risk and protective factors, 
mechanisms and processes); 
• examining the design and evaluation of interventions (for example, random con-
trolled trials or community interventions); and 
Chapter 9
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• epidemiological surveillance of trends and identification of new problems 
(monitoring and early-warning systems). 
An important additional component in the drugs field, although not unique to this
area, has received greater emphasis than in other, more traditional areas of 
epidemiological research. This is the application of qualitative ethnographic, 
sociological and behavioural research methods to complement statistical 
investigations. The reason for this, in part at least, is that drug use and drug addiction
are complex phenomena with cultural, social, historical, economic and psychological
as well as pharmacological dimensions. Furthermore, individual and collective 
subjective perceptions play an important role in shaping the behaviour and 
responses of all involved, whether drug users or non-users, the general public, 
practitioners, researchers or policy-makers. Statistical data and analysis can provide
the structured and ‘objective’ framework necessary for describing and monitoring
the phenomenon, for testing hypotheses about its aetiology, and for designing and 
evaluating interventions. However, this is often insufficient for interpreting the 
patterns and trends that are observed within their local or national context, or for
appreciating the all-important nuances of how the different actors perceive, con-
struct and react to the world as they understand it. This takes on even greater 
significance when comparing across countries and cultures. Broadening the 
epidemiological paradigm thus adds to the potential for linking epidemiological data
to the development of policies and interventions. 
Why, then, the perception of some practitioners that epidemiology is not really 
relevant to their daily work? A comparison with the emergence of epidemiology in
the field of public health is illuminating. Historically, epidemiology developed 
within the context of public-health practice as a practical tool to help identify and
monitor problems, and to design and evaluate interventions. There was thus no real
gap, either between epidemiology and public-health interventions, or between 
epidemiology and evaluation research. Public-health practitioners have been, and
usually are, also epidemiologists. 
Epidemiology in the drug field developed relatively autonomously as a research-
oriented discipline dealing with questions that often tend to be more relevant to 
policy-makers than to practitioners. As noted above, epidemiology expanded
beyond the original medical model to incorporate many elements from disciplines
such as sociology, anthropology, social psychology, psychiatry and economics.
However, many interventions in the drug field, and especially prevention, have
grown out of other sectors, for example social services, counselling, education or
health promotion. It is not surprising, therefore, that a gap exists between 
practitioners and epidemiologists. They come from different backgrounds and have
different training. Most practitioners (in prevention at least) are not involved in
research, and researchers are rarely involved in prevention.
Furthermore, prevention research has often involved social scientists who do not
consider themselves to be epidemiologists, even though many of the techniques they
use are similar to those used in epidemiology and many of the methodological issues
101
Chapter 9
with which they are concerned – for example, study design, sampling, control
groups or inferring causality – are identical. Prevention and epidemiology are not
really separate disciplines and have much more in common than is sometimes
recognised. 
Relevance of epidemiology to prevention
Three examples demonstrate how epidemiological data and methods can be of 
relevance to drug prevention and evaluation: 
• Drug problems and needs assessment Is there a problem and if so what sort of
problem is it and what are the needs? How far do existing interventions and 
prevention efforts address them? What are the dimensions and characteristics of
the target groups most at risk?
• Early identification of emerging trends How to identify important new trends and
potential problems in time to develop appropriate preventive measures.
• Evaluating the impact of drug prevention Do interventions reach their targets?
What is their impact at individual level? What is their impact at group or com-
munity level?
Drug problems and needs assessment
One of the first questions that epidemiology addresses is ‘how many?’ – how many
drug users? How many addicts? – or, in other words, prevalence. The answers are
usually sought either through surveys of the general population or of subgroups,
such as school pupils, or through estimates based on various registers or indirect 
indicators, for example of people treated for drug problems or those arrested by the
police. Some non-epidemiologists may consider this as the major goal of 
epidemiology. However, for the purposes of developing responses and interventions,
a simple prevalence figure begs more questions than it answers. This can be 
illustrated by the fairly narrow example of assessing needs in relation to problems
related to opiates, in particular heroin. Issues regarding the broader spectrum of drug
use, drug problems and prevention will be discussed later in this chapter.
For example, a prevalence study may conclude that there are around 100,000 
heroin addicts in a given country. But so what? Is this a large number, or only a few?
Is the number increasing or not? What are the characteristics of the individuals
involved and of the communities most affected? What sorts of problems and costs
are implied by such a figure? What are the major needs, what types of interventions
are most appropriate, and how should resources be allocated? 
In this hypothetical yet realistic scenario, the value of an epidemiological approach
lies not in the figure itself, but rather in following up the questions that such a figure
raises. To take the first question – is this a large number of addicts or not? – the 
initial step is to set the number against the size of the population of the country con-
cerned. In the smallest EU country, Luxembourg, this would represent 25% of the
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whole population, a level of heroin addiction probably unmatched in any society in
history. In the largest country, Germany, it would represent a little over one-tenth of
1%. In practice, the range in Europe is towards the lower of these two extremes, and
is typically under 1% of the total population. So the question remains: is this a 
serious problem or not, and if so, in what way is it serious?
Continuing for the moment to focus on the example of heroin addiction, even if its
prevalence represents a small proportion of the total population across a whole 
country, the distribution of that prevalence can be, and often is, very uneven. Heroin
addiction in many European countries at present occurs primarily in the 18–40-year-old
age range, especially amongst males, and can be associated with various cultural, social
and individual risk factors. It can also be highly concentrated in cities or in certain 
districts within major metropolitan areas, for example amongst more socially 
marginalised or disadvantaged communities with high unemployment rates and other
social problems, and in some cases in areas linked to heroin trafficking and distribution.
This means that prevalence can be many times higher than the national average, for
example up to 5–10% among young people in the highest-risk groups or communities.
A thorough epidemiological analysis would go beyond a detailed description of how
the prevalence is distributed in the population to examine its health and social 
consequences. These can include the demand for treatment for drug-related 
problems, such as addiction, the level of excess mortality and the extent of other
drug-related health problems, such as infectious diseases or non-fatal overdoses.
Investigations of the social consequences are less commonly included in epidemio-
logical assessments, and can in any case prompt a debate about the boundaries of
epidemiology. Issues here can include drug-related crime, the extent to which
addicts and other drug users are arrested or are imprisoned, or the characteristics
and possible dimensions of illicit drug supplies and drug markets.
What is the value of this sort of information? On the one hand, information about
addiction, its prevalence, distribution and characteristics can be very relevant to the
provision of treatment services. For example, are there enough treatment centres, are
they situated in the right places, do they offer services that are appropriate to the
characteristics of the addicted population and important subgroups within it?
Information on hidden populations who are not well provided for can be particularly
useful, since treatment staff tend to identify needs in terms of the problems presented
by the clients whom they do see rather than those they do not. The information may
also be useful for developing harm-reduction programmes (for example, on 
changing patterns of drug injection or on factors such as risk perceptions and others
associated with sharing needles). More broadly, information on the scale and nature
of drug problems and associated needs – as well as their implications in terms of
costs – provide valuable ammunition for arguing for adequate resources to target
well-identified problems.
On the other hand, this information refers to a phenomenon for which prevention,
by definition, is already too late. What, then, are the implications for prevention? It
would be a mistake to see epidemiological information on prevalence, problems and
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needs related to heroin addiction as irrelevant to prevention or early interventions just
because the data immediately to hand refers to already addicted groups. Valuable
lessons can be learned from these and other historical data, both in terms of the risk
factors that they identify, and in terms of the light they cast on the processes by which
heroin use and addiction become established and spread within communities or
develop over time in individuals.
Information on the risk factors of problematic patterns of drug use – such as heroin
addiction – or of serious consequences – such as overdose or HIV infection – is
rather scattered across the literature. One of the tasks on which the EMCDDA has
recently embarked is to review and synthesise some of this information, taking account
of other useful reviews that have already been undertaken. It is clear, however, that the
notion of risk factor should be extended beyond individual or family characteristics to
the environment, including the socio-economic dimension and situations linked to
problematic drug use or risky behaviour. It is also necessary to include what could be
called ‘developmental epidemiology’, which seeks to integrate individual 
developmental patterns with environmental and contextual processes. Although no
single blueprint for prevention is likely to emerge, this body of knowledge should give
a more informed basis for identifying interventions that offer greater possibilities for
slowing rather than increasing the development of problematic drug use and its
adverse health and social consequences.
Regarding the processes by which heroin use and addiction spread and become
established within communities, an accumulating body of epidemiological evidence,
for example from the United States and some European countries, suggests a degree
of consistency in the longer-term patterns and cycles of so-called ‘heroin epidemics’.
It is important to avoid simplistic generalisations on this point, both because there are
important local variations, and because significant innovations can arise that alter
some of the parameters of these epidemiological models – for example, new routes of
administration (such as heroin smoking), new risks (such as HIV infection) or new
combinations of drugs (such as crack cocaine). However, despite these reservations,
some broad and common themes have emerged, both across countries and over time. 
Models for analysing these patterns are still at a relatively early stage of develop-
ment. However, even without a detailed analysis, it is realistic to suggest that in the
long term, in higher prevalence areas where heroin use and addiction are estab-
lished and endemic, prevalence is likely to continue at broadly similar levels for the
foreseeable future, despite short-term fluctuations in the incidence of new cases and
changes in the age distribution of the addicted population. If so, then the prevalence
figures suggested earlier would translate on average into at least one – and possibly
up to three – potential heroin addicts in every school classroom in a high-risk area.
If the example is broadened beyond heroin addiction to include other heavy and
problematic patterns of substance use, then the challenge for prevention should be
clear. A further example of the long-term evolution of patterns in drug use and drug
problems is that ‘epidemics’ in larger cities often spread some time later to smaller
towns and rural areas, a pattern that can be seen in some European countries. Thus
it is important to anticipate needs by, for example, training professionals or 
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developing models of service delivery that are appropriate to larger, low-density
areas.
An under-developed level of analysis, but one that is receiving increasing attention,
concerns not only the consequences of drug addiction, but also the social and 
economic costs that these entail. As in the case of prevalence, the consequences and
their costs are likely to be much more substantial in some areas or on some topics
than in others. Here, too, the process of differentiation renders the information much
more valuable than the sort of global figure with which this analysis began. This
allows priorities and targets to be set that correspond more closely to actual needs
than to preconceived notions of the nature of the problem.
Apart from prevalence, consequences and costs, a comprehensive assessment of
problems and needs can address the lifestyles of drug users and the social contexts
of their drug use. Alternatively, it can address their experiences and perceptions of
risks, prevention messages and treatment services. This can give insight into the
social, economic and cultural constraints that have to be taken into account when
implementing strategies and interventions. Such a project could examine public
knowledge, attitudes and perceptions about, for example, fears related to drug
addiction, or attitudes towards prevention and treatment that could help in 
developing information strategies and interventions that will gain acceptance.
Information of the type described in this example is of considerably greater value for
developing effective and informed interventions than the simple prevalence figure
with which this section began. A similar exercise could be undertaken starting with
the results of a school survey, taking the finding, for example, that ‘20% of 15-year-
olds have tried cannabis at least once in their lives’. This would engender a similar
process of step-by-step delineation and elaboration of questions. The result would be
the same – that it is not the prevalence figure itself that is the important contribution
of epidemiology, but rather the answers to the questions that lie behind that figure. 
Early identification of emerging trends
The previous section examined the assessment of problems and needs related to
established and more problematic patterns of drug use, such as heroin addiction.
This section examines some of the issues involved in identifying new trends or 
anticipating emerging problems in time to take appropriate preventive measures. 
The starting point for this discussion is a ‘prevention dilemma’. If there is no problem,
prevention is either not needed or, if it is, what must be prevented? If, however, there
is a problem, prevention is needed, but it is already too late. 
Many countries undertake prevention activities based on the assumption that some
form of pre-emptive prevention is needed, and on the (valid) observation that drugs
are available and used to a greater or lesser extent in virtually every community across
the globe. These activities tend to be broad, fairly non-specific programmes aimed at
discouraging drug use in general or at providing information about the effects and
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risks of different drugs in the hope that this will have a preventive effect by promoting
informed choices. Other approaches are set within broader perspectives that do not
specifically single out drugs, such as health education and healthy lifestyles. Some
might also argue that other social programmes can have non-specific drug-prevention
effects, for example programmes concerned with crime prevention, reducing social
exclusion, promoting urban renewal or stimulating community involvement. 
The priority and level of resources devoted to drug prevention in this general, pre-
emptive sense often seems to reflect the level of social and political concern more
than it does the objective level of drug use or drug-related problems. However, in
cases where public and political pressure reacts to increases in identified, more 
specific patterns of drug use or drug problems by demanding more prevention, then
the second part of the dilemma becomes apparent: it is already too late. Yet, the
response might then be that it is not too late for subsequent generations. In part, this
may be true, but it makes the questionable assumption that approaches developed
with reference to the problems of yesterday’s generation are appropriate to the 
as-yet-to-be-observed problems of tomorrow. How relevant were the preventive
messages aimed at discouraging heroin use or the sharing of syringes in the 1980s
to the increased use of synthetic drugs in the 1990s? 
The dilemma becomes important once the discussion moves from the general, non-
specific level to the question of how to identify, track and understand new trends to
distinguish whether and in what ways they are potentially serious, and to do so in a
timely fashion. The demand is thus for information that enables intelligent and
appropriate responses to be implemented quickly, but which does not generate false
alarms or lead to preventive actions that are misinformed and lacking in credibility.
This highlights the need for reliable early-warning indicators that identify emerging
trends and problems in time for more focused and appropriate actions to be taken if
necessary. 
This prevention dilemma raises a parallel one for epidemiology. Indicators reflect
changes in drug use and drug-related problems only after they have already
occurred. If the goal is to identify new trends before they have emerged, then how
to measure what does not yet exist? And when it does emerge, how to know that a
trend is a trend until after it has indeed become one? Even the less ambitious goal of
improving the ability to track trends and identify problems at an earlier stage than is
currently the case presents a serious challenge. 
New trends in drug use, like many innovative developments, usually first arise in
specific localities or in restricted social groups or settings. Methods such as surveys
of the general population or of school pupils cannot identify these trends until some
time after the behaviours have been more widely adopted, nor can reliable mea-
surements be obtained until the prevalence has risen to quantifiable levels.
Traditional indicators based on problematic consequences, such as the demand for
treatment or other health issues, are also slow to respond, since in many cases there
is a time lag between, for example, first use and first contact with a treatment 
centre (if indeed there is any contact).
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There are several ways of developing methods for identifying, tracking and under-
standing new trends. Most of these are based on networks of key informants. These
key informants include people in touch with groups where new trends in drug use
are most likely to be observed at an early stage. While the list may vary between
countries and local contexts, it could include researchers (especially qualitative
researchers carrying out fieldwork amongst different groups of drug users), local
practitioners in the fields of prevention and harm reduction (especially those
involved with user groups, outreach activities and at-risk groups of young people),
and a diverse collection of others (for example, workers in the youth media and
entertainment industry).
A complementary approach could be to use forecasting models to project trends,
based not only on epidemiological models of drug use, but also on sociological and
market-based models of the diffusion of innovation and fashion. This could include
monitoring music and other youth-cultural magazines, Internet sites and similar
forms of communication.
The feasibility of improving epidemiological monitoring to identify new trends more
rapidly and reliably is currently being studied by the Epidemiology Department at the
EMCDDA. The Department is examining the possibilities described above, and more
concrete results should be available by the end of 1998. Two key aspects are how to
assess the reliability of reported trends, and how to understand their significance.
In parallel with improving epidemiological systems for monitoring new trends, it is
essential to establish links with practitioners in the field of prevention and harm 
reduction so that the information can be applied in a relevant manner. This implies that
those practitioners who are in the best position to apply the information should also be
involved in the network of key informants who provide the information in the first place.
One way to link epidemiology and prevention in this field is to build the partnership
into the system from the beginning. This linking is probably best pursued at local level,
which is where the data originates and where the results will be implemented.
Evaluating the impact of drug prevention
The other chapters in this monograph deal with different aspects of evaluating 
drug prevention. This section is thus restricted to selected critical observations that
an epidemiological perspective can provide – although, as noted earlier, there is an
important degree of overlap between epidemiology and prevention research.
Epidemiological methods can provide information relevant to the evaluation of 
several questions: do preventive interventions reach their targets? What is the 
outcome of prevention? What is the impact at individual level? What is the impact
at group or population level? 
An appropriately designed epidemiological study can describe the knowledge, 
attitudes and perceptions of the population, the distribution of drug use and the 
characteristics of the users within that population, and analyse some of the risk or
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protective factors associated with drug use or non-use. Since many prevention activ-
ities are school-based and targeted at school-aged children, this population is used
here for illustrative purposes.
The most common method for studying drug use in school populations is an anony-
mous, self-completion questionnaire given out in the classroom. A large number of
such surveys have been carried out in Europe and elsewhere. Sometimes they are
conducted primarily for research purposes to measure levels of drug use in that
population and/or to study risk factors, and the results may only indirectly feed into
prevention measures. In other cases, they are carried out as part of a prevention 
programme so as to identify levels of experience, knowledge and attitudes towards
drugs and, on occasion, also to evaluate changes that may be linked to preventive
interventions.
Other methods for studying this age range include household surveys that sometimes
involve those as young as 12 – although such surveys more commonly start at age
16 or 18 – and a variety of more targeted studies of selected groups of young 
people, including those in a range of non-school settings. 
The results of these surveys and other studies suggest that large differences exist in
experiences of drugs, not only between countries or localities, but also between
school-age children with different characteristics. Sometimes, these characteristics
are described as risk or protective factors, although whether they are risk factors in
a causal sense is unclear. It is likely that many would be better described simply as
correlates of broader dimensions that characterise adolescents and their lives.
Certain common themes emerge from all these studies, although there is also an
important degree of divergence in terms of the presence and relative importance of
so-called risk and protective factors. 
The strongest and most consistent theme is that experience of drugs increases very
quickly between the ages of 12 or 13 and 19. This refers both to the proportion who
try illegal drugs (which can increase from a small percentage at age 12 to over
30–40% or more by the ages of 18 or 19) and to the number of different drugs they
take. This is presumably why drug prevention is targeted at schoolchildren (although
this is also a fundamental period of personal development and transition in a much
broader sense). The rapid increase in drug use over this period is also a major 
obstacle to evaluating prevention, since there appears to be a built-in bias towards
failure. How to plan evaluative studies to overcome this problem is beyond the
scope of this chapter, but involves at a minimum carefully selecting control groups
within a longitudinal design.
A second consequence for evaluating prevention in the steep gradient observed in
drug use between the ages of 12 and 20 is related to the diversification of school
careers after the age of 15 or so. In many countries, some young people stay in 
academic schooling, whilst others move to a variety of vocational or technical
schools. In other countries, a significant proportion leave school to begin work (or
not), and others, in anticipation of leaving school, do not attend so frequently. This
means that a diminishing proportion of young people aged 16–19 are still in the
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school system where they received their drug education, and in many cases they are
no longer in settings covered by school surveys (many school surveys do not involve
the older age range). The significance of this for evaluating prevention increases if the
transition from schoolchild to young adult and from school to vocational training,
work or unemployment is itself an important risk (or protective) factor for drug use or
for increased consumption of a wider range of drugs.
In this respect, data on the age of first use of different drugs based on school-survey
data, for example among 15-year-olds, excludes by definition any initiation after that
age and can give a very misleading picture of the ages of first use and patterns of 
initiation in the population as a whole. This is especially true of drugs other than
cannabis. For example, in many countries, the most common age for initiation into
heroin or cocaine (amongst people who subsequently enter treatment) is around 19
or 20 or sometimes even older.
This presents serious problems in evaluating whether the drug prevention has any
longer-lasting impact on behaviour, either on an individual or on an aggregate basis.
Thus, most evaluation studies of changes in individuals rely on short-term or proxy
measures, such as knowledge and changes in attitude, perceptions of risk or the
expressed willingness to try drugs. Unless the evaluation design is longitudinal and
longer term, there is no way of knowing whether any relationship exists between
school-based prevention and various other factors, behaviours or attitudes measured
before the age of 16, and behaviour thereafter. Assuming that those who remain in
the school system are representative of those who do not begs the question of
whether or not school-based prevention has a protective effect on subsequent 
non-school behaviour. Nor does it take any account of whether leaving school is
itself a risk (or a protective) factor and if so under what circumstances. The same 
limitations hold for evaluations based on measures of drug use in school surveys of
young people above the ages of 15 or 16.
A further issue with implications for evaluating school-based prevention is whether
evaluations measure separately the impact of prevention on the highest-risk groups,
who by definition are most in need of prevention (although see the prevention
dilemma referred to above – it may already be too late), or whether global measures
are used that refer to the school population as a whole (or at least to those who
received the prevention). It is quite conceivable that prevention messages have least
effect, or even a negative effect, on those at highest risk, but their main impact is to
reinforce the non-drug attitudes of those at lower risk. The balance of the effects will
probably depend on whether the school concerned is in a high- or low-prevalence
setting, a factor that may also influence the nature of the risk factors identified. A 
special case involves how to influence truants, who are likely to constitute a
particularly high-risk group, but who are also likely to be absent both from drug-
prevention sessions and from school surveys that measure their behaviour.
There is no doubt that attempting to evaluate the impact of prevention is a formidable
task. The methodology required to analyse these complex issues is probably beyond
the resources of most evaluation designs. The corollary is that considerable caution
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should be exercised when reporting the results of any evaluation of school-based
prevention, especially when the data both on drug use and for evaluating prevention
are collected solely from those at school.
Conclusions: linking epidemiology, prevention and prevention research 
In conclusion, epidemiological analysis offers powerful tools for examining a simple
prevalence figure to tease out some of the complexity of the phenomenon, to identify
risk factors, risk groups and risk situations related to drug use, the development of
addiction and its consequences, to assess the relative costs of those consequences,
and to differentiate problems and processes that in turn imply differentiated responses.
Epidemiological analysis can contribute to the identification of emerging trends and
to the evaluation of interventions. It can also, although this has not been considered
here, offer models of drug use and drug problems relevant to developing a theoretical
framework to underpin prevention strategies, for example the question of whether
prevention should aim to reduce the level of drug use in the population as a whole,
or whether it should simply focus on high-risk groups.
It must be added, however, that this potential has often not been fully exploited and
even less commonly have the results been communicated in intelligible or useful
fashion to those who could use them. It should also be noted that information and
analysis of data at the national or European level provides a framework, but that
most value for practice is likely to be achieved at the local level through collaboration
between local policy-makers, researchers and practitioners. The potential may be
substantial, but so too is the task of realising that potential.
This chapter has also touched on how closer links could be established between
epidemiology and prevention, between research and practice. On a pragmatic level,
the way forward is to build in these links from the very beginning of any prevention
project – that is, to design interventions as multi-disciplinary efforts involving both
practitioners and researchers (including epidemiological researchers where relevant).
Conversely, relevant epidemiological studies should involve practitioners from an
early stage as both information providers and information users.
At another level, epidemiologists and researchers are responsible for making greater
efforts to render their information both intelligible to practitioners and accessible to
them in a way that they can use. Conversely, it is the responsibility of prevention
practitioners, especially perhaps those who hated mathematics at school, to accept
that practice is based on theory, whether implicit or explicit, and that both theory
and practice can be analysed constructively and evaluated using both quantitative
and qualitative evidence and methods. This involves more than just producing and
exchanging attractive and well-written booklets. It should also include face-to-face
encounters and joint projects where some of the mutual wariness of each other’s
roles and some of the barriers to communication can be resolved. This may be easier
to say than to do, but this is true of all partnerships.
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Introduction
he six workshops summarised here all took place at the ‘First European
Conference on the Evaluation of Drug Prevention’, held in Lisbon in March
1997. Further workshops discussed the draft of the EMCDDA’s Guidelines for
the Evaluation of Drug Prevention, but, as ‘work in progress’, these are not reported
on below.
The first workshop covered mass-media public-information campaigns and how they
can be used in the field of drug prevention. They were categorised in two ways: as a
monologue; and by the fact that many ‘speakers’ were involved in attracting the 
attention of the target group. The workshop developed a model of a mass-media 
campaign with four stages, ranging from initial contact with the message to its final
acceptance. The group felt that such communication could usefully complement 
traditional one-to-one prevention techniques, although it was crucial to evaluate them
adequately.
The second workshop discussed how prevention interventions can be constructed to
deal with synthetic drugs and their users. Because the use of ecstasy was such a
recent development, few interventions – many of which had been set up almost
overnight with little planning – had been fully evaluated. This local level of sponta-
neous prevention had also at times been reflected at the regional level, where find-
ings from earlier evaluations were not taken into account. Preventing synthetic drug
use, therefore, requires a strong base of evidential research, and young people’s
expectations of the form and content of preventive messages should be analysed on
an almost daily basis. Standard prevention techniques that stress controlling con-
sumption tend to be rejected by synthetic drug users, who generally view their drug
use as a ‘lifestyle choice’. Furthermore, synthetic drug use often takes place in social 
situations, while prevention is conventionally undertaken on a one-to-one basis. The
workshop concluded that, for these reasons, prevention strategies for this particular
target group need to focus on harm reduction rather than on primary prevention. 
The third workshop examined the issue of prevention and its evaluation in the com-
munity setting. It was quickly established that to avoid resistance to the programme
and doubts about its outcome, all those who could be affected by an intervention
should be involved in its implementation and evaluation. Programme-planners
should always be prepared to encounter problems when designing a community
strategy, as issues of participation, responsibility and transparency are never far from
the surface. This means that drawing up a timetable is essential, as is recognising the
often delicate balance of power that may exist between individual players.
Compromise is therefore the key to successful community working. The group also
discussed any ‘value-added’ objectives and agendas that different participants may
pursue in evaluating the intervention.
The fourth workshop tackled youth culture. It was felt that cultural influences were
too often ignored when planning prevention activities, creating a shortfall between
T
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the amount of time spent on the ‘message’ and the time spent on its intended ‘audi-
ence’. The problem is that those prevention activities that do define their target
groups in terms of lifestyle are normally difficult to evaluate. The workshop therefore
felt that more research needed to be carried out if a consideration of ‘youth culture’
was to be incorporated into basic prevention interventions, and to enable prevention
measures to be more subtly differentiated.
School-based prevention was the subject of the fifth workshop, which discussed the
issue as a natural, continuing part of the curriculum. It was accepted that since this
form of prevention should progress from non-specific primary prevention to more
targeted secondary prevention, it was very difficult to refer to any generic target
group, as different age groups had different needs. While the workshop felt that
schools were appropriate settings for educational prevention strategies, how to
develop those activities was open to debate. The relative involvement of teachers
and parents in a prevention intervention was discussed, and it was generally agreed
that it was difficult to convince teachers of the need for ‘global prevention’ in
schools, while parents are rarely involved in developing prevention strategies. Since
evaluation relates to the whole development process, it was agreed that a realistic
outcome measurement needed to be discussed in advance.
The sixth workshop looked at peer-led prevention. If young people are to heed a 
prevention initiative, it must be credible in their eyes, and peer-based programmes
may be the best way of ensuring this. As part primary prevention, part harm reduction,
such schemes are, however, resource-intensive. The controversy surrounding peer 
education was mirrored in the group’s discussions, with disagreement as to whether
drug users should be used as peer leaders and whether abstinent peers can deliver
effective harm-reduction messages. Some group members felt that peer-led prevention
helped increase knowledge, but had little effect on behavioural change. Others, 
however, saw sharing knowledge as a peripheral component of peer-group prevention. 
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Chaired by Jürgen Töppich
In his introductory presentation, Jürgen Töppich explained the characteristics of
mass-media communication before examining the process model of persuasive 
messages. This model is linked to the planning and evaluation stages of prevention
initiatives, and can be used to evaluate current mass-media campaigns.
Two essential features characterise mass-media communication: first, it involves a
one-way communication from a ‘sender’ to an anonymous ‘recipient’; and second,
many senders vie for the attention of the target audience.
According to the process model, mass-media communication involves four main stages:
• the recipient is physically contacted and exposed to the communication; 
• the recipient becomes aware of the message; 
• the recipient understands the message; and 
• the recipient accepts and absorbs it.
Ways of planning and evaluating mass-media campaigns can be derived from
these four stages. During planning, a major consideration is how to expose the
recipient to the message. This involves selecting appropriate media and channels
of communication, as well as assessing the frequency and intensity of exposure
to the message. In order to hold the recipient’s attention at the second stage, the
message must be attractive and appealing. Linguistic style and mode of 
expression, the scope of the message, and the quantity and depth of the 
information it contains are therefore highly relevant at the planning stage. The
logic and clarity of the argument, its credibility and any educational elements
must also be included in the planning process if the message is ultimately to be
accepted by the recipient.
Exposure to the message during the first stage must be evaluated, while attentiveness
during the second stage can be assessed using recall tests, depending on the length
of contact with and interest in the message. This may still not be enough, however,
to verify whether the message has been fully understood (the third stage). To verify
this, the recipient must be able to reproduce the content and substance. As a final
stage, the degree to which the message has been accepted must be evaluated by any
changes in or confirmation of intentions.
In the discussion that followed Töppich’s introduction, it emerged that one of the
problems identified with mass-media campaigns was that social groups other than
the target group may respond to the message and so confuse the evaluation.
Preliminary tests should thus be carried out to prevent unwanted reactions.
Workshops
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In order to reach the target group, appropriate media must be selected. Radio was 
considered a tried and tested means of reaching young people, while the target group
itself could help to evaluate the campaign by participating in a listener phone-in.
It was also seen as more difficult to define and assess the intended effects of a mass-
media campaign than when using face-to-face communication as measures, since
campaigns are frequently intended to encourage or support change.
Evaluating what would happen if no campaign was run was seen as good practice, and
the only way to ensure that the assumed effects of a campaign were not 
measured by time alone. The group considered a number of ways to approach this
evaluation problem. One solution was to compare the expected development (with no
campaign) with the actual development (with a campaign). Another was to 
compare two regions or countries (one with and one without a mass-media campaign).
As well as highlighting the problems of evaluation, specific mass-media campaigns
were provided as examples. One of these, the ‘stark statt süchtig’ (‘better strong than
addicted’) campaign from Vorarlberg, Austria, was judged to have successfully 
combined mass-media campaigns with face-to-face prevention.
In sum, mass-media campaigns were seen as important tools that could usefully
complement face-to-face prevention. However, verifying the effectiveness, and
therefore evaluating, a campaign was also considered vitally important.
Ecstasy and other synthetic drugs 
Chaired by Roger Lewis and Jim Sherval
By way of introduction, Roger Lewis and Jim Sherval discussed their involvement in
an EMCDDA project to review ecstasy-related interventions in Europe and their eval-
uation.1 Lewis and Sherval also provided a brief definition of the term ‘synthetic
drugs’: psychoactive substances artificially produced in laboratories from chemical
raw materials (precursors) rather than from natural products. In this instance, the
term refers to ecstasy and its analogues, amphetamines and LSD.
In the subsequent discussion, it was asked whether preventive measures should be
geared towards events associated with the drug scene, or whether they should be
more broadly based. A number of participants felt that the media indirectly encour-
aged the use of synthetic drugs, as young people often do not believe what is 
reported about drugs. The irrational, knee-jerk reaction of many politicians to the
ecstasy phenomenon was also criticised.
Because ecstasy had spread unpredictably and rapidly, low-level projects had been
established relatively spontaneously without built-in evaluation. Many programmes
had yet to be evaluated at a higher level. Sometimes, badly planned and poorly
1 This project formed the basis for part of the EMCDDA’s publication, New Trends in Synthetic Drugs in
the European Union (Insights Series, No. 1).
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designed measures had been implemented at the regional level, without taking 
sufficient account of findings from earlier preventive and evaluative research. Often,
no primary-prevention measures had been taken in the early stages of the ecstasy
phenomenon because the emerging use of synthetic drugs seemed not only to be
containable within an integrated society, but also socially less conspicuous than, for
example, heroin use. Although some medical advice had been given, this had not
been evaluated either.
Evidence of the ecstasy phenomenon was beginning to emerge in areas that had
previously experienced no problems. While the use of this type of drug had now
become the subject of primary prevention, little still seemed to be known about ecstasy
users. Several studies have revealed that ecstasy users are not in fact a completely new
target group, but are also usually cannabis users. Ecstasy users had been involved in
developing earlier initiatives, and one view was that preventing ecstasy use, compared
to other substances, posed no specific problem. What was new, however, was that
ecstasy was seen as fun and enjoyable by its consumers and often not as a ‘drug’ at all.
How youth culture could be influenced was also discussed. Despite differences
between countries, the ecstasy culture has acquired a degree of uniformity in much
of Europe through music, radio, video and other events. Effective prevention, 
therefore, requires researchers to analyse young people’s expectations on an almost
daily basis – in the same way that promoters of new drug-related styles do – given
that these expectations are constantly changing. This ongoing analysis could form
part of a strategy of better communication with ecstasy users. They often know when
to stop using the drug, a decision generally linked to poor work performance and a
loss of enjoyment associated with excessive consumption. 
In this context, the group also discussed what messages had been found to provide 
useful prevention information. Since such messages normally entail controlling con-
sumption, those relating to synthetic drugs were often rejected by the target group.
Another dilemma is that consumption often takes place in social situations, whereas
prevention tends to occur on an individual basis. For these reasons, strategies should
now be geared towards harm reduction rather than primary prevention.
The dynamics of harm reduction and primary prevention were repeatedly discussed.
At what point is a certain level of consumption acceptable, if ever? It was agreed that
it is important to find out what matters to young people, so that appropriate action
can be taken. A shift from primary prevention towards harm reduction was felt to be
visible across the spectrum, from high-level politics to on-the-spot measures.
Work in the community
Chaired by Fernando Bertolotto
In his introduction, Fernando Bertolotto stressed the need to involve all concerned
in a prevention initiative in its implementation and evaluation. This would help to
prevent any resistance to the work or doubts about its outcome. Working in the
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community also means involving non-experts, something which may alarm the experts.
The problems that arise in such situations relate above all to issues of 
participation, responsibility and transparency.
As a result, some convergence of opinion must be sought amongst all the 
community players. It is also important to remember that when working in the commu-
nity, setbacks will occur and the project may at times come to a complete standstill. It is
therefore essential to create a timetable. Recognising the balance of power between indi-
vidual players is likewise vital, and allowances have to be made to ensure the project’s
success. Thus, when working in the community, compromise is always necessary.
Members of the community will be all too aware that evaluating the work is linked to
programme funding. Regardless of the actual outcome, evaluation therefore also
depends on the commissioning body’s agenda. In the case of drug prevention, a kind
of ‘social compromise’ is often arrived at between funders and implementers. This 
represents a prior agreement on the general outcomes that cannot be compared to 
scientifically based results. Evaluation, however, should be seen as a continuing part of
the process, not as a retrospective assessment.
In the discussion that followed, it was proposed that working in the community is only
possible if the programme’s objectives are perfectly clear and do not conflict with the
individual’s work. Setting prior goals is essential, as most programmes still have no clear
objectives in terms of their target groups or outcomes.
Community work is rarely rational and tends to be influenced by emotion. As a result,
scientifically objective criteria cannot always be applied. Evaluation has to take full
account of this subjectivity, and not merely apply and implement statistical techniques.
Neglecting this aspect could have far-reaching implications for future cooperation in
that particular community.
Another view was whether evaluation should focus purely on technical issues, such as
process, outcome, demand reduction or dependency. Evaluation can be carried out at a
conceptual level, taking into account ideological aspects, such as cultural, ethical or
moral values. 
The difference between the design of a prevention programme and its actual 
implementation was pointed out. While the programme must have a strong scientific
basis, its implementation in the community must be geared to that community’s 
specific problems. Creating and sustaining the motivation to undertake the programme
is a highly complex process, but all those involved – be they politicians, the public or
the administrative authority – must share that motivation. It is therefore necessary to
involve all concerned, because everyone is needed to carry out the project as a whole.
It was also mentioned that, in some circumstances, the various groups involved pursue
different objectives to those laid down by the programme. These ‘value-added’ 
objectives should also be included in the evaluation.
It was felt that the ultimate objective of community-based initiatives is always difficult to
define, since it is impossible to determine in advance whether a reduction in demand or
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an increase in community safety could be achieved in any other way. It may be easier
to evaluate the outcome in a single setting, such as a school or home, but the problem
is far more complex in an unbounded community. The community is thus a far-from-
ideal setting for evaluation, since it is heterogeneous and subject to constant changes in
time and place. Owing to the large number of players and participants involved, change
is only possible in the very long term. Regarding organisational development, the only
way to achieve change is to pursue a bottom-up strategy rather than a top-down one.
However, one- or two-year funding arrangements do not allow for long-term planning,
even though it would take 10–15 years to achieve any real change.
Another difficulty this group identified is that prevention programmes are frequently
commissioned by people who are not part of the community at all. It is therefore impor-
tant to involve community members in the process so that they can accept some
responsibility for, and not undermine, the work. The same applies to the evaluation. In
the community, many unforeseen factors prompt constant change, including changes
to the programme. Evaluation in the community, therefore, must always be related to
the process as an intermediate variable.
Youth subcultures
Chaired by Alfred Springer
In his opening presentation, Alfred Springer introduced four areas for discussion:
• special features of prevention interventions in the ‘youth-culture’ setting;
• characteristics of evaluation in this area (for example, special methods of data
collection);
• features of process evaluation; and
• the evaluation of results.
Incorporating subcultural lifestyle patterns into everyday culture is perhaps the most
fundamental problem when addressing youth culture. The sociocultural level of
influence is all too often neglected in planning and developing drug-prevention 
campaigns. One of the main weaknesses of current prevention work is that the 
primary interest at stake is the message itself, its content and how it is presented. On the
other hand, too little attention is focused on the senders and recipients of that message.
The workshop examined various levels of preventive work within the area of youth
culture. Many of these initiatives define their target groups in terms of culture or
lifestyles, and are therefore difficult to evaluate. Some non-specific, school-based 
primary preventions also take youth culture into account. Research into different
media should be included in the catalogue of basic prevention-research disciplines,
and the drug-related aspect of youth-oriented media must be thoroughly investigated.
At the start of the discussion, the term ‘subculture’ was abandoned in favour of
‘lifestyle’, which it was felt could be described with a whole range of associative
symbols, such as music, clothing, magazines and so on.
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The point was made that as the ‘techno/rave‘ scene was highly differentiated, how
should prevention projects approach such a disparate array of target groups? It was 
proposed that youth culture should be regarded as a ‘free space’ which should not 
simply be taken away from the young. The workshop saw drug misuse as an actual 
stabilising factor in youth culture – it would be an entirely new concept in drug
prevention if it were implemented only in places where young people were not at risk.
It was further argued that risk-taking was a feature of adolescence and that prevention
would therefore have to set standards and impart values. It was emphasised, however,
that primary prevention was essential to ensure that drug culture did not completely
take over youth culture.
It was agreed that identifying trends was a further problem faced by research in this area.
In some cases, too much attention had been focused on developments that were not
actually trends (ecstasy use, for example).
Setting up international studies to compare youth cultures was also discussed. It was
observed that there are extremely significant differences between national youth 
cultures, with youth lifestyle playing a greater role in, say, the UK than in Sweden.
Furthermore, it was emphasised that the aim of prevention was to help young 
people overcome difficulties. An important, hitherto neglected strategy for doing so was
to ask young people what they needed in order to cope with the risks. In this way, a
basis for both prevention and evaluation could be created.
In conclusion, there was a call for preventive measures to be more subtly differentiated.
Previous findings should be used and future measures devised in such a way that state-
ments can be made about specific aspects of prevention among youth cultures.
School involvement
Chaired by Michel Orban
After briefly outlining his experience in the field of primary prevention, Michel
Orban discussed how prevention can be undertaken with different age groups. The
prevention activity should be seen as an integral part of the school curriculum, 
progressing from non-specific primary prevention to more targeted secondary 
prevention. It is therefore impossible to refer to any specific ‘target group’, since 
different age groups require different programmes.
The success of a school project largely depends on whether teachers support the idea
of a prevention programme. As the people best suited to undertake the work, they are
initially the most important intermediate target group. While external health-education
staff can also be involved in this process, teachers should deal with it first, since they
are involved in the general process of education. Professional experts could in turn train
and supervise the teachers to allow the intervention to be extended to the final target
group – the pupils.
In general, the group felt that the school was a good place for a comprehensive,
educational, prevention strategy. As well as providing straightforward information, this
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approach includes developing children’s psychosocial skills, as prevention should not
just be aimed at drug use, but at all deviant behaviour. As people of trust, teachers can
also offer guidance in personal development. To date, however, it has proved difficult
to convince teachers that ‘global prevention’ in schools could also correct other forms
of deviant behaviour.
A school’s demand for a prevention intervention is invariably linked to the urgency
of the school’s drug problem. At present, however, parents tend not to be involved
in the discussions that lead to a call for prevention, and they are seldom mentioned
as a target group.
A possible reason for this is that young people do not wish to talk about their problems
with adults, especially their parents. The family structure is changing so much that it is
becoming increasingly difficult for parents and children to understand one another.
Hence the need for mediators who can pass on messages and explain concerns. It was
suggested that the pupils themselves should choose these ‘mediating people of trust’.
However, it must be remembered that many teachers are unable to distance them-
selves from their pupils’ problems and can thus react rather like parents. 
Since parents are not formally involved in the education process, under certain 
conditions they might oppose the implementation of a prevention programme.
Parent involvement was discussed, and although it was favoured, it was felt that in
some cases pupils might not want their parents to be involved in their problems.
All the factors that might facilitate or impede the planning, implementation and 
evaluation of a programme must be considered. It is extremely important to ascertain
whether the programme can be incorporated into the normal curriculum and whether
it can be co-ordinated with other school projects. Moreover, a positive climate in the
school was seen as vital for promoting the programme. Another important, but often
overlooked, issue in prevention planning is the institutional arrangements for the 
programme, such as the size of the class.
School development – changing both the institution as a whole and the individuals
within it – is a lengthy process which cannot be accomplished in a few days. Merely
introducing a prevention programme is a complex matter, and it is not always 
possible to give funding bodies any absolute measurement of the programme’s effect.
The evaluation of school-based prevention activities relates not just to the effects 
actually achieved, but to the whole process of development. It was accordingly felt
that a realistic outcome measurement should be discussed in advance.
Peer-group approaches
Chaired by Michael Shiner
Michael Shiner emphasised that credibility was the most important element in 
making young people take notice of a prevention programme, and that peer-led 
initiatives were the most likely form of initiative to succeed. These initiatives should
be viewed as part primary prevention, part harm reduction. However, process 
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evaluation has revealed that such an intensive approach is costly in terms of
resources, particularly time and support.
The group discussed whether drug users should be used as peer leaders, and the
involvement of ex-users was regarded as a problem. They might either directly or
indirectly convey the impression that giving up drugs is ‘no big deal’ and that life
could be lived to the full before giving up. The complex interaction between the 
personality of the peer leader and the message being put across was also recognised.
Some of the group felt that harm-reduction messages delivered by abstinent peers
was highly questionable.
However, this was countered with reference to psychotherapy research, which has
found that abstinent peers can be used to convey primary-prevention messages 
effectively. It was also felt that attention should be focused on the interests of the 
target group rather than on the interests of those working towards prevention – people
who had no experience of drugs would often have little credibility with the young.
However, one participant reported rather negative experiences of using peers as 
leaders: they were poor listeners and unable to communicate their message 
effectively. It was therefore preferable for them to support the intervention leaders than
to take the lead themselves, particularly during the planning stage.
The issues of selecting and training peers were also raised. One view was that if
training was so expensive, it may in fact be cheaper to send the members of the 
target group who are most at risk on a suitable one-week course. But it was also felt
that, if properly planned, costs could be reduced.
Peers should not be defined in terms of use or abstinence, but rather in terms of 
attitude, dress code and age. The involvement of drug users was not essential.
Instead, it was felt that the emphasis should be placed on experiences and 
personality, not on the pharmaceutical properties of drugs. However, whether a peer
leader was for or against drug use was, of course, important.
Why young people would believe a peer was also discussed, as was the position of
the peers among their own contemporaries and friends. There were also felt to be
ethical problems with requests for teachers not to be present, and a related issue was
that the expectations of programme-developers did not always match the actual
message which the target group received.
Some members of the group felt that using peers increased knowledge, but did not
change attitudes or behaviour. However, another participant reported some success
in terms of behaviour – abstainers were often strengthened in their resolve –
although no change was evident in the case of socially integrated drug users. As for
the content of the programme, some participants felt that knowledge was not an
absolutely essential component. But others felt that knowledge could be important,
since young people have to contend with much uncertainty and many untruths.
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he last working session of the ‘First European Conference on the Evaluation
of Drug Prevention’ was introduced by a roundtable discussion entitled
‘How to Promote Evaluation Practice in Europe?’.
Michaela Schreiber, from Germany’s Federal Ministry of Health, chaired the 
discussion and introduced the other participants:
• Wim Buisman, Manager of International Programmes, Jellinek Consultancy,
Amsterdam, and Director of the European Addiction Training Institute,
Amsterdam.
• Armand Wagner, Luxembourg Ministry of Health, and Member of the EMCDDA
Management Board.
• Véronique Wasbauer, European Commission, Directorate General V, Brussels.
• Alan Lopez, Programme on Substance Abuse, World Health Organisation,
Geneva.
• Enrico Tempesta, Permanent Observatory on Young People and Alcohol, Rome.
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How can drug professionals interest politicians in evaluation? 
How can evaluation help with the daily allocation of funds? 
How can policy-makers be supported in their discussions? 
Buisman was not optimistic about the benefits of presenting the results of evalua-
tions to politicians. Persuading policy-makers of the importance of drug prevention
must take their own position into account, and the media can play a major role in
doing so. Emphasising the whole picture, not just focusing on the drug users, is
equally important. If 1% of young people in Europe use drugs, then 99% do not,
and whether this can be presented as a success or not must be taken into account.
Wagner referred to his daily experience of politicians at the Luxembourg Ministry of
Health and understood why drug professionals complain about politicians. This
complaint is based on inconsistencies between politicians’ public statements and
their actions, a lack of understanding of the drug professional’s work and a lack of
financial support for long-term activities. Drug professionals for their part, however,
should also try to ‘understand’ politicians.
Evaluating drug-prevention activities is of more interest to professionals and the 
general public than to politicians, as it allows the professional to step back from and
reflect on daily practice. However, the differences between politicians at the local,
national and European level should not be forgotten, and while budgetary choices
reflect political decisions, drug professionals are in a position actively to seek funds.
Drug-prevention activities should help develop positive approaches to life and make
parents and teachers more aware of the fundamental problem of drugs. Ultimately,
the public should be more directly involved.
Wasbauer felt that, above all, the aim of evaluation has to be clearly defined.
Evaluation is about more than just justifying funding – it should first of all support
the professionals working in the drug-prevention field. It is therefore important to
distinguish between qualitative improvements in evaluation and their institutional or
political justification. In fact, measuring the costs of non-intervention – as has been
done with the European Commission – can bring home to politicians the importance
of prevention activities.
Just as politicians need to be told about the impact of measures they have already
taken, they need information to help them make decisions about measures to take
in the future. They should therefore be informed clearly and concisely about the
intermediate and final objectives of prevention.
A core issue in budgetary discussions is the cost-effectiveness of a strategy. The lack
of information about this aspect can only be damaging, as, in the final analysis,
politicians have to answer to their electorate. As Eurobarometer surveys demon-
strate, the electorate is largely in favour of repressive measures. Perhaps drug 
professionals should try to influence the opinions of the European public?
Roundtable
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Lopez agreed that politicians need to know what works, under what conditions and
at what cost. Policies and programmes must be founded on good science, and politi-
cians’ ability to understand good science should not be underestimated.
Evidence should be clearly presented and unambiguous. Politicians should also
know the benchmarks against which prevention evaluation is measured. Equally,
policy-makers need to know what does not work. For example, prevention activities
have often been carried out which have not been shown to have a positive outcome,
especially regarding tobacco control.
A culture of positivism needs to be instilled around a combination of different 
prevention measures (‘a prevention cocktail’), which may work better than one 
measure alone. Such a cocktail may also be politically more acceptable.
Tempesta saw the relationship between policy and drug use as very complex, a 
complexity which is often encouraged by politicians. In some cases, too many 
prevention programmes have received significant funds without changing attitudes,
and this has left politicians disillusioned. As a result, in Italy at least, the general 
attitude is to leave drug users well alone.
Policies, however, are now more oriented towards local and regional interventions.
The scientific world, therefore, has to elaborate community interventions using
research knowledge which can be adapted and evaluated at the local level.
The Chair commented that all those on the panel make political decisions them-
selves by influencing prevention decisions. The issue seems to be whether global
aspects or good evaluative practice is used to influence politicians.
Buisman supported Lopez’s approach and Wasbauer’s first statement. Does it make
sense to provide politicians with evaluation results? Sometimes it seems that even
with this knowledge politicians make the wrong decisions – in the Netherlands, the
Minister of Health is increasing the budget for mass-media anti-smoking campaigns
even though evaluation shows that the last campaign failed.
Reactions from the floor were that the current situation is too confusing for 
decision-makers. The problem may not be so much one of evaluation, but of the
speed with which the drug problem evolves. David Turner (International Council on
Alcohol and Addictions) felt that there was a danger in speaking of politicians, as
all participants are ‘politicians’ in their own field. Reducing the issue to a 
discussion between experts and politicians is not enough – the community and 
target groups should also be involved. Life is not rational, so all involved should be
‘politicians’, and be modest in their attempts at evaluation. Finally, scientists do not
only have to bring new knowledge to decision-makers; decision-makers also have
to look for new science.
In conclusion, it was agreed that politicians appear to be motivated – as proved by
many political programmes on prevention and evaluation – but they are not suffi-
ciently informed and do not always act on the information they have received.
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How can duplication between institutions be avoided? 
How can evaluation results be used by practitioners?
Tempesta pointed out that in Italy, centrally directed school programmes have
received funding for a long time. Only in the 1990s did financial resources begin to
be allocated to regional, local and city governments. This generated a great many ini-
tiatives, and the general public became aware of the scale of the drug problem. Thus,
facing up to drug misuse has to be seen in the community context – how can 
experience and local creativity be made more widely available? This context is 
fundamental, and is also valid at the European level. A programme carried out in
three European cities to examine people’s attitudes towards alcohol found different
views in each city.
Lopez believed that the issue is one of ‘operationalising’ prevention research. Results
need to be communicated scientifically, as there are many prevention outcomes
(changes in attitudes, increased personal resources, higher age of initiation into drug
use, shortening the careers of drug users). From the public-health point of view, 
prevention evaluation should focus on behavioural change.
Other organisations such as the World Health Organisation should also be lobbied
to help instil a culture of monitoring. Institutions are often asked about what works,
but it is difficult to find actual evaluation results. The Programme on Substance
Abuse, for instance, attempts to instil a culture of monitoring and evaluation in every
project it supports, and it favours approaches that involve both project-funders and
project-operators. By involving them from the start, any fears felt by the operators
can be addressed.
Buisman pointed out that before discussing the need to avoid duplication and improve
co-ordination, what it was that needed to be co-ordinated should be identified.
There should first be more consensus on the theoretical base, while not forgetting that
although programme development has been greatly emphasised, programme implemen-
tation has received little attention, and without implementation there is no evaluation.
Furthermore, no long-term or follow-up studies are being carried out in Europe.
Concentrating on behavioural change is a challenge, but it is also problematic.
Practitioners and researchers should therefore co-operate more. 
Trying to avoid duplication and enforcing co-operation is precisely one of the tasks of
the EMCDDA, and the European Commission and other funding bodies can also avoid
duplicating their efforts. One possible co-operative venture could actually result from
this Conference itself – the establishment of a European Society of Drug Prevention
made up of the Conference participants.
Wagner agreed that more co-ordination is necessary, especially at the European
Commission level, where a dozen Directorates General are involved in drug issues. In
general, the European prevention sector could be much more effective if it adopted
long-term approaches and coherent evaluation.
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Reactions from the floor were that evaluation is a very heterogeneous concept which
has to be clearly defined – for instance, behavioural-oriented efficacy studies are
very different from quality control in a small programme. The current state of knowl-
edge of prevention and evaluative research is very difficult to assess. Perhaps the
EMCDDA should attempt to do so with a public, peer-reviewed competition to gain
an overview of past and present actions.
In conclusion, the need for increased co-operation and the flow of reliable 
information between researchers, practitioners and international organisations was
generally recognised. Suggestions for improved co-operation included focusing on
behavioural change, theoretical consensus and monitoring evaluation.
What is the EMCDDA’s role in this field? 
Are the first steps taken by the EMCDDA with the publication 
of the Guidelines for the Evaluation of Drug Prevention important, 
and should they be continued?
Wasbauer said that the EMCDDA’s mandate is to collect and disseminate 
information about evaluation and its results in Europe, including transnational 
evaluation projects financed by the European Community’s prevention programme.
This is a long-term process and the current Guidelines for the Evaluation of Drug
Prevention and this Conference are just one aspect of it. They should be applicable
to different settings and practices, and answer the question of how drug 
professionals can be convinced of the need for evaluation.
Lopez saw the Conference as a very valuable first step. Establishing common guide-
lines makes sense, as normative standards are needed, just as in other fields. The
EMCDDA should have a ‘clearing-house’ function, acting as a repository for 
information and promoting training in evaluating prevention. The Centre can also
help countries to get the science right, advise on what outcomes to measure and
help to define the appropriate conceptual framework for evaluation. Essentially, the
EMCDDA can play a critical role as a catalyst in forging intellectual partnerships,
investing in epidemiological methods and promoting the view that prevention
research is part of the epidemiological continuum.
Tempesta believed that the EMCDDA should be the production centre for the spread
of a culture of prevention through the National Focal Points. The Guidelines should
be translated into each country’s language so that all actors can familiarise them-
selves with the evaluation concept.
Wagner was satisfied that the EMCDDA was playing an active role in diffusing infor-
mation on evaluation approaches in Europe. Progressively reliable data are being
transmitted at the European level, but a problem remains in that the EMCDDA’s 
mandate only mentions illicit drugs, whereas most prevention activities deal with
dependence diseases.
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Conclusion
In conclusion, it was agreed that the EMCDDA has a key role to play in collecting
and disseminating information about evaluation and its results in Europe. As such, it
should act as a catalyst for promoting partnerships, training and good practice. 
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his monograph has traced the history and general characteristics of drug-
prevention evaluation, as well as its technical and practical elements. It has
given some major examples of evaluation research, as well as information
about the methods and instruments used. In addition, the workshop reports illustrate
the use to which the EMCDDA Guidelines for the Evaluation of Drug Prevention can
be put in the most common settings for drug prevention – schools, mass media,
youth groups, the community and peer groups – and regarding synthetic drugs. The
summary of the roundtable held at the end of the Conference highlights the major
issues raised in the discussion on how to promote evaluation in Europe. Some
important conclusions can be drawn from this work and from the Conference itself.
Evaluation is necessary
The level of accurate evaluation in Europe is still low. Yet current knowledge about
prevention and how it works has only been gained through thorough evaluation
studies. As large-scale preventive activities are implemented more and more in
Europe, it is becoming increasingly necessary to evaluate them. Owing to this close
link between prevention practice and research into drugs, evaluation within a 
programme structure should be an integral part of daily work, not a specialist task.
Scientific advances must be communicated to practitioners in a way that they under-
stand and are able to use. While prevention research has made good progress in
developing and testing new models for family, school and community-based 
programmes, evaluation studies are still required to validate these programmes and
to test various ways of putting them into practice. 
Barriers have to be overcome
Among the barriers that need to be overcome are the fear of negative or 
unexpected results. These fears, however, should be seen rather as challenges and
cornerstones for further improving programmes, since identifying a programme’s
weaknesses is just as important as identifying its strengths.
The central challenge for drug professionals is to convince politicians of the need for
evaluation, and the European Union can play a key role in this. Its institutions can
become a forum in which to agree a set of evaluation standards. This monograph
itself, and the accompanying Guidelines for the Evaluation of Drug Prevention, are
successful examples of the European effort to promote such a strategy. Co-operating
with research institutes and universities, as well as co-ordinating various programmes,
can reduce the costs of investing in evaluation.
Conclusions
T
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Evaluation is more than just assessing the outcomes of interventions
Outcome evaluation (results) is important, but process evaluation (the ‘how‘ and
‘why‘ certain results are obtained) is even more so. The need to strike a balance
between the two has been underlined in this monograph, since outcome cannot be
interpreted effectively without sound information on processes. Process evaluation
is necessary for improving prevention and providing feedback to those involved. 
Evaluation must be thoroughly planned
In any evaluation, it is essential to involve all the actors from the planning stage to
the dissemination of the results, as transparency is a key issue at all stages. This is 
especially true for community prevention programmes. Since different actors have 
different agendas, defining goals and processes involves constant negotiation. In
cases where an evaluation has not been planned and agreed by all the evaluators,
the process will be disturbed. From the beginning, evaluation calls for public 
relations and communication skills: as evaluation is a tool to improve and develop
future preventive work, it is essential that people accept it and pay attention to its
recommendations.
Evaluation helps to structure preventive strategies and to enhance 
their impact
Every prevention programme has a theoretical background, if only in the mind of the
programme-planner. Experts in the field have demonstrated that, if these theories are
sound, they may not only provide a framework for understanding health behaviour,
but also help to define the outcome of drug-prevention efforts. In turn, if 
implemented properly, these efforts may increase knowledge, enhance social norms
and attitudes opposed to drug use, increase social skills and eventually decrease
drug consumption.
A need to develop methods
Purely experimental designs for scientific evaluation have proved to be inadequate
in practice and do not provide sufficient information on policy-relevant issues.
Instead, qualitative and quantitative methods should be combined, provided that the
results can be generalised and their validity ensured. Prevention programmes based
on theoretical models that involve analysing mediating variables help in interpreting
outcomes and improving the intervention.
Evaluation instruments required
Standardised evaluation instruments are essential, and the reliability and validity
of these tools is the key to sound results. Reliable instruments do exist, but evalu-
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ators need to use them properly. The contributors noted that evaluation instruments
are often invented for, and geared to, specific studies, which makes comparison
across projects difficult. Special instruments for process evaluation are important,
because assessing the quality of a programme’s implementation is highly relevant for
its success.
The role of epidemiology
Developing a partnership between epidemiology and prevention is another key
requirement. It is acknowledged that the science of epidemiology provides instru-
ments for evaluation and for measuring outcomes, and can also help prevention
experts to define problems, needs, objectives and target groups. However, epidemi-
ological indicators cannot always keep pace with the needs of prevention experts,
who are often called upon to respond to situations urgently. In this context, the 
challenge for epidemiologists is to identify new trends and problems in a way that
enables prevention experts to respond rapidly. 
Economic considerations
Economic evaluation has been seen as a necessary, but sometimes unwelcome,
addition to other forms of evaluation. Estimating the costs and benefits of interven-
tions in monetary terms is difficult, and efforts should continue to help calculate the
value of outcomes. In all countries, the resources available for drug prevention are
limited and both programme-providers and funders are keen to get value for money.
However, the success or failure of a prevention may only become apparent many
years later, and it is therefore very difficult to measure in economic terms.
The major problem in this area is the lack of a body of evidence, but even with the
little data that exist, ongoing preliminary work should be undertaken so that major
economic issues can at least be established. Economic evaluation must be made
more accessible and its advantages as a tool for making more explicit policy 
choices demonstrated. Adequate economic measures suitable for drug-prevention
programmes must therefore be developed.
Practical aspects of evaluating special preventive approaches
Mass-media preventions
Evaluating mass-media prevention should focus on how the recipient is exposed to
the message (its frequency and intensity), its attractiveness and appeal, as well as on
the recipients’ attentiveness and interest in the message. To verify whether it has
been understood, the content and substance must be reproduced by the target
group. Finally, whether or not the message has been accepted must be evaluated
through any changes or confirmation of intentions.
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Community interventions
In evaluating community interventions, scientifically objective criteria are not
always applicable since much of the work in a community is affected by subjective
factors and is rarely rational. This makes it more difficult simply to apply and imple-
ment scientific methodology and statistical techniques. Implementing a prevention
programme in a community should be geared to the specific situation of that com-
munity. In evaluating community interventions, it is essential that features such as
cultural, ethical or moral values are assessed.
Youth culture
In evaluating prevention in the context of youth culture, it is important to ask young
people what they feel they need to help them cope with the risks they perceive in
their daily life, since the aim of prevention is to help young people overcome diffi-
culties.
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